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ABSTRACT 
The genus Mycobacterium represents a complex family containing a number of clinically 
significant pathogens such as Mycobacterium ulcerans, Mycobacterium leprae and 
Mycobacterium tuberculosis (Mtb), the latter known to be the etiological agent of tuberculosis 
(TB). TB remains a global health issue, claiming approximately two million lives annually, with 
much of this burden being carried in the developing world in countries such as India and South 
Africa. The emergence of drug-resistant strains of Mtb and the synergistic relationship between 
TB and HIV/AIDS has crippled efforts to eradicate this disease by rendering many of the current 
therapeutics ineffective. This has created an urgent need for new drugs with novel modes of action 
and in this regard, peptidoglycan (PG)-associated enzymes constitute attractive targets for drug 
development. This study focused on a group of PG hydrolysing enzymes, the N-acetylmuramyl-L-
alanine amidases (amidases), which have been linked to a number of essential cellular processes 
including cell division, antibiotic tolerance and pathogenicity in other organisms. Using the gene 
sequences of previously characterised cell wall amidases as queries, our bioinformatics analysis 
revealed that Mtb and Mycobacterium smegmatis contained 4 amidases, designated ami1-ami4. 
Analysis of an ami1 deficient M. smegmatis strain highlighted a role for this enzyme in cell 
division, cell elongation, cell shape maintenance and antibiotic tolerance. Deletion of ami1 resulted 
in the formation of chains consisting of 3 to 8 cells in approximately 20 % of the bacterial 
population assessed. Growth in these chains was characterised by ectopic mis-localisation of 
DivIVA, which resulted in the formation of lateral branches and Y-formed cell division. Single-
cell localisation of the -sliding clamp (DnaN) and ParB, required for chromosome segregation, 
revealed that these ectopic branches were able to coordinate chromosome replication and 
partitioning. Additionally, increased cell permeability was noted in the ∆ami1 strain, which was 
associated with increased antibiotic susceptibility. These cell division defects were not observed 
in the Mtb ∆ami1 mutant. However, in this case, lateral growth appendages were observed under 
nutrient limited conditions. Deletion of ami1 in Mtb also resulted in a reduction in bacterial 
persistence upon challenge with isoniazid. In contrast, loss of ami4 in Mtb did not appear to have 
an impact on bacterial growth or survival rather, the mutant displayed increased survival under 
oxidative stress. The ami2 gene has been predicted to be essential, a hypothesis that was confirmed 
herein through the generation of a merodiploid strain wherein ami2 could be deleted. As such, 
characterisation of the role of Ami2 was conducted using a previously generated gene depletion 
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strain. Depletion of Ami2 resulted in retarded growth, altered colony morphology, defective 
sliding motility, the formation of short cells and cells which contain bulges at the pole. Single-cell 
time lapse microscopy revealed that depletion of ami2 resulted in cessation of growth. Analysis of 
the localisation pattern of Ami2 revealed a polar localisation pattern, confirming a role for this 
enzyme in bacterial elongation. Collectively, these data highlight novel, specialist functions for 
mycobacterial amidases in cell elongation and division. The essentiality of Ami2 for mycobacterial 
growth also validates this enzyme as a possible drug target for TB.   
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NOMENCLATURE  
Δ   : Delta 
µ  : Micro  
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1 The Tuberculosis (TB) Epidemic 
1.1 Mankind’s TB history 
Throughout the existence of humanity, there has always been an invisible threat to the livelihood 
and survival of the race in the form of infectious diseases caused by fungi, viral agents or bacteria. 
This is evident by the numerous epidemics and pandemics, which have plagued mankind at one 
point or another (Karlen, 1996, Gottfried, 2010, Patterson and Pyle, 1991). Two such documented 
historic epidemics include the bubonic plague and the Spanish flu, which individually wreaked 
havoc in Europe in the 1300s and 1918-1920, respectively (Gottfried, 2010, Patterson and Pyle, 
1991). Though these ultimately claimed millions of lives, both were cured and today remain 
effectively eliminated (Patterson and Pyle, 1991, Gottfried, 2010). In recent times, the emergence 
of the HIV/AIDS epidemic has garnered much attention as the latest in a long line of persistent 
threats. As before, humankind has managed to respond to these threats by mobilising global 
resources and cooperation. However, tuberculosis (TB) stands out as the one disease which has 
persisted throughout human history, with little hope of eradication. 
TB, which is caused by infection with the bacterial agent Mycobacterium tuberculosis (Mtb), is an 
extremely successful infectious disease, which still claims approximately 1.5 million lives 
annually (WHO, 2016a). Early evidence of this disease has been confirmed through DNA analysis 
of bone samples belonging to the pre-pottery Neolithic civilisation, dating back 9 000 years 
(Hershkovitz et al., 2008). Furthermore, analysis of fauna from the Pleistocene age has indicated 
the presence of corrosive TB-type disease, suggesting the possible existence of TB for more than 
20 000 years (Rothschild and Martin, 2003). These studies support the hypothesis that Mtb has co-
evolved with human kind over centuries, which contributes towards its success as a pathogen today 
(Hershkovitz et al., 2008, Rothschild and Martin, 2003). One of the contributing factors to the 
current global burden of TB is the ability of the tubercle bacillus to generate diverse clinical 
outcomes in patients, ranging from active disease to latent infection (Lin and Flynn, 2010). Latent 
infection is an asymptomatic form of TB wherein the bacteria have been hypothesised to remain 
quiescent in the host, until conditions become favourable for growth. An example of this would be 
compromised host immunity (Lin and Flynn, 2010, Wayne, 1994). However, this hypothesis has 
been recently challenged by emerging data that suggest a dynamic host immune response during 
latent infection, suggesting that this form of disease is the result of a complex interplay between 
the bacterium and the host (Barry et al., 2009). Furthermore, the responsiveness of latently infected 
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individuals to isoniazid therapy also points to dynamic growth heterogeneity in the prevailing 
bacteria during latent infection (Semu et al., 2017). 
Despite decades of effort to control TB through the use of combination chemotherapy and 
sanatoria, the World Health Organisation (WHO) was compelled to declare TB a global health 
emergency in 1993 (WHO, 2016a). This lead to increased basic and translational research and the 
introduction of policies, such as the directly observed treatment short course (DOTS), which aided 
in curbing the epidemic throughout the world (WHO, 2016a).  Though globally successful, these 
policies have not had the desired effect in developing countries, primarily Africa and some parts 
of Asia, where the TB burden still remains unacceptably high (WHO, 2016a, WHO, 2016b). This 
can be attributed to a number of factors including a lack of infrastructure, shortage of trained staff, 
poor diagnostics, inadequate linkage to care, and the paucity of drugs. This prompted African 
nations to view TB as an emergency on the continent, in an attempt to increase political will and 
strengthen health systems to more effectively deal with TB (Chudi, 2010). 
Another factor which has hampered the elimination of TB in Africa is the synergistic relationship 
between TB and HIV/AIDS. It is currently estimated that 1/3 of the world’s population is infected 
with latent TB (WHO, 2016a, Lin and Flynn, 2010). In HIV-negative individuals, this poses a 5 – 
10 % lifetime risk of reactivation to cause active TB disease (Aaron et al., 2004, McShane, 2005). 
In HIV-positive individuals, however, this risk increases exponentially to an annual risk of 7 to 10 
% (McShane, 2005, Aaron et al., 2004). This is alarming, as currently Africa has the highest 
prevalence of incident HIV infection, with 4.5 % of the adult population (aged 15 - 49) currently 
infected with HIV/AIDS; significantly more than the second highest region (the Americas) and the 
global prevalence, at 0.5 and 0.8 %, respectively (Figure 1.1) (WHO, 2016b). As a result, the 
African HIV/AIDS problem has created a reservoir of people with a high risk of progressing to 
active TB, which will lead to an increase in incidence and mortality. Also, HIV-infected 
individuals have a greater risk of getting infected with TB due to their weakened immunity. 
Considering this, a more granular understanding of how these two diseases synergise will be 
important for the development of novel therapeutic interventions.  
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Figure 1.1: Global prevalence of HIV in individuals aged 15 – 49 years (taken from WHO, 2016b).    
 
1.2 Mtb infection, development of TB and the eternal arms race 
One of the key components required for the elimination of TB is an understanding of how Mtb 
infects susceptible individuals and the processes that follow, ultimately resulting in disease. A vast 
amount of research has been conducted to try and answer this question. Infection by Mtb is a 
consequence of the inhalation of aerosolised droplets, which contain tubercle bacilli (Wells, 1934, 
WHO, 2016a, Smith, 2003). These bio-aerosols are expelled by individuals presenting with active 
TB disease through coughing, talking or heavy breathing (Jones-López et al., 2013). The precise 
parameters, with regards to the inoculum size (which include the aerosol size and the number of 
bacilli), necessary to yield successful infection are still unclear. Much attention has been directed 
to defining the size of an effective bio-aerosol. Research conducted in the 60’s and 70’s suggested 
the optimal size for an aerosol destined for the alveolar space is smaller than 5 µm, containing 1 
to 3 bacilli (Grosset, 2003, Wells, 1934). The production of such aerosols containing Mtb was 
further confirmed in the 21st century (Jones-López et al., 2013, Wurie et al., 2016). Furthermore, 
an increase in the production of aerosols in the optimal range was observed in individuals with 
active pulmonary TB, when compared to individuals with latent TB (Wurie et al., 2016). The 
minimum size of these aerosols and diversity of clinical outcomes associated with them has been 
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difficult to replicate in most small animal models (Orme and Gonzalez‐Juarrero, 2007). A recent 
study assessing transmission of TB through aerosols in households was able to identify a culturable 
Mtb concentration threshold required for the transmission of TB in the household. It was shown 
that individuals expelling 10 or more colony forming units (CFU) per cough were more likely to 
transmit TB to their close contacts when compared to individuals with less than 10 (Jones-López 
et al., 2013). The question of whether repeated exposure to bio-aerosols is required, or determines 
trajectory of infection and disease, remains unanswered.   
Once these aerosols reach the intended location, the bacilli are released and phagocytised by 
alveolar macrophages (Smith, 2003). This process is regulated by interactions between Mtb and a 
number of essential macrophage borne cell surface receptors (Smith, 2003, Houben et al., 2006, 
Schlesinger, 1993, Gaynor et al., 1995, Ferguson et al., 1999). These receptors have been shown 
to either promote or repress the phagocytosis of foreign elements. In the case of Mtb, adhesion and 
subsequent phagocytosis appears to be regulated by mannose receptors, complementary receptors 
(CR1, CR3 and CR4), human toll-like receptor 2 (TLR2) and surfactant protein A and D. With the 
exception of surfactant protein D, these receptors have been shown to promote adhesion (Smith, 
2003, Houben et al., 2006). Inhibition of the mannose and complementary receptors resulted in a 
significant reduction of the adhesion potential of Mtb (Schlesinger, 1993). Additionally, the 
mannose receptors appear to promote the adhesion of virulent strains of Mtb, as repression of this 
receptor did not affect the phagocytosis of the avirulent H37Ra or that of heat-killed mycobacterial 
strains (Schlesinger, 1993). Surfactant protein A, functions as an enhancer for Mtb adhesion. 
Elevated levels of this glycopeptide led to an increase in phagocytised Mtb. However, the removal 
of this protein did not diminish phagocytosis, indicating it is not an essential adhesion protein and 
that this is a multifactorial process (Gaynor et al., 1995). Furthermore, the lack of a mannose 
receptor in the presence of elevated surfactant protein A, phenocopied the mannose receptor 
suppression phenotype, indicating surfactant protein A activity is dependent on the mannose 
receptor and suggesting that it enhances the activity of the receptor (Gaynor et al., 1995). This, 
however, seems to have an antagonistic function to that of surfactant protein D, which reduces the 
level of adhesion, by binding directly to Mtb lipoarabinomannan, preventing the association of 
bacilli with mannose receptors (Ferguson et al., 1999). Another receptor which plays an important 
role not only in the adhesion of Mtb but also the immunological cascade which follows is the TLR2 
receptor, which will be discussed in-depth, later.  
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Following phagocytosis, Mtb is enclosed within a lipid containing vacuole called a phagosome, 
which serves to contain the infecting agent (Smith, 2003). Under ordinary conditions, this 
combines with a secondary vacuole (the lysosome), containing lytic enzymes, to form the 
phagolysosome (Fairn and Grinstein, 2012). This combined vacuole exerts unfavourable 
conditions on the invading bacilli, possessing elements such as toxic reactive oxygen and nitrogen 
intermediates (ROI and RNI) and lytic enzymes, which serve to eliminate bacteria (Ehrt and 
Schnappinger, 2009, Fairn and Grinstein, 2012). In the case of Mtb, it is well-accepted that the 
bacterium prevents the maturation of the phagosome and the ultimate production of the 
phagolysosome, by inhibiting the fusion of the phagosome to the lysosome (Ehrt and 
Schnappinger, 2009). This results in formation of moderately acidic conditions, containing ROI, 
wherein Mtb can survive and propagate (Ehrt and Schnappinger, 2009). Whilst it is generally 
accepted that tubercle bacteria replicate in the arrested phagosome, recent studies have shown the 
presence of Mtb in the cytosolic space, suggesting that bacteria escape the phagosomal vacuole 
(van der Wel et al., 2007, Smith et al., 2008).  It was previously thought the bacterium continues 
to propagate, resulting in the ultimate eruption of the phagosome and subsequent release of the 
bacterial agents into the cytoplasm. In addition, secreted factors such as ESAT-6 and CFP-10 have 
been shown to be important for colonisation of the macrophages (Smith et al., 2008).  
ESAT-6 and CFP-10 are immunogenic, virulence factors located in the Region of Difference 1 
(RD1) (Guinn et al., 2004, Tan et al., 2006). These are released by the bacterium and play a crucial 
role in the pathogenicity of mycobacteria (Xu et al., 2007, Guinn et al., 2004). Previously, it was 
postulated that these components produce nano pores on the phagosome membrane, creating 
channels which can be used for the extrusion of signalling molecules and recruitment of nutrients 
required for growth (Smith et al., 2008). This hypothesis was proven incorrect as this pore forming 
activity was shown to be a by-product of residual detergent remaining from the enzyme preparation 
(Conrad et al., 2017). Subsequent work has revealed a more elaborate network of processes 
controlled by these components, which leads to the release of infectious mycobacterial agents in 
the alveolar space, primed for the infection of healthy macrophages (Smith et al., 2008, Derrick 
and Morris, 2007). The first step of this model requires the release of mycobacteria from the 
phagosome to the cytosol. The exact mechanism through which ESAT-6 and CFP-10 exert this 
function is unknown. However, it has been shown that the absence of either results in abrogation 
of cytosolic translocation (Smith et al., 2008). It is currently unclear whether mycobacteria 
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continue to propagate in the cytoplasm. The presence of the bacterial agents in the cytoplasm leads 
to apoptosis and ultimately the release of infectious agents into the alveolar space (Derrick and 
Morris, 2007). This apoptotic process seems to be reliant on the release of ESAT-6 and CFP-10 
into the cytoplasm (Derrick and Morris, 2007). It has been shown that treatment of macrophage 
cells with exogenous ESAT-6 leads to the increased expression of various caspases and ultimate 
death of the cell (Derrick and Morris, 2007). Though escape to the cytoplasm prevents any 
phagosome associated killing of Mtb, there are mechanisms which the macrophage can use to kill 
cytosolic bacilli, an example of these is autophagy. 
Autophagy is the process responsible for the delivery of cytosolic elements to the lysosome for 
degradation (Deretic, 2014). This process is generally utilised as a quality and quantity control 
mechanism, tasked with the removal of defective elements such as misfolded proteins, deficient 
mitochondria and protein aggregates (Deretic, 2014). Autophagy can be further classified into two 
standard forms; bulk and selective. Bulk autophagy is a process that primarily occurs during 
starvation (Deretic, 2014, Bento et al., 2016). This results in the bulk degradation of cellular 
components, leading to the release of energy, through lipolysis and amino acids, which can be used 
for protein synthesis (Deretic, 2014, Bento et al., 2016). Selective autophagy, as the name 
indicates, is driven by the tagging of substrates, sequestered for degradation (Deretic, 2014, Deretic 
et al., 2013, Zaffagnini and Martens, 2016). In the case of bacteria, autophagy is initiated by the 
ubiquitination of the bacterial element by the E3 ligase; this is followed by the recognition of 
ubiquitin by Sequestosome 1/p62 like receptors (SLRs) (Ponpuak et al., 2010, Bento et al., 2016, 
Zaffagnini and Martens, 2016). This results in the recruitment of autophagy-related gene (atg8) 
product, LC3, leading to further recruitment of subsequent atg gene products responsible for the 
formation of a lipid membrane (Ponpuak et al., 2010, Deretic et al., 2013, Bento et al., 2016, 
Zaffagnini and Martens, 2016). This is followed by fusion of the autophagosome and lysosome, 
producing the autophagolysosome and subsequent degradation of the bacterial agent (Deretic et 
al., 2013, Ponpuak et al., 2010, Bento et al., 2016, Zaffagnini and Martens, 2016).  
Like many other host-derived antimicrobial processes, mycobacteria have devised mechanisms to 
evade autophagy. One of these mechanisms is the activation of mTOR. The initiation of the 
autophagy process is regulated by two essential kinases (AMPK and mTOR) through the 
phosphorylation of the autophagy-initiating kinase Ulk1 (Kim et al., 2011). Phosphorylation of 
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Ulk1 by AMPK leads to the initiation of autophagy and phosphorylation by mTOR leads to the 
inhibition of autophagy (Kim et al., 2011). The second mechanism utilised by Mtb to avert 
autophagy is the accumulation of intracellular lipid droplets. Infection of host macrophages leads 
to reprogramming of cellular processes, which results in an increase in the production of lipid 
droplets (Russell et al., 2009). These can be used by Mtb as a nutrient source. The influx of lipids 
can also serve a secondary function, which is the inhibition of the macrophage autophagy pathway 
(Singh et al., 2009). These and relates studies illustrated that although the human immune system 
has devised methods to deal with Mtb, it appears the pathogen has developed specific 
countermeasures to inhibit these. This metabolic flexibility in the pathogen has made the 
development of drugs to combat this bacterium challenging. As such, the history of TB drug 
development is filled with short term successes, which are constantly threatened by the emergence 
of drug-resistant TB. 
1.3 The history of TB and drugs 
Drug development for TB can be described as a never-ending arms race as the tubercle bacillus is 
able to readily evolve resistance to current and newer treatments. Since the discovery of antibiotics, 
the search for the elusive “magic bullet” to try to solve this age-old problem has been ongoing. 
Currently, the treatment of drug-susceptible TB is a six month antibiotic regimen, which consists 
of 4 antibiotics (WHO, 2016a). The regimen involves the administration of rifampicin (RIF), 
isoniazid (INH), pyrazinamide (PZA) and ethambutol (EMB) for two months, followed by 
treatment with RIF and INH for a further four months. This long term treatment duration, together 
with the toxicity of some of the drugs, has created concerns regarding patient non-compliance 
(WHO, 2016a, Chudi, 2010). In developing countries, the lack of efficient health care systems, 
inappropriate infrastructure and poverty contribute to a lack of compliance to the TB treatment 
regimen as patients cannot access drugs and effective support systems (Chudi, 2010, Raviglione 
and Sulis, 2016). These issues contribute to the emergence and transmission of drug-resistant Mtb 
strains. Drug resistance TB remains a major problem, predominantly in the developing world 
(Figure 1.2) (WHO, 2016a). The occurrence of drug-resistant TB can be dated back to the 
introduction of the first TB drug, streptomycin in 1944 (Keshavjee and Farmer, 2012). Four years 
later streptomycin resistant Mtb was isolated from relapse patients treated with streptomycin 
(Crofton and Mitchison, 1948). This led to the discovery and introduction of new drugs into the 
regimen, resulting in the current combination treatment program for TB (Keshavjee and Farmer, 
8 
 
2012). Administration of multiple drugs reduces the chance for composite drug resistance to occur 
however, it’s important to note that Mtb isolates resistant to individual drugs in the regimen have 
been identified since the introduction of these drugs into the clinical setting. 
 
Figure 1.2: Venn diagram depicting countries with high burden TB infection as well as high burden MDR-TB and 
TB/HIV co-infection (Taken from WHO, 2016a). 
 
In addition to mono-resistance, there has been a rapid emergence of strains resistant to two or more 
TB drugs, including multi-drug-resistant (MDR) and extensively drug-resistant (XDR) TB. This 
form of TB is characterised by infection with Mtb strains that are resistant to RIF and INH (MDR) 
or RIF, INH, an aminoglycoside and a fluoroquinolone (XDR) (WHO, 2016a). Given that RIF and 
INH are rendered ineffective, the treatment of MDR essentially involves the introduction of more 
drugs (including aminoglycosides and fluoroquinolone) initially not used due their low efficacy or 
high toxicity (WHO, 2016a). This highly toxic regimen is administered for 9 – 12 months, with 
significant compliance challenges (WHO, 2016a). XDR-TB presents further limitations in 
therapeutic options and treatment in this case is somewhat individualised with a variety of drugs 
that have limited efficacy (Zumla et al., 2013). Together, these challenges underscore the urgent 
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need for the development of novel TB treatments that have a shorter duration of treatment, a 
reduced pill burden and negligible side effects (WHO, 2016a). 
The first new drug to be developed for TB over the past 60 years is bedaquiline, which has shown 
some promise in the treatment of MDR TB (Keshavjee and Farmer, 2012, Diacon et al., 2014). 
Furthermore, the repurposing of drugs, initially developed for the treatment of other conditions 
such as mental disorders and anti-inflammatory medications, for TB treatment has shown 
promising results (Zumla et al., 2013, Zumla et al., 2012). The repurposing of drugs is 
advantageous as limited new research is required to determine the toxicity effects, which reduces 
time and cost that would have been spent on the development and assessment of the drug (Zumla 
et al., 2012, Zumla et al., 2013). The success of bedaquiline has been followed by the identification 
of other agents that show promise in TB drug development initiatives, especially for treatment of 
drug-resistant TB (Keshavjee and Farmer, 2012).  
1.4 Mechanisms of antibiotic tolerance in Mtb 
An important factor that hampering the development of new TB drugs is the inherent tolerance of 
Mtb to external compounds, which makes it difficult to kill using antimicrobial agents. This is 
primarily because the tubercle bacillus is equipped with mechanisms to either avoid or eliminate 
drugs and antibiotics. These systems include mechanisms such as efflux pumps and the inherent 
complexity of the cell wall that limits diffusion of drugs. 
Efflux pumps are transporter proteins that are usually embedded in the inner membrane 
(Lomovskaya et al., 2001). These are found in both gram positive and gram negative bacteria and 
have been shown to play an important role in the removal of a wide range of cytoplasmic 
antibiotics (Lomovskaya et al., 2001, Vila et al., 2007, Webber and Piddock, 2003). The active 
efflux of drugs by these pumps necessitates that more drug is required in order to overwhelm these 
pumps and increase effective cytosol concentrations of drug in the bacterium (Lomovskaya et al., 
2001). To address this issue, a number of efflux pump inhibitors have been developed with the 
intent of using them in combination with antibiotics in order to reduce the amount of antibiotic 
required to kill the pathogen. As an illustration, verapamil (an efflux pump inhibitor), in 
combination with bedaquiline has been used for clinical trials in order to determine whether the 
combination leads to a reduction in the amount of effective bedaquiline required to achieve 
functional cure (Gupta et al., 2014). This study confirmed that combining drugs with efflux pump 
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inhibitors has the potential to reduce the minimum inhibitory concentration of the drug (Gupta et 
al., 2014). However, an important limitation with this approach is the toxicity of efflux pump 
inhibitors but this may be offset if the effective drug concentration required is reduced to a point 
where TB drug related toxicities become negligible. This will reduce the overall toxicity of the 
regimen, which may provide a substantive benefit in the longer-term. 
The other notable physical barrier to the development of new TB drugs is the cell wall. The 
mycobacterial cell wall is a uniquely complex structure consisting of multiple layers, including the 
capsule, mycolic acid, arabinogalactan, peptidoglycan (PG) and plasma membrane, with the 
inherent ability of not only protecting the organisms from host derived stresses but also preventing 
the penetration of antibiotics (Jarlier and Nikaido, 1994). Unlike the gram negative capsule, the 
mycobacterial capsule is shrouded in mystery. The exact structural composition is unclear and the 
ability to detect this structure is highly dependent on the manner in which the sample is prepared 
(Daffe and Etienne, 1999). Extensive research conducted on the capsule has identified the basic 
structural composition, primarily comprising polysaccharides and proteins as well as small 
amounts of lipids (Daffe and Etienne, 1999). The capsule, in addition to serving as a barrier against 
the diffusion of compounds, forms a niche for the settlement of enzymes, such as peroxidase and 
superoxide dismutases which play an important role in the scavenging of harmful radicles, thus 
protecting mycobacteria in the macrophage environment (Daffe and Etienne, 1999).  
The next layer is generally classified as one large polymer, referred to as the MAP (mycolic acid, 
arabinogalactan and PG) layer and accounts for the impermeable nature of mycobacteria (Jarlier 
and Nikaido, 1994, Liu et al., 1996). The mycobacterial mycolic acid layer consists of various 
forms of mycolic acids with varying sizes and numerous studies have demonstrated the importance 
of this layer in pathogenicity and antimicrobial tolerance (Liu et al., 1996, Nataraj et al., 2015, 
Marrakchi et al., 2014, Jarlier and Nikaido, 1994). The limited permeability of the mycolic acid 
layer has been associated with the length of mycolic acids as it has been demonstrated that the 
corynebacterial mycolic acid layer (which contains shorter mycolic acids) is far more permeable 
than that of mycobacteria (Liu et al., 1996). The arabinogalactan layer is made up of long,      
branch-like structures consisting of arabinan and galactan subunits and serves an important 
structural role whereby it is thought to anchor the mycolic acid layer to the PG layer (Jarlier and 
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Nikaido, 1994). A diagrammatic description of the mycobacterial cell wall, and how it differs from 
that found in other bacteria, is given in Figure 1.3. 
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Figure 1.3: Diagrammatic representation of the cell wall of various classes of bacteria. (A) Shown is the gram positive 
cell wall, which consists of a plasma membrane and a thick PG layer, (B) The gram negative cell wall consisting of a 
plasma membrane, thin PG layer and a capsule layer and (C) the complex mycobacterial cell wall consisting the 
plasma membrane, thick PG, arabinogalactan, mycolic acid and capsule like layers (adapted from Hett and Rubin, 
2008, figure drawn by S. Senzani). 
The final layer of the MAP complex is the PG layer. PG is a complex, essential bacterial 
macromolecule consisting of long saccharide chains with alternating N-acetylmuramic acid 
(MurNAc) and N-acetylglucosamine (GlcNAc) residues linked via a -1, 4-glycosidic bond 
(Brennan, 2003). These sugar chains are linked by crosslinks that form between adjacent stem 
peptides, which are covalently attached to the muramic acid residues (Brennan, 2003). This 
structure plays a crucial role in a variety of cellular processes including the determination of cell 
shape, as organisms lacking PG exhibit an amoeboid form, lacking any form or structure (Weibull, 
1953). PG also plays an essential role in protecting the cells from osmotic pressure (Rayman and 
MacLeod, 1975). This intrinsically allows PG containing organisms the ability to survive under 
conditions of varying salt concentration as opposed to their PG deficient counterparts (Sumaryati 
et al., 1992, Rayman and MacLeod, 1975).  In pathogenic organisms such as Mtb, PG plays an 
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essential role in modulating host immune systems to allow for pathogen evasion of host immune 
responses, as well as a number of other essential functions which will be discussed later.   
PG is an extremely dynamic molecule, which is continuously remodelled to allow for bacterial 
growth, insertion of extracellular structures, including pilli or porins, as well as to allow for various 
growth switches that can occur under different growth conditions, such as the switch from 
vegetative growth to dormancy (Driks, 2002, Hett and Rubin, 2008, Vollmer et al., 2008). As such, 
this remodelling process is important and is conducted by a plethora of enzymes that are required 
for the synthesis of PG subunits, hydrolysis of the PG complex, insertion of PG subunits into the 
complex and modification of PG (Egan et al., 2016). The large number of enzymes associated with 
this single structure has drawn some interest with regards to the identification of novel drug targets 
in order to disrupt the maintenance of PG. Due to the covalently linked nature of the MAP 
structure, disruption of the PG layer (even in the absence of killing) could result in a cascade which 
would lead to disturbances in the mycolic acid layer.  With this in mind, a number of antibiotics 
that target PG synthesis already exist, including penicillin (-lactams), vancomycin 
(glycopeptides) and meropenem (carbapenems) (Caminero et al., 2010, De Lorenzo et al., 2013). 
The majority of these drugs unfortunately are not used for the routine treatment of TB and as such, 
the remodelling of the PG layer has yet to be fully exploited in mycobacteria. 
In this study, we attempt to advance the knowledge on mycobacterial PG remodelling during cell 
division to identify enzymes that can be used for the development of new drugs.  We focus on a 
group of PG hydrolysing enzymes termed N-acetylmuramyl-L-alanine amidases (hereafter 
referred to as amidases for simplicity) and their role in mycobacterial growth and cell division. 
Previous research conducted in our lab identified four mycobacterial amidases designate Ami1-
Ami4 (Machowski et al., 2014). Preliminary work identified a role for Ami1 in cell division and 
Ami2 in cell elongation in Mycobacterium smegmatis. In this PhD, we further resolved these 
observations and establish a role for Ami1 in the degradation of septal PG (Senzani et al., 2017) 
We also advance the research related to the other mycobacterial amidases mentioned above. Ami1 
and Ami2 were characterised in detail in M. smegmatis. Following this, Ami1 was studied further 
in Mtb, followed by an analysis of the biological role of Ami4. Due to time constraints and the 
focus on M. smegmatis, the work presented for Mtb amidases is only preliminary. The overall 
frame work for the dissertation research, and this dissertation report, is outlined in Figure 1.4. 
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Figure 1.4: Flow chart depicting the outline of the study. Shown are the various aspects of the study indicating the chapters in which each amidase is addressed as 
well as the major question associated with each enzyme, and the steps taken to interrogate the question (Figure drawn by S. Senzani). 
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2 General Methods 
2.1 Bacterial strains, vectors and growth conditions 
General vectors used in this study are listed in Table 2.1. Other vectors and bacterial strains are 
listed in the respective chapters that detail the findings. Freezer stocks for all these were stored at 
– 80 ˚C in liquid media containing 6.6 % (v/v) glycerol. 
Table 2.1: Basic vectors used in this study 
Vectors Genotype 
 
Reference 
p2NIL E. coli cloning vector; KanR (Parish and Stoker, 
2000) 
pFLAGEM E. coli-Mycobacterium episomal shuttle vector carrying a 
3X FLAG epitope sequence downstream Pmyc-tetO; HygR
 
E. Machowski 
pSE100 E. coli-Mycobacterium shuttle vector carrying Pmyc-tetO; 
HygR 
(Ehrt et al., 2005b) 
pGOAL17 Vector carrying lacZ and sacB genes as a PacI cassette; 
AmpR 
(Parish and Stoker, 
2000) 
pMV306(H) pMV306 derivative carrying HygR marker H. Boshoff 
KanR: Kanamycin Resistance, HygR: Hygromycin Resistance 
 
2.1.1 Growth of E. coli DH5α and derivative strains 
E. coli strains were grown in Lysogeny broth (LB) or agar (LA) at 37 °C, supplemented with the 
appropriate antibiotic (Appendix A). Antibiotic concentrations used were: Kanamycin (Kan) 50 
μg/ml and Hygromycin (Hyg) 200 μg/ml. E. coli strains cultured in LB were grown with shaking 
at 250 rpm unless stated otherwise. 
2.1.2 Growth of M. smegmatis strains 
M. smegmatis strains were cultured in Middlebrook 7H9 liquid media supplemented with 0.2 % 
glucose, 0.5 % glycerol, 0.085 % NaCl, and 0.05 % Tween 80 containing appropriate antibiotic at 
37 °C (herein referred to as 7H9S media) with shaking at 100 rpm. Where necessary, M. smegmatis 
was grown on or Middlebrook 7H10 solid media supplemented with 0.2 % glucose, 0.5 % glycerol, 
and 0.085 % NaCl (herein referred to as 7H10). Antibiotic concentrations used were: Kan 25 μg/ml 
and Hyg 50 μg/ml. 
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2.1.3 Growth of Mtb strains 
Mtb strains were cultured in Middlebrook 7H9 liquid media supplemented with Middlebrook 
OADC enrichment, 0.5 % glycerol, and 0.05 % Tween 80 at 37 °C (herein referred to as 7H9T 
media).  Where necessary, bacteria were growth on Middlebrook 7H11 solid media supplemented 
with Middlebrook OADC enrichment and 0.5 % glycerol containing appropriate antibiotic (herein 
referred to as 7H11). Antibiotic concentrations used were: Kan 25 μg/ml and Hyg 50 μg/ml. 
2.2 DNA manipulation 
2.2.1 Mycobacterial chromosomal DNA extraction 
2.2.1.1 Cetyltrimethylammonium bromide (CTAB) DNA extraction in M. smegmatis 
Bacterial strains were grown on 7H10 agar for 2 to 5 days, until a lawn of cells had formed on the 
plates. The cells were harvested by scraping the surface of the agar plate and suspending in 500 μl 
TE buffer. This was followed by killing of bacteria through incubation at 65 °C for 35 min.  The 
cells were then cooled to room temperature and a 50 μl aliquot of lysozyme (10 mg/ml) was added 
to the sample, followed by incubation at 37 °C for 1 h. Thereafter, 70 μl of 10 % SDS and 6 μl of 
proteinase K (10 mg/ml) was added to the sample and incubated at 65 °C for 2 h. Following this, 
100 μl of 5 M NaCl and 80 μl pre-warmed CTAB/NaCl was added, mixed and incubated at 65 °C 
for 10 min. An equal volume of 24:1/Chloroform:Isoamyl alcohol was added, the solution was 
mixed and centrifuged at maximum speed for 10 min at room temperature. The aqueous layer was 
transferred into a clean Eppendorf tube, followed by the addition of 0.6 volume equivalent of 
isopropanol and centrifugation for 20 min at room temperature. The supernatant was discarded, 
the pellet was washed in 70 % ethanol and dried using an Eppendorf Concentrator 5301. The DNA 
pellet was resuspended in 50 μl sterile distilled water (sdH2O), quantified using NanoDrop and 
stored at 4 °C. 
2.2.1.2 Cetyltrimethylammonium bromide (CTAB) DNA extraction in Mtb 
Bacterial strains were grown on 7H11 agar for 3 to 4 weeks until lawn had formed on the plates, 
the cells were then harvested by scraping the surface of the agar plate and suspending in 500 μl of 
TE buffer. The bacteria were killed by incubation at 80 °C for 1 h and the cells were then cooled 
down to room temperature. A 50 μl aliquot of lysozyme (10 mg/ml) was added to the sample and 
incubated at 37 °C for 1 h. From this point, the same procedure was followed as described for M. 
smegmatis.   
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2.2.1.3 Small scale DNA extraction for PCR in M. smegmatis and Mtb 
A single colony was scraped from an agar plate and resuspended in 30 μl sdH2O. A 10 μl sample 
was spotted on 7H11 agar for a sample reference. The remaining suspension was incubated at       
95 °C for 5 min, followed by the addition of 20 μl of chloroform. The solution was mixed, 
centrifuged at 16 000 × g for 5 min and the aqueous layer was transferred into a fresh Eppendorf 
tube.  A 2 μl aliquot of this was used as template for PCR, where necessary. 
2.2.2 E. coli vector extraction 
2.2.2.1 Bulk vector preparation using Nucleobond Xtra vector purification kit 
Vector DNA preparation using the Nucleobond Xtra kit was done as per manufacturer’s 
instructions (Macherey Nagel). Briefly, 50 ml of E. coli culture was grown in LB containing 
appropriate antibiotic at 37 °C with shaking at 250 rpm until the OD600nm was greater than 3. The 
cells were harvested by centrifugation at 3 900 × g for 10 min. The supernatant was discarded and 
the cells were resuspended in 8 ml of RES buffer containing RNAse A. Thereafter, 8 ml of the 
lysis buffer, LYS buffer, was added to the sample and mixed gently by inverting 10 to 15 times, 
followed by incubation at room temperature for 3 to 5 min. Then, 8 ml of neutralisation buffer, 
NEU buffer, was added to the sample, which was mixed gently by inverting the tube. The sample 
was placed on ice for 5 min. During the neutralisation stage, a new Nucleobond Xtra column 
containing the accompanying filter was equilibrated by adding 12 ml of EQU buffer into the 
column and allowing the buffer to flow through. The supernatant from the neutralised vector 
extraction was then decanted into the column and allowed to flow through. Thereafter, the column 
was washed with 8 ml WASH buffer and the DNA was eluted using 5 ml ELU buffer into a sterile 
tube. The DNA was precipitated by adding 3.5 ml of isopropanol into the tube, followed by 
centrifugation at 16 000 × g at 4 °C for 30 min. The resulting supernatant was discarded and the 
pellet was washed with 70 % ethanol. Thereafter, the pellet was dried, resuspended in 50 μl sdH2O 
and quantified using the NanoDrop. 
2.2.2.2 Small scale vector preparation using QIAGEN vector purification kit 
Vector DNA preparation using the QIAGEN vector purification kit was done as per manufacturer’s 
instructions (QIAGEN). Briefly, 5 ml E. coli culture was grown in LB containing appropriate 
antibiotics at 37 °C with shaking at 250 rpm overnight. The cells were harvested by centrifugation 
at 16 000 × g for 1 min. The supernatant was discarded and the cells were resuspended in 300 µl 
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of Buffer P1. Following this, 300 µl of the lysis buffer, Buffer P2, was added to the sample and 
mixed gently by inverting 10 to 15 times, followed by incubation at room temperature for                   
3 to 5 min. Then, 300 µl of Buffer P3 was added to the sample to neutralise the reaction, which 
was then mixed gently by inverting, followed by centrifuged at 16 000 × g for 10 min. The 
supernatant was then decanted into a QIAGEN DNA extraction column and centrifuged at              
10 000 × g for 30 sec. The flow-through was discarded and the column was washed by adding    
700 µl QC buffer. The flow-through was discarded and the excess QC buffer was removed through 
centrifugation at 10 000 × g for 2 min.  The column was then placed in a fresh Eppendorf tube and 
DNA was eluted by adding 50 µl of sterile distilled water  
(equilibrated to 65 ˚C) and centrifugation at 10 000 × g for 2 min. The resulting DNA was 
quantified using the NanoDrop spectrophotometer. 
2.2.2.3 Vector miniprep using alkaline lysis method 
A single E. coli colony was grown in 2 ml LB containing appropriate antibiotics at 37 °C. A 10 μl 
sample was spotted on LA containing appropriate antibiotics as a reference. The remaining cells 
were harvested from the culture through centrifugation at 10000 × g and resuspended in 100 μl 
cold solution I. Thereafter, 200 μl of room temperature solution II was then added to the sample, 
this was mixed by inverting 10 times and placed on ice for 5 min. Following incubation, 150 μl of 
cold solution III was added and the sample was placed on ice for a further 10 min. The sample was 
centrifuged at room temperature for 10 min and the supernatant was transferred to a clean 
Eppendorf tube. A 300 μl aliquot of isopropanol was added, and the mixture was centrifuged at 
room temperature for 20 min. The supernatant was discarded, the pellet washed with 70 % ethanol 
and dried using an Eppendorf Concentrator 5301. The DNA pellet was then resuspended in 20 μl 
sdH2O and quantified using agarose gel electrophoresis explained further in section 2.2.10. 
2.2.3 Sodium acetate DNA precipitation 
A one-tenth volume equivalent of 3 M sodium acetate, pH 5.2, and 2.5 volume equivalent of cold 
100 % ethanol was added to the DNA solution. The sample was mixed and incubated at -20 °C for 
20 min. The sample was then centrifuged at room temperature for 20 min at maximum speed, the 
supernatant was discarded and the pellet washed in 70 % ethanol. The pellet was dried using the 
Eppendorf Concentrator 5301 and resuspend in 20 μl sdH2O. 
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2.2.4 DNA restriction enzyme digestion 
Restriction digests were conducted using Roche (Roche Applied Sciences) and /or NEB (New 
England Biolab) enzymes and reactions were set up as per manufacturer’s instructions. Briefly, 
reactions were set up in a 20 μl volume, unless stated otherwise, containing 1 × appropriate 
restriction buffer, 1 μg DNA, 1 U restriction enzyme and sdH2O. Digests were incubated at the 
appropriate temperature for 1 h. The enzyme was heat inactivated at 65 ˚C for 10 min unless 
advised differently by the manufacturer. 
2.2.5 Phosphorylation of DNA 
Phosphorylation of DNA was conducted using Polynucleotide kinase (PNK) (Roche Applied 
Sciences) in 20 μl reactions containing 1 × PNK buffer, 1 μg of PCR product, 1 U of PNK and 
sdH2O. This was incubated at 37 ºC for 30 min and then heat inactivated at 65 ºC for 20 min. 
2.2.6 Dephosphorylation of 5′ends of vector DNA 
Dephosphorylation of 5′ ends was conducted using FastAP (Fermentas) in 20 μl reactions 
containing 1 × FastAP buffer, 1 μg of digested DNA, 2 U of FastAP phosphatase and sdH2O. This 
reaction was incubated at 37 ºC for 10 min, then heat inactivated at 65 ˚C for 20 min. 
2.2.7 DNA ligation 
All ligations were carried out using the Fermentas T4 Ligase (Fermentas) or Fastlink DNA ligation 
kit (Epicenter). For optimal ligation conditions a molar ratio of 1:1 vector:insert was used in all 
reactions. A constant amount of vector, 50 ng, was used for all ligation reactions and the insert 
mass required to make up a molar ratio of 1:1 (vector:insert) was calculated using the following 
equation: 
Amount of insert (ng) =
Amount of vector (50 ng) × Size of insert (bp)
Size of vector (bp)
 
 
Either T4 DNA ligase or the Epicenter ligase was used. In the case of T4 ligase, the reactions were 
set up in 20 μl volumes containing 1 × ligation buffer, 50 ng vector DNA, 1 molar equivalent insert 
DNA, 5 U T4 ligase and sdH2O, which were incubated at 22 ºC for 10 min. In the case of blunt 
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end ligations, the reaction was supplemented with one-tenth volume PEG4000 and incubated at  
22 ºC for 1 h. T4 ligase was then heat inactivated at 75 ºC for 10 min. 
With regards to the Epicenter ligation kit, the reactions were set up in a 15 μl volume containing 
1 × Fast-link ligation buffer, 50 ng vector DNA, 1 molar equivalent insert DNA, 2 U T4 ligase and 
sdH2O, which were incubated at 22 ˚C for 5 min. With blunt end ligations, the reaction was 
supplemented with one-tenth volume PEG4000 and incubated at 22 ˚C for 1 h. Ligase was then 
heat inactivated at 75 ºC for 10 min. 
2.2.8 Agarose gel electrophoresis 
Agarose gel electrophoresis was conducted using agarose gels containing 0.5 μg/ml ethidium 
bromide. Separation of high molecular weight DNA was accomplished by using 0.8 % agarose 
gels made in 1 × TAE buffer (40 mM Tris-acetate, 1 mM EDTA) and separation of low molecular 
weight DNA was conducted using 2 % agarose gels. Electrophoresis was carried out in 1 × TAE 
buffer at 80 – 100 V in electrophoresis tanks (Bio-Rab laboratories). Appropriated DNA molecular 
weight markers were separated on the same gel to indicate the molecular weight of the samples 
examined. Bands were visualised using a G:Box SYNGENE system in conjunction with the 
GeneSnap image acquisition software (Syngene). 
2.2.9 Purification of DNA fragments 
Purification of DNA fragments was conducted from agarose gels to extract either PCR or DNA 
restriction products for use in subsequent cloning steps. DNA purification was conducted using 
the Nucleospin PCR and Gel purification Kit (Macherey-Nagel) as per the manufacturer’s 
instructions. In the case of PCR products, a small sample was separated on a gel to ensure the PCR 
amplified the desired product. Thereafter, a 2 × volume equivalent of binding Buffer was then 
added to the remaining product. This was loaded on the column provided and centrifuged at              
11 000 × g for 30 s. The flow-through was discarded, the column was then washed using 700 µl 
of wash buffer at 11 000 × g for 2 min. The DNA was eluted by adding 50 μl of 65 ˚C dH2O to the 
column and centrifuging at 11000 × g for 1 min. The DNA was quantified using the NanoDrop. In 
the case of gel extractions, the desired fragment was excised from the gel. The gel fragment 
containing DNA was then weighed and melted in a 2 volume equivalent of binding buffer at           
42 ˚C. The DNA was loaded onto the column and purified as described above. 
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2.2.10 Nucleic acid quantification 
All DNA and RNA was quantified either using the NanoDrop ND-1000 Spectrophotometer 
(NanoDrop Technologies), used in conjunction with software provided by the manufacturer 
(Coleman Technologies) or though gel  electrophoresis by comparing the intensity of sample DNA 
to the various DNA marker bands. 
2.2.11 DNA Sequencing 
Sequencing, which was outsourced to the DNA Sequencing Facility of Stellenbosch University, 
was performed using the Big Dye terminator v3.1 Cycle Sequencing kit and Bioline Half Dye Mix. 
Finch TV version 1.4 was used to analyse the sequencing data. 
2.3 Polymerase chain Reaction (PCR) 
Screening for knockout mutant strains was conducted using the Roche Fast-Start kit (Roche 
Applied Science). Amplification of products for cloning was done using the Phusion High-Fidelity 
DNA polymerase (New England Biolab), which retains DNA proofreading capacity to ensure 
sequence fidelity, thus preventing the introduction of mutations. 
2.3.1 Roche Fast-Start Taq PCR 
PCR experiments were conducted in 25 μl volumes each containing 1 × PCR buffer, 2 mM MgCl2, 
0.2 mM dNTP, 0.5 mM forward and reverse primers, 1 × GC rich buffer, 50 ng DNA template, 1 
U of Taq polymerase and sdH2O in 200 μl PCR tubes. These reactions were incubated in a 
thermocycler using the following parameters: enzyme activation at 95 ºC for 4 min, then 35 cycles 
of denaturation at 95 ºC for 30 s, annealing temperature, which was dependent on the specific 
primer, set for 30 s and elongation at 72 ºC for a time period dependent on the length of the desired 
product (Fast start Taq amplifies 1 kbp/min). This was followed by a final elongation at 72 ºC for 
10 min. 
2.3.2 Phusion High-Fidelity DNA polymerase 
PCR experiments were conducted in 50 μl volumes containing 1 × GC buffer, 0.2 mM dNTP, 0.5 
mM forward and reverse primers, 3 % DMSO, 50 ng template, 1 U Phusion polymerase and sdH2O 
in 200 μl PCR tubes. The reactions were incubated in a thermocycler using the following 
parameters: enzyme activation at 98 ºC for 30 s, then 35 cycles of denaturation at 98 ºC for 10 s, 
annealing temperature, which was dependent on the specific primer set, for 30 s and elongation at 
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72 ºC for a time period dependent on the length of the desired product (Phusion polymerase 
amplifies at        1 kbp/30 s), followed by a final elongation stage of 72 ºC for 10 min. 
2.4 Transformation of bacterial cells 
2.4.1 Transformation of chemically competent DH5α 
Chemically competent cells were prepared using rubidium chloride. A single colony was 
inoculated in 5 ml LB broth then grown overnight. Thereafter, 1 ml of the overnight culture was 
inoculated in 100 ml LB broth and grown to an optical density (OD)600nm of between 0.48 - 0.55. 
The cells were placed on ice for 15 min and harvested by centrifugation at 3 900 × g for 5 min at 
4 °C. The cells were then resuspended in 20 ml TfbI solution (30 mM potassium acetate, 100 mM 
rubidium chloride, 10 mM calcium chloride, 50 mM manganese chloride, and 15 % v/v glycerol - 
pH 5.8), and placed on ice for 15 min. The cells were then centrifuged at 3 900 × g for 5 min at    
4 °C, resuspended in 2 ml TfbII solution (10 mM MOPS, 75 mM calcium chloride, 10 mM 
rubidium chloride and 15 % v/v glycerol-pH 6.5), 500 μl aliquots were flash-frozen in ethanol and 
stored at -80 °C until further use. 
For transformations, E. coli DH5α competent cells were thawed on ice and 100 μl of the cell 
suspension was used per transformation. Vector DNA was incubated with the cells on ice for          
20 min, heat-shocked at 42 °C for 90 s. Thereafter, 750 μl of 2 × TY was added to rescue the cells 
followed by incubation at 37 °C for 1 h. The cells were plated on LA media containing the 
appropriate antibiotics, and incubated for 1 - 2 days at 37 °C with the exception of larger vectors 
(>8 kb), which were incubated at 30 ºC for 2 days. 
2.4.2 Electroporation into M. smegmatis 
 A 5 ml culture was grown overnight using single colony. This was then inoculated into 100 ml 
7H9S media and grown to an OD600nm of 0.6 - 0.8. The cells were harvested at 2 630 × g for             
10 min at 4 °C and the pellet washed 4 times by gentle resuspension in successive steps of 45 ml, 
20 ml, 10 ml and 5 ml of ice-cold 10 % glycerol, followed by centrifugation at 2 630 × g for           
10 min at 4 °C. The final cell pellet was resuspended in 2 ml ice-cold 10 % glycerol and these 
competent cells were used immediately. Up to 10 μg vector DNA was added to a 400 μl aliquot of 
M. smegmatis competent cells. This was transferred to a 0.2 cm electroporation cuvette (Bio-Rad 
laboratories) and pulsed using the following conditions: 2.5 kV, 25 μF and 1000 Ω using the Gene 
PulserX cell (Bio-Rad Laboratories). The cells were rescued immediately with 800 μl 2 × TY for 
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at least 3 h at 37 °C and plated on Middlebrook 7H10 media containing the appropriate 
supplements and antibiotics, followed by incubation for 3 - 7 days at 37 °C before scoring CFUs. 
2.4.3 Electroporation into Mtb 
A 5 ml culture was grown to stationary phase. This was inoculated into 100 ml 7H9T media then 
grown to an OD600nm of 1 – 1.5. The culture was then supplemented with glycine to a final 
concentration of 1.5 %, and then incubated at 37 ˚C for 16 h. The cells were harvested at                       
2 630 × g for 10 min at room temperature and the pellet washed 4 times by gentle resuspension as 
described above for M. smegmatis. The final cell pellet was resuspended in 2 ml 10 % glycerol 
and these competent cells were used immediately. Up to 10 μg vector DNA was UV-irradiated 
(100 mJ/cm2) then immediately inoculated into 400 μl aliquot of Mtb competent cells. This was 
transferred to a 0.2 cm electroporation cuvette (Bio-Rad laboratories) and pulsed using the 
following conditions: 2.5 kV, 25 μF and 1000 Ω using the Gene PulserX cell (Bio-Rad 
Laboratories). The cells were rescued immediately with 800 μl 7H9 for 16 h at 37 °C and thereafter 
plated on Middlebrook 7H11 media containing the appropriate supplements and antibiotics, 
followed by incubation for 3 – 6 weeks at 37 °C before scoring CFUs. 
2.5 Southern blotting 
2.5.1 Labelling of Probe DNA 
Alkali-labile digoxigenin (DIG)-dUTP probes were constructed using a commercially available 
kit (PCR DIG Probe Synthesis Kit -Roche Applied Sciences) by PCR. A modified version of the 
manufacturer’s instruction, using the Fast start Taq polymerase, was used. Briefly, two 50 μl 
reactions (labelled and unlabelled) were set up containing 1 × PCR buffer, 2 mM MgCl2, 0.5 mM 
forward and reverse primers, 1 × GC rich buffer, 50 ng DNA template, 1 U of Taq polymerase and 
sdH2O in 200 μl PCR tubes. The labelling reaction was supplemented with 2.5 μl PCR DIG 
labelling mix and 0.1 mM dNTPs, while the negative control was supplemented with 0.2 mM 
dNTPs only. The PCR amplification conditions were first optimised using Roche Fast-start Taq to 
ensure that a single, pure product was produced during the labelling reaction. The DIG-labelled 
and unlabelled reactions were run on the same agarose gel to confirm labelling, as incorporation 
of the DIG label results in a molecular weight shift on agarose gels. 
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2.5.2 Blotting 
For restriction digests, 2 μg of chromosomal DNA was digested with 5 U of selected enzyme 
overnight. DNA was then separated on 0.8 % agarose gel with either Lambda pUC mix 4 Marker 
(Fermentas), Roche marker IV (Roche) or Roche marker III (Roche) at 80 V for 2 to 3 h. After 
photographing of the gel, using the G-Box SYNGENE system, the DNA was depurinated by 
soaking the gel in 0.2 M HCl for 15 min with gentle shaking. The depurination solution was then 
removed and the gel was soaked in a solution of 0.5 M NaOH and 1.5 M NaCl for 30 min to 
denature the DNA. The gel was then washed in 1 × TBE. The gel was then overlaid with Hybond™ 
-N nitrocellulose membrane, sandwiched between 4 Whitman filter papers and 2 sponges, and pre-
soaked in 1 × TBE (89 mM Tris-Borate, 2 mM EDTA, pH 8.3). The sandwich was carefully placed 
in a gel cassette (Bio-Rad Laboratories) and transferred to an SB10 tank (Bio-Rad Laboratories) 
containing 1 × TBE. DNA was transferred to the nitrocellulose membrane at 600 mA for 2 h. The 
DNA was cross-linked to the nitrocellulose membrane by UV irradiation twice, at 2500 mJ/cm3 in 
a UV Stratalinker 1800 (Stratagene). The membrane was incubated in 10 ml of DIG-EASY-HYB 
solution for 30 min at 42 ºC. The DIG labelled probe was added to the hybridisation solution and 
incubated at 42 ºC overnight. The DIG-EASY-HYB and probe mixture was decanted into a 50 ml 
Falcon tube and stored at -20 ºC for future use. The membrane was washed with a solution 
containing 2 × SSC (300 mM NaCl, 30 mM Sodium citrate) and 0.1 % SDS for 5 min at room 
temperature. This was followed by two washes in a solution containing 0.5 × SSC and 0.1 % SDS 
for 30 min at 68 ºC. The membrane was rinsed in wash buffer (0.1 M maleic acid buffer and           
0.3 % Tween 20) for 5 min at room temperature and incubated in 1 × blocking solution (made by 
diluting 10 × blocking solution – Roche Applied Sciences - in 0.1 M maleic acid buffer) for             
30 min. Thereafter, the membrane was incubated in 20 ml of antibody solution (20 ml 1 × blocking 
solution and 2 μl Anti-Digoxigenin-AP [Roche Applied Sciences]) for 30 min, followed by rinsing 
twice for 15 min in wash buffer. The membrane was placed in a hybridisation bag (Roche 
Diagnostics; Mannheim, Germany) DNA side facing up and 1 ml chloro-5-substituted adamantyl-
1, 2-dioxetane phosphate (CSPD) substrate was aliquoted on to the DNA side of the membrane 
and incubated at room temperature for 10 min, the excess CSPD was then removed, the 
hybridisation bag was sealed and incubated at 37 ºC for 5 min. The membrane was exposed to X-
ray film (Kodak Biomax Light or CL-Xposure™ Film-Thermo Scientific) for 10 min and the film 
was developed using an automated Axim developer. 
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2.6 Assessment of gene expression 
Expression primer sets for genes of interest were designed to contain a forward and reverse primer 
pair for amplification and a second reverse primer (RT primer) for cDNA synthesis. Expression 
analysis was conducted in two steps, the first being cDNA synthesis from purified RNA, using RT 
primers, followed by real-time amplification of cDNA. 
2.6.1 RNA extraction from mycobacterial cells 
RNA extraction was carried out using the Nucleospin RNA purification Kit (Macherey-Nagel) as 
per the manufacturer’s instructions. Cells were grown in 7H9S or 7H9T media containing the 
appropriate antibiotics to an OD600nm = 0.3. The cells were harvested at 3 900 × g for 10 min at    
4 ºC. Pellets were resuspended in 350 μl lysis buffer and 3.5 μl β-mercaptoethanol was added to 
the sample. The cell suspension was transferred to lysis matrix B tubes (IEPSA) and ribolysed        
3 times using the FastPrep Savant FP-120 Ribolyser for 45 s (Speed = 6), with incubation on ice 
for 2 min between each ribolysis. The lysate was transferred to the supplied lipid filters tubes and 
centrifuged at 11 000 × g for 30 s. Thereafter, 350 μl of 70 % ethanol was added to the flow-
through and the solution was transferred to nucleic acid binding columns, centrifuged at                    
11 000 × g for 30 s and the flow-through was discarded. A 350 μl aliquot of membrane desalting 
buffer (MBD) was added to the column, which was centrifuged at 11 000 × g for 30 s and the flow-
though was discarded. A 100 μl aliquot of the DNAse reaction mixture containing 10 μl of 
reconstituted rDNAse (reconstituted as per manufacturer’s instruction) and 90 μl of Reaction 
buffer for rDNAse was added to the column, followed by incubation at room temperature for          
30 min. Thereafter, the column was washed by aliquoting 200 μl of Buffer RA2 into the membrane 
and centrifuging for 30 s at 11 000 × g. A second and third wash was conducted using 600 μl 
Buffer RA3 at 11 000 × g for 30 s, followed by 250 μl Buffer RA3 at 11 000 × g for 2 min. 
Following the third wash, the column was placed in a fresh Eppendorf tube, 60 μl of RNAse free 
water was aliquoted onto the membrane, incubated at room temperature for 10 min and RNA eluted 
by centrifugation at 11 000 × g for 1 min. The RNA was then quantified using the NanoDrop 
spectrophotometer. 
2.6.2 Reverse Transcriptase PCR (RT-PCR) 
RT-PCR was carried out using the Superscript III reverse transcriptase [RT] (Invitrogen). 
Reactions were set up in 25 μl volumes containing 1 μg of DNA free RNA and 0.2 mM reverse 
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primer mix consisting of the sigA mRNA conversion primer and the necessary gene-specific 
mRNA conversion primers. The sigA gene is a housekeeping gene, which is generally expressed 
at a consistent level throughout different growth phases and is used for normalisation for 
differential RNA amounts isolated or used in the analysis. Primers were annealed to the RNA by 
incubation at 94 ºC for 90 s, 65 ºC for 3 min and 57 ºC for 3 min, followed by incubation on ice. 
The nucleic acid mix was split into two 12.5 μl aliquots, one for the RT reaction and another to 
serve as an RT free reaction control, to confirm the absence of any contamination/residual DNA 
in these samples. To the RT conversion sample, the following was added: 5 μl 5 × first strand 
buffer, 4 μl of 25 mM MgCl2, 2 μl of 0.1 mM Dithiothreitol, 1 μl of 10 mM dNTP and 0.5 μl 
Superscript III reverse transcriptase (SSIII). The RT free control contained the same components; 
however, the SSIII was substituted by sterile nuclease free water. These reactions were incubated 
at 50 ºC for 50 min, followed by heat inactivation of the enzyme at 85 ºC for 5 min. The cDNA 
was then used for qPCR. 
2.6.3 Quantitative real-time PCR (qPCR) amplification 
Using either genomic or cDNA, qPCR amplification was conducted using the Biorad SsoFast 
Evergreen Supermix (Bio-Rad Laboratories). In this case, 20 μl reactions containing 10 μl 
Supermix, 0.25 mM qPCR forward primer and the qPCR reverse primer, 2 μl template cDNA and 
sterile distilled nuclease free water were set up and incubated in the CFX96 Real-Time PCR 
detection system (Bio-Rad Laboratories). The following parameters were used: enzyme activation 
step of 95 ºC for 30 s, followed by a ten cycle touchdown stage consisting of 3 steps; denaturation 
at 95 ºC for 10 s, annealing beginning at 65 ºC for 10 s and gradually decreasing by 0.5 ºC after 
each cycle, elongation at 72 ºC for 10 s, followed by SYBR Green quantification at the end of each 
cycle. The touchdown was followed by a 35 cycle stage consisting of a 95 ºC denaturation step for 
10 s, a 60 ºC annealing step for 10 s and a 72 ºC elongation step for 10 s, followed by SYBR Green 
quantification at the end of each cycle. Melt curve analysis was conducted beginning at a 
temperature of 50 ºC, then gradually increasing by 0.5 ºC every 0.05 s to 95 °C, SYBR Green 
quantification was conducted continuously throughout this stage. Raw data was then processed 
using the Biorad CFX Manager 2.1 software (Bio-Rad Laboratories). 
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2.7 Analysis of bacteria growth 
2.7.1 Growth rate analysis 
Bacterial growth analysis of wild type and mutant strains was conducted using growth curve 
experiments. Pre-cultures for each strain were set up in 10 ml culture volumes using either 1 ml 
frozen stocks or a single colony. These were grown at 37 ˚C, shaking at 100 rpm in the case of M. 
smegmatis, until they reached stationary phase (OD600nm ≈ 2).  The pre-cultures were then diluted 
to a final OD600nm = 0.05 in 50 ml 7H9S or 7H9T containing appropriate antibiotic, when 
necessary, and incubated at 37 ºC, with shaking at 100 rpm for M. smegmatis. Growth was 
determined by recording OD600nm measurements at 3 h intervals for M. smegmatis or daily for 
Mtb. Ten-fold serial dilutions were also set up for each time point and plated on 7H10 or 7H11, 
containing appropriate antibiotics and incubated at 37 ˚ C for 3 - 5 days in the case of M. smegmatis 
or 4 to 6 weeks for Mtb. The colonies that emerged were then counted to determine the colony 
forming units per ml (CFU/ml). Data were displayed as a scatter plot. 
2.7.2 Fluorescence microscopy 
Cells were grown in 10 ml 7H9S containing appropriate antibiotics to an OD600nm = 0.8, followed 
by harvesting and washing twice in PBS. Cells were then resuspended in 1 ml of 7H9S containing 
appropriate antibiotics. Thereafter, 0.2 μl of 5 mg/ml vancomycin and 1 μl of 1 mg/ml BODIPY-
fluorescent vancomycin (Invitrogen) were added to the culture, followed by incubation at 37 ºC 
for 1.5 h. The cells were then washed twice in 7H9 and resuspended in 50 μl 7H9S. Agarose pads 
were then prepared by spotting 500 µl of molten 2 % agarose, dissolved in dH2O, on a slide then 
placing a second slide on the spot to flatten the agarose. This was allowed to set for 5 min, the top 
slide was removed, and 5 μl of sample was spotted on the agarose pad and left at room temperature 
for 2 min. A cover slip was placed on the agarose pad and the slides were then viewed using an 
Axio Observer Z1 base microscope (Zeiss). Images were taken using an AxioCam HRm camera 
and processed using the Zen blue Ver 5.1.2600 (Zeiss) or ImageJ Ver 1.48.  Any image 
manipulation was applied to the entire image. 
2.7.3 Time-lapse microscopy 
A 5 ml culture was grown in 7H9S or 7H9T, containing appropriate antibiotics, to an                
OD600nm = 0.8. This was centrifuged at 500 × g for 5 min to remove clumps. The pellet was 
discarded and the cell suspension was passed through a 5 µm filter to remove remaining bacterial 
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clumps. A 10 µl sample was then spotted and gently spread on a cellulose membrane, followed by 
incubation for   2 min at room temperature to allow the bacteria to settle on the membrane. The 
slide was then placed a microfluidic device.  The bacteria were then imaged using a Delta vision 
Personal DV imaging system (GE HealthCare Life Sciences), using a 100x objective (Olympus 
Plan Semi Apochromat, 1.3 NA). The images were acquired at 10 or 15 min intervals using a 
CoolSnap HQ2 camera. Images were acquired on FITC (GFP fluorescent reporter strains; 
excitation 490/20 nm; emission 528/38 nm); TRITC/Cy5 (FM4-64 staining; excitation            
542/27 nm ; emission 676/34 nm). Either 7H9S of 7H9T medium was circulated through the device 
at a flow rate of 25 µl/min. Images were analysed and processed using Softworx 4.1 (Applied 
Precision, GE HealthCare) or ImageJ v 1.48. 
2.8 Scanning electron microscopy (SEM) 
A 50 ml culture was grown in 7H9S or 7H9T containing appropriate antibiotic to an OD600nm of 
0.8. The cells were harvested by centrifugation, washed twice with PBS and resuspended in 2.5 % 
gluteraldehyde in PBS overnight at 4 °C. The cells were then washed twice with PBS and 
resuspended in 100 μl of 2 % osmium tetraoxide in PBS and incubated at room temperature for       
1 h. Cells were then washed twice with PBS and dehydrated by submerging in a series of ethanol 
concentrations for 2 min at each concentration beginning with 30 % then 50 %, 70 % and twice at 
100 % ethanol, followed by storage in 100 % ethanol. Cells were spotted on a filter, coated twice 
with carbon and viewed using the FEI Nova NenoSEM 230. 
2.9 Transmission electron microscopy (TEM) 
A 50 ml culture was grown in 7H9S or 7H9T containing appropriate antibiotic to an OD600nm of 
0.8. The cells were harvested by centrifugation and washed twice in 1 ml PBS. Cells were 
resuspended in fixing solution containing 0.1 mM HEPES, 2 % (v/v) formaldehyde, 2.5 % (v/v) 
gluteraldehyde and 0.05 % (w/v) ruthenuim red and incubated at room temperature for 1 h. The 
cells were then harvested and resuspended in 100 μl of 2 % osmium tetraoxide in PBS and 
incubated at room temperature for 1 h. The samples were then washed twice in PBS and dehydrated 
by submerging in a series of ethanol concentrations for two min at each concentration beginning 
with 30 % then 50 %, 70 % and twice at 100 % ethanol. The dehydrated samples were then washed 
in propylene oxide twice and incubated for 1 h in a solution made up of 50 % propylene oxide and 
50 % resin mixture, which consists of 5.62 g araldite, 7.75 g epon 812 and 15 g DDSA. The 
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propylene oxide resin mixture was then removed and the cells were resuspended in 100 % resin 
mixture and incubated at room temperature overnight. Cells were harvested, the resin mixture was 
removed and fresh resin mixture containing DMP 30 at a ratio of 1:40 (g: g) of DMP 30 to resin 
mixture was added to the cells and incubated at 60 °C for 48 h. The solidified resin was sectioned 
using a Relchert Ultracut Ultramucrotome (Circa) and viewed using a Tecnai F20 TEM. 
2.10 Antibiotic susceptibility assays 
The concentration of antibiotic required to inhibit the growth of various mycobacterial strains was 
determined using a microtiter assay. Briefly, bacterial strains were grown to an OD600nm = 0.3. The 
microtiter plates were then set up using 96 well plates containing 12 rows. Antibiotic stocks, 
containing 4 × the initial concentration required for the first row in the plate, were set up and       
100 µl of the stock was inoculated into the first row. Thereafter, 50 µl of media was inoculated 
into rows 2 to 12, then a 50 µl aliquot of the antibiotic stock from row 1 was inoculated into row 
2, mixed and 50 µl was removed from row 2 and inoculated into row 3. This was done through to 
row 12 and a 50 µl aliquot was removed from the last row and discarded. Bacterial cultures were 
diluted 10 000 fold and a 50 µl aliquot was added to each well. These plates were sealed and 
incubated at 37 ˚C for 3 – 7 days at which point, growth was examined to determine the antibiotic 
minimum inhibitory concentration (MIC). 
2.11 Ethidium bromide diffusion assay (EtBr) 
A 20 ml culture was grown in 7H9 containing appropriate antibiotic to an OD600nm equal 0.8. The 
cells were harvested by centrifugation at 3900 × g for 10 min, washed twice with PBS and 
resuspended in 1 ml PBS containing 0.4% glucose. The cell density was adjusted to an OD600nm of 
0.4. A 95 µl aliquot of the adjusted bacterial sample was placed into flat, clear bottom, black 96-
well plates, followed by addition of EtBr to final concentration of 8 µg/ml. Fluorescence was 
measured with an excitation and emission wavelength of 530 nm and 585 nm, respectively, every 
60 seconds for 60 min at 37 °C. 
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Figure 3.1: Flow chart highlighting the focus of chapter 3. Highlighted is the portion of the study which will be addressed in the following chapter (Figure drawn 
by S. Senzani). 
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3 The role of MSMEG_6281 (Ami1) in mycobacterial cell division 
3.1 Introduction 
3.1.1 Bacterial cell division 
Cell division is an essential process occurring in all living organisms ranging from highly complex 
multicellular organisms down to single-cell life-forms (Khalilgharibi et al., 2012). Though 
mechanistically complex, cell division can be broken down into two vital processes. The first 
involves the duplication and partitioning of genetic material into two identical copies, also known 
as karyokinesis, followed by the division of cytoplasmic material into two similar (or dissimilar) 
daughter cells (cytokinesis) (Khalilgharibi et al., 2012). Owing to the complex nature bacterial cell 
division, this process is regulated and facilitated by complex multiprotein elements, which play a 
vital role in ensuring correct progression and ultimate completion of the process (Egan and 
Vollmer, 2013). In bacteria, a key element required for cell division is the protein FtsZ. 
FtsZ is a tubulin-like bacterial protein, which possesses GTPase activity and is found in almost all 
bacteria (RayChaudhuri and Park, 1992, Wang and Lutkenhaus, 1993). It is central to cell division 
as it is believed to be the key component driving bacterial cytokinesis (Ortiz et al., 2016). FtsZ 
conducts two crucial functions during cell division, the first being an anchor for the recruitment of 
various cell division components, resulting in the formation of the cell division complex called the 
divisome (Ortiz et al., 2016, Mukherjee et al., 2001). The second is the provision of contractile 
force to drive the constriction of the inner cell membrane resulting in the formation and separation 
of the two daughter cells (Mukherjee et al., 2001). Both functions depend on the formation of the 
FtsZ-ring (Z-ring) (Mukherjee et al., 2001). 
3.1.1.1 The assembly of the ring 
The Z-ring is a ring-shaped complex consisting of multiple FtsZ polymers, bound to the 
circumference of the cell membrane at the site of cell division (Ortiz et al., 2016). Assembly of the 
ring begins with the polymerisation of FtsZ monomers with the aid of GTP (Scheffers and 
Driessen, 2002). The N-terminal GTPase region of FtsZ possesses a GTP binding pocket (Löwe 
and Amos, 1998). Binding of GTP results in further association of an adjacent C-terminal region 
with the GTPase domain of another FtsZ monomer, resulting in polymer formation (Scheffers and 
Driessen, 2002). These structures are not stable as GTP hydrolysis leads to dissociation of the       
C-terminal regions, leading to breakdown of the polymer. Consequently, there are components 
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which stabilise the Z-ring by inhibiting GTPase activity (Scheffers and Driessen, 2002). These 
include the bi-functional proteins ZapA, ZapB, ZapC and ZapD (Scheffers and Driessen, 2002, 
Low et al., 2004, Galli and Gerdes, 2012, Ortiz et al., 2016). These are somewhat functionally 
redundant proteins as they are individually non-essential. They stabilise FtsZ polymers and also 
play a role in the connection of neighbouring FtsZ polymers to form the ultimate structure of the 
Z-ring (Durand-Heredia et al., 2012). Deletion of multiple Zap components results in the formation 
of cellular filaments, which are unable to divide or form a Z-ring, indicating the collective 
essentiality of these proteins in the maturation and stabilisation of the Z-ring (Durand-Heredia et 
al., 2012). This extensive complement of zap genes is only found in γ-proteobacteria. In other 
organisms only ZapA is conserved and, in some instances, including actinomycetes, the zap genes 
are absent. The lack of clear zap homologues suggests alternate methods capable of stabilizing the 
Z-ring in actinomycetes. These mechanisms however remain currently unknown (Hale et al., 2011, 
Ebersbach et al., 2008, Marteyn et al., 2014). In addition to the Zap components, there are two 
other proteins that play an essential role in the maturation of the Z-ring, these are FtsA and ZipA. 
Though FtsZ retains the ability to interact with various cell division elements, it cannot bind to the 
cell membrane and requires FtsA and ZipA for this (Hale and de Boer, 1997).  
FtsA is an actin-like ATP binding protein which retains ATPase activity. The main function of 
FtsA is to anchor the Z-ring to the site of cell division (van den Ent and Löwe, 2000, Hale and de 
Boer, 1997). FtsA activity is dependent on the binding of ATP (van den Ent and Löwe, 2000). The 
interaction between FtsA and ATP leads to conformational changes, which result in the attachment 
of FtsA to the plasma membrane and polymerisation of FtsA components forming membrane 
associated protofilaments (Szwedziak et al., 2012, van den Ent and Löwe, 2000, Osawa et al., 
2008, Chen et al., 2017). These interact with the Z-ring, anchoring it to the cell membrane (Osawa 
et al., 2008, Cabré et al., 2013). ZipA conducts a similar function with one exception; ZipA does 
not form filaments and interacts directly with individual FtsZ monomers within the Z-ring 
filaments (Cabré et al., 2013, Loose and Mitchison, 2014, Chen et al., 2017). This protein, like the 
Zap complement of proteins, is only found in γ-proteobacteria (RayChaudhuri, 1999). ZipA also 
protects the Z-ring from ClpX protease degradation (Pazos et al., 2013). Association of ZipA 
inhibits interaction between ClpX and the Z-ring, thus preventing Z-ring degradation. This 
function cannot be conducted by any other cell division component (Pazos et al., 2013).  
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The localisation of the Z-ring is determined by various proteins that promote or inhibit assembly 
of the ring at the incorrect sites (Liu et al., 1999, Addinall and Lutkenhaus, 1996). These include 
multiple mechanisms such as the Min system, the Nucleoid Occlusion System (Noc) and other 
distinct components in organisms which do not possess clear homologues of these proteins. 
Alternate mechanisms include EzrA, which prevents FtsZ localisation at incorrect locations and 
SepF, MapZ, PomZ, SsgA and SsgB, which localise at sites of future septum formation prior to 
FtsZ and function to recruit FtsZ to these sites (Singh et al., 2007, Gola et al., 2015, Fleurie et al., 
2014, Treuner‐Lange et al., 2013, Willemse et al., 2011). Deletion or reduction of these 
components  results in multiple cell division defects including, misplacement of septa, leading to 
mini-cells and anucleate cells, as well as the formation of filaments as a result of the inability to 
recruit FtsZ (Singh et al., 2007, Gola et al., 2015, Fleurie et al., 2014, Treuner‐Lange et al., 2013, 
Willemse et al., 2011). 
Following the assembly and maturation of the Z-ring, a number of Fts components are then 
recruited to the septum, the first being FtsE and FtsX, which play an important role in the activation 
of cell wall amidases in E. coli and other cell wall hydrolases in Bacillus species (Yang et al., 
2011, Meisner et al., 2013, Egan and Vollmer, 2013). This is followed by the recruitment of FtsK, 
a DNA binding protein which plays a crucial role in the last phases of chromosome segregation by 
shuttling DNA to neighbouring daughter cells, ensuring that the complete genome is present in 
both daughter cells (Massey et al., 2006). Next is FtsQ, FtsB and FtsL, which appear to be recruited 
as a complex. However, the exact function of this carefully coordinated sequence of events 
currently remain unclear (Egan and Vollmer, 2013). This is followed by recruitment of FtsW, 
which functions as a lipid II transporter. Following this, FtsI, a penicillin-binding protein 
responsible for the synthesis of septal PG, is recruited to the septum (Mohammadi et al., 2011, 
Egan and Vollmer, 2013). The last component recruited is FtsN, which initiates septum synthesis 
and membrane constriction. FtsN is also essential for the septal recruitment of the cell division 
amidase, AmiC, and the penicillin-binding protein, PBP1B, in E. coli (Rico et al., 2010, Peters et 
al., 2011). This complex, termed the divisome, forms the core machinery driving cell division and 
separation in bacteria, shown in Figure 3.2. This dissertation focused on amidase function in cell 
division in mycobacteria. 
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Figure 3.2: Cross sectional diagrammatic representation of a bacterial septum indicating two divisomes formed at 
adjacent sites of the Z-ring. Shown are the various components which make up the bacterial divisome and the direction 
of Z-ring constriction depicted by the red arrows. CM: cell membrane and PG: PG. Figure was drawn by S. Senzani 
using microscoft PowerPoint 2012. 
3.1.2 The function of cell wall amidases 
Cell wall amidases have different roles in a wide variety of organisms. Many organisms encode a 
multiplicity of these genes and though they catalyse the same reaction, their fundamental 
physiological role in different organisms varies, mainly due to the expression patterns and 
subcellular localisation. The most extensively studied group of cell wall amidases to date are those 
found in the gram-negative E. coli and the gram positive B. subtilis. These are discussed further 
below. 
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ZipA
FtsEX
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Cytoplasm
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3.1.2.1 Cell wall amidase function in the model organisms 
A majority of the work conducted to understand the function of cell wall amidase during cell 
division has been conducted in the model species E. coli, which encodes 5 distinct cell wall 
amidases [designated as AmiA, AmiB, AmiC, AmiD and AmpD (Heidrich et al., 2001, Korsak et 
al., 2005)].  
AmiA is a periplasmic, amidase_3 domain-containing amidase. Deletion of this enzyme pointed 
to a possible role in cell division, as strains lacking AmiA displayed septation defects which were 
illustrated by the formation of cellular chains consisting of three to four cells attached by division 
septa (Korsak et al., 2005, Heidrich et al., 2001). The mechanism through which AmiA conducts 
this role is still unknown, as fluorescence-based localisation of AmiA has shown the enzyme 
localises diffusely throughout the cell. Furthermore, interaction between AmiA and elements 
localizing at the division septa has not been demonstrated (Bernhardt and de Boer, 2003). Analysis 
of the domains contained within this enzyme indicates AmiA is comprised of only the amidase_3 
domain, containing no putative PG binding domains. This suggests the enzyme interacts with 
additional components in order to associate with the PG substrate. 
AmiC is a periplasmic, amidase_3 domain containing amidase. AmiC is hypothesised to function 
as the major septation amidase, as analysis of E. coli strains lacking AmiC displayed significant 
septation defects as depicted by the formation of cellular chains consisting of three to 6 cells 
attached by division septa in 20 to 30 % of the cellular population (Heidrich et al., 2001, Korsak 
et al., 2005). Analysis of the cellular localisation of AmiC amidase has demonstrated that the 
enzyme localises exclusively at the division septa, supporting the hypothesis that it is a septal 
division enzyme (Bernhardt and de Boer, 2003). Analysis of the domains contained within this 
enzyme indicates AmiC is comprised of an amidase _3 domain and an AMIN domain, which is a 
PG binding domain hypothesised to play an important role in the correct septal localisation of 
AmiC (Rocaboy et al., 2013).  
AmiB is a periplasmic, amidase_3 domain containing amidase (Peters et al., 2011). Analysis of E. 
coli strains lacking AmiB yielded no defects in cell division; however, deletion of this enzyme in 
combination with AmiA or AmiC resulted in exacerbation of the AmiA or AmiC deletion 
phenotype (Korsak et al., 2005, Heidrich et al., 2001). Like AmiC, AmiB localises at the division 
septa and this localisation is also dependent of FtsN (Peters et al., 2011). This suggests AmiB 
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functions synergistically with AmiC to hydrolyse septal PG. Analysis of the domains contained 
within this enzyme indicates AmiB is comprised of an amidase_3 domain, containing no putative 
PG binding domains, suggesting interaction with additional components in order to interact with 
septal PG. 
Further analysis of these amidases revealed the presence of amidase activators, designated as EnvC 
and NlpD (Uehara et al., 2010). These are non-catalytic Peptidase_M23 domain-containing 
proteins that possess the ability to enhance AmiA, AmiB or AmiC mediated PG hydrolysis (Uehara 
et al., 2010). The amidase activator EnvC activates AmiA and AmiB (Uehara et al., 2010). EnvC 
localises at the division septum and this recruitment is dependent on the ABC transporter complex, 
FtsEX, which forms part of the divisome (Yang et al., 2011, Peters et al., 2011). EnvC interaction 
with the FtsEX complex is facilitated through the trans-membrane protein FtsX. Both EnvC and 
FtsX possess coiled coil domains that may play a role in interaction. NlpD is responsible for the 
activation of AmiC and also localises to the division site however, NlpD recruitment is FtsN 
dependent (Yang et al., 2011, Peters et al., 2011). Direct interaction between NlpD and FtsN has 
not been demonstrated. The mechanism through which these proteins activate amidases is 
unknown. Currently, the proposed model of activation suggests that the native conformation of the 
three amidases consists of a closed active site preventing PG attachment. The interaction with 
activator is expected to lead to conformational alterations in the amidase which would result in an 
open active site (Uehara et al., 2010). 
3.1.2.2 Cell wall amidases in Chlamydia 
Organisms in the genus Chlamydiales do not possess any genes coding for FtsZ and a number of 
components belonging to the Fts complement are not present. Thus, lack the central component 
required for cell division in other bacteria suggests a divergent mechanism of cell division 
(Pilhofer et al., 2013). Initially, it was proposed that the absence of FtsZ did not affect cell division 
primarily due to the hypothesis that Chlamydiales do not possess the classical bacterial cell wall 
containing PG, subsequent studies have shown that these organisms do retain genes required for 
PG synthesis and revealed synthesis of septal PG during cell division, suggesting that other 
components compensate for the lack of FtsZ (Pilhofer et al., 2013). Two proposed candidates for 
this role are MreB and RodZ, which localise to future septal sites and appear to play a role in the 
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constriction of the inner membrane, similar to the Z-ring. The ability of these components to recruit 
other Fts elements however is unclear (Ouellette et al., 2012). 
Though lacking FtsZ, Chlamydiales retain a gene coding for a bi-functional amidase, AmiA 
(Klöckner et al., 2014). The Chlamydiales AmiA is unique in the sense that it possesses both 
amidase and carboxypeptidase activity (Klöckner et al., 2014). Furthermore, it has been shown to 
be an active amidase as complementation of the amidase deficient E. coli mutant with AmiA from 
Chlamydia reversed the chaining phenotype, indicating that the enzyme can function as a septal 
amidase (Klöckner et al., 2014). It is postulated that AmiA is responsible for the processing of 
lipid II material prior to incorporation into the cell wall, as well as cleavage of cell wall material 
at the septum resulting in cell separation (Klöckner et al., 2014). 
As illustrated above, amidases play important and sometimes non-redundant roles in bacterial cell 
division. Their biological function in mycobacteria has yet to be fully unravelled. Preliminary data 
obtained in our lab identified and bio-infomatically characterised two mycobacterial amidase_3 
containing proteins in Mtb and their M. smegmatis homologues (Appendix D, Figure D1) (Senzani, 
2014 [MSc dissertation], Machowski et al., 2014). As one of these, MSMEG_6281 (herein referred 
to as Ami1), was predicted to be non-essential for growth, this protein was deleted in the mc2155 
background and preliminary analysis indicated a possible role for the mycobacterial amidase.  
Herein, we aimed to expand on these observations.  
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Hypothesis: Ami1 plays a central role in cell division and deletion thereof will result in division 
defects and changes in the mycobacterial cell wall. We also expect that these defects will result in 
morphological changes in the mycobacterial cell. 
Preliminary work prior to this PhD. As part of an MSc study (Senzani, 2014) an Ami1 defective 
mutant was generated and a preliminary phenotypic characterisation was carried out. 
Aims and objectives: The main aim of this section was to carefully characterise the existing Ami1 
defective mutant to establish a biological function for this enzyme. As such, the specific objectives 
included: 
1. An ami1 defective mutant was constructed in an MSc study (Senzani, 2014) and herein, 
the first objective was construction of a genetically complemented derivative, 
Δami1::pSEami1. 
2. Confirming previously identified phenotypic defects in the Δami1 mutant through 
microscopy. 
3. Assessing individual bacterial growth through single cell microscopy. 
4. Construction of a reporter strain, mc2155::pAmi1GFP to assess cellular localisation of 
Ami1GFP. 
5. Confirming Ami1GFP functionality through genetic complementation of the ∆ami1 strain. 
6. Construction of strains, mc2155::pFtsZGFP and Δami1::pFtsZGFP for cellular localisation 
of FtsZGFP in both mc2155 and the ami1 deficient strains. 
7. Construction of a ∆ami1::ParBM-DnaNG strain for localisation of DnaN and ParB in the 
ami1 deficient strain.  
8. Assessing antibiotic susceptibility and cell wall permeability of the ∆ami1 strain. 
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3.2 Methods 
3.2.1 Construction of the ami1 complementation derivative, Δami1::pSEami1  
Primers were designed; ami1pSECF and ami1pSECR listed on Table 3.3, to amplify the ami1 gene 
as well as 400 bp upstream the transcriptional start codon. PCR amplification of the respective 
fragments was carried out using Phusion polymerase, using an annealing temperature of 60 °C for 
ami1 and an elongation time of 1 min to allow for complete amplification of the ami1 fragment, 
which is 1245 bp. The PCR products were purified using the Nucleospin PCR purification Kit. 
Thereafter, 3 µg of pSE100 and the PCR products were digested with HindIII and XbaI, removing 
the Pmcy-tet. The pSE100 restriction product was then treated with FastAP phosphatase for 30 min. 
The restriction products were separated on a 0.8 % agarose gel and the respective bands (5172 bp 
for pSE100 and 1239 bp for ami1) were excised from the gel and purified using the Nucleospin 
gel purification kit. These were then quantified using the NanoDrop and ligations were set up 
containing 50 ng of pSE100 and varying molar ratios of ami1. The fragments were ligated using 
Fermentas T4 ligase for 10 min, transformed into DH5α cells and plated on LAHyg200. 
Ten possible clones were selected and screen by restriction with EcoRI, which would yield two 
fragments, a 4105 bp and a 2306 bp band. A single positive clone was grown in 50 ml LBHyg200 
overnight and bulk vector extraction was carried out using the Nucleobond bulk vector extraction 
kit. Extracted vector DNA was quantified and digested with a variety of enzymes to profile the 
ami1 complementation vector (pSEami1). The vector was also sent for sequencing to check for the 
presence of mutations within the amplicon. Following this, 1 µg of pSEami1 was electroporated 
into electrocompetent Δami1 cells, plated on 7H10Hyg50 and incubated at 37ºC for 5 days to create 
the Δami1::pSEami1 strain. Subsequently, 5 colonies were selected and PCR was conducted on 
these using the ami1pSECF and ami1pSECR primers which would yield a 489 bp band for the 
∆ami1 strain and both a 1240 bp band representing the pSEami1 copy and the 489 bp ∆ami1 band 
respectively  
A single clone was selected (Δami1::pSEami1), cultured and qPCR was conducted on the WT, 
Δami1 and Δami1::pSEami1 strains to compare the levels on ami1 transcription. The sigA gene 
was included to serve as a normaliser for RNA amounts.  
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Table 3.1: Bacterial strains created/used in this study 
Strain 
 
Genotype 
 
Reference 
 
Escherichia coli DH5α SupE44 ΔlacU169 hsdR17 recA1 endA1 gyrA96 
thi-1 relA1 
Promega, Madison, WI 
mc2155 High frequency transformation mutant of M. 
smegmatis ATCC 607 
(Snapper et al., 1990) 
Δami1 Derivative of mc2155 carrying an unmarked, out-
of-frame deletion in ami1 
Senzani, 2014 
Δami1::pMVami1 Derivative of Δami1 carrying pMVami1 
integrated at the bacterial attB phage attachment 
site, HygR 
Senzani, 2014 
Δami1::pSEami1 Derivative of Δami1 carrying episomal pSEami1, 
HygR 
This study 
mc2155::pAmi1GFP Derivative of mc2155 carrying an episomal 
pSAmi1GFP vector, HygR 
This study 
mc2155::pFtsZGFP Derivative of mc2155 carrying pMFtsZGFP 
integrated at the attB bacterial phage attachment 
site, HygR 
This study 
mc2155::plS220 Derivative of mc2155 carrying plS220 integrated 
at the bacterial attB phage attachment site, HygR 
This study 
mc2155::pMAmi1GFP Derivative of mc2155 carrying pMAmi1GFP 
integrated at the attB bacterial phage attachment 
site, HygR 
This study 
Δami1::pFtsZGFP Derivative of Δami1 carrying pMFtsZGFP 
integrated at the attB bacterial phage attachment 
site, HygR 
This study 
Δami1::plS220 Derivative of Δami1 carrying plS220 integrated at 
the bacterial attB phage attachment site, HygR 
This study 
Δami1::pAmi1GFP Derivative of Δami1 carrying episomal 
pAmi1GFP, HygR 
This study 
mc2155::ParBM-DnaNG Derivative of mc2155 in which parB and dnaN are 
replaced with parB-mCherry and dnaN-gfp, 
respectively 
Santi and McKinney 
(2015) 
∆ami1::ParBM-DnaNG Derivative of mc2155::ParBM-DnaNG, containing 
an out of frame deletion in ami1 
This study 
Δami1::pAmi2GFP Derivative of Δami1 carrying episomal 
pAmi2GFP, HygR 
This study 
KanR: Kanamycin Resistance, HygR: Hygromycin Resistance 
3.2.2 Construction of the Ami1 localisation strain, mc2155::pAmi1GFP 
Localisation of Ami1 was conducted using the rsEGFP fluorescent tag. The approach involved 
PCR amplification of the rsEGFP tag, and fusion to the ami1 gene by three-way cloning of the  
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Table 3.2: Vectors created and/or used in this study 
Vectors Genotype 
 
Reference 
pSEAmi1 Derivative of pSE100(H) carrying a functional ami1 gene 
and the upstream native promoter region HygR 
This study 
pAmi1GFP Derivative of pSE100 carrying the ami1-rsEGFP fusion 
gene downstream the Pmyc-tet HygR 
This study 
pFtsZGFP Derivative of pMV306(H) carrying the ftsZ-rsEGFP 
fusion gene downstream the ftsZ native promoter HygR 
This study 
pIS220 Derivative of pMV361 carrying a DivIVA-GFP fusion 
under the regulation of the hsp60 promoter, HygR 
(Santi and McKinney, 
2015)  
pFtsZGFP Derivative of pMV306(H) carrying the ftsZ-rsEGFP 
fusion gene downstream the ftsZ native promoter HygR 
This study 
KanR: Kanamycin Resistance, HygR: Hygromycin Resistance, AmpR: Ampicillin Resistance 
 
Table 3.3:  list of primers used in the M. smegmatis, ami1 study 
Gene primers Amplicon 
ami1pSECF GCGCGCTCTAGACTGCGCCATGATCGTCAC 1240 bp ami1 amplicon including  400 
bp upstream the ami1 start codon ami1pSECR GCCGCCAAGCTTGGAGAACCTCAAGAAGCA 
ami1RTF CCGGAATGATCGTGTTCCT qPCR product, a 106 bp region within 
the ami1 ORF  ami1RTR  CTCTCCTGGCAGTTCTTGGT 
ami1RTR2 GTCCCACGTGAAGCTGTGTT RT-PCR conversion primer 
SigARTF GGGCGTGATGTCCATCTCCT qPCR product,  a 122 bp region within 
the sigA ORF  SigARTR GTATCCCGGTGCATGGTC 
ftsZpSELF CGCGCGTCTAGACGCGTCGATCACGTTGAC 1586 bp ftsZ amplicon including  400 
bp upstream the ftsZ start codon and 
excluding the transcriptional stop 
codon 
ftsZpSELR GGCGGCGAATTCGTGCCGCATGAAGGGCGG 
ami1pSELF GCGCCGCCGCATGCCGCGACGCGGCTACCGTG 825 bp ami1 amplicon excluding the 
transcriptional stop codon ami1pSELR GCGCGCGCGAATTCACGCACGGGGCTGACGGC 
rsEGFPF CGCGCGGAATTCATGGTGAGCAAGGGCGAGGA 720 bp rsEGFP amplicon  
rsEGFPR1 GCGCGCCTGCAGAGGAGTCCAAGCTCAGCTAA 
rsEGFPRF GCGCGCCCATGGAGGAGTCCAAGCTCAGCTAA 
MsmAmi1SF GCCGCCGGATCCCAGGTACAGCCCGATGCT 1704 bp ami1 amplicon including 31 
bp of the 5′ end region of the ami1 
gene and 1673 bp of the region 
upstream the transcriptional start site 
MsmAmi1SR GCCGCCGAATTCGCAGACAGGCTGGGACTC 
*red: restriction endonuclease site 
 
ami1 and rsEGFP fragments into pSE100, downstream the Tet operator. This resulted in a 
construct wherein the Tet operator regulates the expression of ami1 which contains a C-terminal 
rsEGFP tag. 
Primers were designed, ami1pSELF and ami1pSELR, for ami1 and rsEGFPR and rsEGFPR1, for 
rsEGFP, listed in Table 3.3, to amplify the full-length ami1 gene and rsEGFP tag. In the case of 
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the amidase primers, these were designed to amplify a product which does not contain the 
transcriptional stop codon allowing for the fusion of the reading frame with the C-terminus of the 
rsEGFP tag. PCR amplification of the fragments was carried out using Phusion polymerase, using 
an annealing temperature of 60 ºC and an elongation time of 1 min to allow for complete 
amplification of the ami1 fragment. The PCR products were purified using the Nucleospin PCR 
purification Kit. Thereafter, pSE100 was digested with SphI and PstI, the ami1 fragment was 
digested with SphI and EcoRI and the rsEGFP fragment was digested with EcoRI and PstI. The 
digested pSE100 was then treated with FastAP phosphatase for 10 min. The restriction products 
were separated on a 0.8 % agarose gel and the respective bands (5498 bp for pSE100, 803 bp for 
ami1 and 698 bp for rsEGFP) were excised and purified using the Nucleospin gel purification kit. 
Thereafter, these were quantified using the NanoDrop spectrophotometer and ligations were set 
up containing 50 ng of pSE100 and varying molar ratios of the ami1 and rsEGFP fragments. The 
fragments were ligated using Fermentas T4 ligase for 10 min, transformed into DH5α cells and 
plated on LAHyg200. Following the emergence of bacterial colonies, 10 possible clones were 
selected and screen by restriction with EcoRI, which would yield four fragments, a 2461 bp,       
2306 bp, 1538 bp and a 732 bp band. A single positive clone (pAmi1GFP) was grown in 50 ml 
LBHyg200 overnight and bulk vector extraction was carried out using the Nucleobond bulk vector 
extraction kit. Vector DNA was quantified and digested with a variety of enzymes to profile the 
rsEGFP tagged Amidase 1 vector. The vector was also sent for sequencing to check for mutations, 
which might have occurred during PCR amplification. Following confirmation, 1 µg of the vector 
was then electroporated into electrocompetent mc2155 cells, plated on 7H10Hyg50 and incubated at 
37ºC for 5 days to create the mc2155::pAmi1GFP. Clones were selected and assessed by PCR 
screening using the ami1pSELF and the rsEGFPR primers to determine whether they possess the 
full length ami1-rsEGFP fusion fragment. The PCR was run on 0.8 % agarose gel. 
3.2.3 Construction of the FtsZ localisation strains, mc2155::pFtsZGFP and 
Δami1::pFtsZGFP 
Localisation of FtsZ was conducted using the rsEGFP fluorescent tag. As with Ami1, the approach 
involved PCR amplification of the rsEGFP tag and the ftsZ gene including 400 bp upstream the 
transcriptional start site. The amplification would be followed by three way cloning of the ftsZ and 
rsEGFP fragment into the integrating vector pMV306(H). 
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Primers, ftsZpSELF and ftsZpSELR for ami1, and rsEGFPR and rsEGFPRF for rsEGFP, listed in 
Table 3.3, were used to amplify the rsEGFP tag and ftsZ fragment. The ftsZ primers were designed 
to amplify a product which does not contain the transcriptional stop codon allowing for fusion to 
the C-terminus of the rsEGFP tag. PCR amplification of the respective fragments was carried out 
using Phusion polymerase, using an annealing temperature of 60ºC and an elongation time of           
1 min to allow for complete amplification of the ftsZ fragment, which is 1586 bp. The PCR 
products were purified using the Nucleospin PCR purification kit and 3 µg of pMV306(H) and the 
PCR products were digested for cloning. The pMV306(H) vector was digested with NcoI and XbaI, 
the ftsZ fragment was digested with XbaI and EcoRI and the rsEGFP fragment was digested with 
EcoRI. Thereafter, pMV306(H) was treated FastAP phosphatase for 30 min and the rsEGFP 
fragment was phosphorylated with PNK. The digested products were separated on a 0.8 % agarose 
gel and the respective bands (4262 bp for pMV306, 1564 bp for ftsZ, 706 bp for rsEGFP) were 
excised and purified using the Nucleospin gel purification kit. The resulting DNA was quantified 
using the NanoDrop spectrophotometer and ligations were set up containing 50 ng of pMV306(H) 
and varying molar ratios of ftsZ and rsEGFP fragment. The fragments were ligated using 
Fermentas T4 ligase for 10 min, transformed into DH5α cells and plates LAHyg200. Several, possible 
clones were selected and analysed by restriction with EcoRI, which would yield three fragments, 
a 2858 bp, 2943 bp, and a 743 bp band. One positive clone was grown in 50 ml LBHyg200 overnight, 
followed by bulk vector extraction using the Nucleobond bulk vector extraction kit. Vector DNA 
was profiled with a variety of restriction enzymes to confirm integrity. The vector was also sent to 
Inqaba biotech, for sequencing to confirm that no mutations occurred during PCR amplification. 
Once confirmed, 1 µg of the vector was then electroporated into electrocompetent mc2155 and 
∆ami1 cells, plated on 7H10Hyg50 and incubated at 37ºC for 5 days to create the mc2155::pFtsZGFP 
and ∆ami1::pFtsZGFP. Clones were selected and assessed by PCR screening using the ftsZpSELF 
and the rsEGFPR primers to determine whether clones possess the full length ftsZ-rsEGFP fusion 
fragment. PCR products were run on a 0.8 % agarose gel. 
3.2.4 Construction of the ∆ami1::ParBM-DnaNG strain  
To construct the ∆ami1::ParBM-DnaNG strain, the native ami1 gene was knocked out using 
homologous recombination in a strain background that contained chromosomal derivatives of parB 
and dnaN that carry fusions to fluorescent proteins (Santi et al., 2013). This strain was kindly 
provided by N. Dhar. This technique involves the use of a suicide vector carrying a 
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truncated/deleted non-functional version of the gene of interest and a substantial amount (1200 bp 
- 1500 bp) of the 5′ and 3′ regions to create areas of homology. Also included are selectable and 
counter-selectable markers. The vector was inserted into mycobacterial cells and plated on 
antibiotic, which drives the integration of the non-replicating suicide vector into the mycobacterial 
genome using the 5′ or 3′ homologous regions, resulting in the production of a single crossover 
(SCO) strain that retains both the wild type and mutant allele. The second homologous 
recombination event is induced by using a counter-selectable marker on the vector, in this case the 
sacB gene, which encodes Levane Sucrase that converts sucrose to a toxic metabolite, resulting in 
the death of bacterial cells (Reyrat et al., 1998). Thus, plating on media containing sucrose drives 
the occurrance of the second recombination event, removing the vector to abrogate the lethality of 
the sacB gene. The second crossover can occur in the same homologous region as the first 
crossover, resulting in the regeneration of the wild type strain, or it can occur in the homologous 
region opposite to that of the first crossover, resulting in the production of a mutant strain. 
Using the p2ΔAmi1G19 vector generated previously (Senzani, 2014), 1, 3 and 5 µg of DNA was 
electroporated into electrocompetent mc2155::ParBM-DnaNG cells and plated on 7H10 containing 
Kan, Hyg and 0.004 % X-gal, then incubated at 37 ˚C for 5 days to create SCOs. A single blue 
colony was then cultured in 2 × TY supplemented with Kan and Hyg at 37 ºC, then sub-cultured 
in 2 × TY without antibiotic. The resulting cells were subjected to sucrose counter selection by 
plating 100 μl of a 10-fold serial dilution series onto media containing sucrose and X-gal. The 
plates were incubated for 3 - 5 days until blue and white colonies emerged. White colonies 
represent strains which have undergone the second cross over event to yield either a reversion to 
wild type or a mutant strain and blue colonies represent strains that have incurred a mutation in 
sacB to render them resistant to the toxic effects of sucrose. Subsequently, 10 white colonies were 
selected and PCR screening was conducted on these using the ami1pSECF and ami1pSECR 
primers which would yield a 1240 bp band in the case of wild type and a 489 bp band for the 
∆ami1::ParBM-DnaNG strain.  
 
Figure 3.3 illustrates the basic outline of the research undertaken in this chapter, with reference to 
the specific methods.  
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Figure 3.3: Flow chart depicting the experimental layout for the work undertaken to study M. smegmatis ami1, 
described in this chapter.  
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3.3 Results 
3.3.1 Construction of the Ami1 complementation strain 
During an MSc study (Senzani, 2014), a Δami1 mutant was constructed and genotypic 
characterisation of this strain can be found in Appendix D, Figure D2. Thereafter a genetically 
complemented derivative of the ami1 mutant was constructed. However, this strain did not 
display the expected reversion to the wild type phenotype. Hence, a new strain was constructed 
herein. The approach adopted involved the introduction of an episomal variant of ami1, in which 
expression would be driven of the native promoter as opposed to the integrating pMVami1 vector.  
3.3.1.1 Construction of the pSEami1 vector 
PCR amplification was conducted to amplify the ami1 gene and 400 bp upstream the 
transcriptional start codon. The fragments were then cloned into pSE100 and clones were screened 
by restriction digest with EcoRI. A single positive clone was then selected and the genetic integrity 
of the vector was confirmed by extensive restriction profiling, which is shown in Figure 3.4. 
In all cases, with the exception of the SmaI restriction digest, which did not cleave the vector DNA, 
all the fragment sizes observed corresponded to the vector map and expected sizes, confirming the 
genetic integrity of the vector (Figure 3.4). The genetic integrity of the vector was then further 
confirmed by sequencing of the cloned region, which revealed that no mutations had occurred 
during PCR and cloning processes (data not shown). This vector was then used for construction of 
the ∆ami1::pSEami1 strain. 
3.3.1.2 Construction and screening of the ∆ami1::pSEami1 strain  
The pSEami1 vector was electroporated into the mc2155 strain (section 2.4.2); the transformation 
efficiency obtained from the electro-competent cells was 8.4 × 103 CFU/µg vector DNA 
(determined using the pSE100 control vector). Five clones were selected and screened by PCR, 
Figure 3.5A. Clone 1 was selected and RT-qPCR was conducted to determine whether the full 
length variant of the gene was being expressed at similar levels to the mc2155 copy, Figure 3.5B. 
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Figure 3.4: Restriction profile of pSEami1. Shown are the different restriction nucleases used and the expected sizes 
in a table, which result from restriction digests of the pSEami1 vector. The predicted vector map of pSEami1 vector 
and agarose gel depicting the products of restriction digest of pAmi1GFP are also shown. In the agarose gel, Lane 1: 
Roche Marker IV, Lane 2: Uncut, Lane 3: EcoRI, Lane 4: RcaI, Lane 5: SacI, Lane 6: XhoI, Lane 7: SmaI, Lane 8: 
AatII. 
3.3.2 Ami1 is essential for bacterial cell division and cell shape maintenance  
Preliminary work conducted in M. smegmatis depicted a possible role for Ami1 in cell division as 
shown by the formation of chains consisting of three or more cells attached by cell division septa 
(Senzani, 2014). At the time, we did not conduct an in-depth analysis of the observed phenotypes 
to determine the robustness of the data. As such, one of the initial tasks in this PhD was to assess 
the cell division defects observed in the preliminary analysis. Thus, high resolution SEM was 
conducted on the mc2155, ∆ami1 and ∆ami1::pSEami1 strains and representatives of the resulting 
micrographs are given in Figure 3.6. We noted numerous defects including the formation of 
cellular chains, lateral budding and abnormal septa, Figure 3.6. To further quantify this, various 
parameters including cell length, width, percentage of chains and percentage of cells containing 
abnormal septa were measured to get a better understanding of the phenotypes, Figure 3.7 and 
Figure 3.8. 
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Figure 3.5: PCR screen and RT-qPCR of the ∆ami1::pSEami1 strain. (A) Shows the PCR screen for the five possible 
∆ami1::pSEami1 clones showing the expected PCR product size (1195 bp) represent the full length ami1 and the 400 
bp 5′ region; Lane 1: Roche Marker VI, Lane 2: mc2155, Lane 3: no template control and Lanes 4 to 8: clone 1 to 5. 
(B)  Shows a bar graph representing the normalised log phase expression levels of ami1 in the mc2155, ∆ami1 and 
∆ami1::pSEami1 strains. Data are the average of three independent experiments. 
From the ~ 400 cells analysed per strain, 20 % of the ∆ami1 population were in the form of chains, 
while only 1.4 % and 3.7 % of the mc2155 and ∆ami1::pSEami1 strains displayed this phenotype, 
respectively. A more prominent observation was the presence of septa in 94 % of the ∆ami1 
population as opposed to the 18 % and 16 % found in the mc2155 and ∆ami1::pSEami1 strains 
respectively. This indicated that the ∆ami1 mutant was arrested at the late stages of cell division, 
at the cell separation stage. Furthermore, 22 % of the ∆ami1 population displayed the presence of 
abnormal septa, Figure 3.7. Further analysis of bacterial cell length and width revealed that the 
∆ami1 strains was longer and thinner when compared to the mc2155 and ∆ami1::pSEami1 
counterparts. The ∆ami1 mutant strain also displayed a broader range with regards to cell length 
and width when compared to the wild type and genetically complemented counterparts. The ∆ami1 
displayed lengths of between 3 µm to 16 µm with a mean and median of 7.85 µm and 8.16 µm 
respectively, Figure 3.8.  Cells from the mc2155 and ∆ami1::pSEami1 strains fell within a cell 
length range of 2 µm to 9 µm with a mean and median of 4.76 µm and 4.82 µm with a mean and 
median of 0.48 µm and 0.48 µm respectively. The difference between the mc2155 and 
∆ami1::pSEami1 cell widths was marginal, ranging between 0.49 µm and 0.54 µm, with a mean 
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and median of 0.51 µm and 0.52 µm for the mc2155 population and ranging between 0.47 µm and 
0.54 µm with a mean and median of 0.51 µm and 0.52 µm for the ∆ami1::pSEami1 population. 
 
Figure 3.6: Microscopic analysis of the mc2155, ∆ami1 and ∆ami1::pAmi1GFP strains. Shown are SEM images of 
the mc2155, ∆ami1 and ∆ami1::pAmi1GFP strains. Strains were grown in 7H9 to log phase then fixed, dehydrated, 
carbon coated and imaged using high resolution SEM. Red arrows depict multiple septa found in ∆ami1 cell chains, 
Blue arrows indicate cell bulges found in the ∆ami1 strain, yellow arrows indicate ectopic buds and the insert and 
green arrow depict an abnormal septum.  
3.3.3 Ami1 does not affect septal PG synthesis 
In addition to high resolution SEM, fluorescence microscopy was conducted. This was done to 
evaluate the potential role of Ami1 during PG synthesis. To do this, the mc2155, ∆ami1 and 
∆ami1::pSEami1 strains were stained with BODIPY-vanc. This is a green fluorescent probe which 
binds to the terminal D-ala-D-ala moiety, found predominantly in newly synthesised PG and can 
be used to spatially monitor sites of new PG synthesis. Fluorescence microscopy was then 
conducted to assess spatial distribution of the BODIPY signal, Figure 3.9A. 
 
mc2155 ∆ami1 ∆ami1::pSEami1
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Figure 3.7: Histogram showing the quantification of the various ∆ami1 associated phenotypic defects out of 
approximately 400 cells per strain. Displayed are the three distinctive phenotypes which emerged as a result of ami1 
deletion and the proportions in which they were observed in the mc2155, ∆ami1 and ∆ami1::pSEami1 strains from 
three biological replicates, p-values were obtained using the student’s t – test. ***: p < 0.001. 
All three strains displayed a similar staining pattern, with BODIPY-vanc localizing primarily at 
the cell pole and division septum, suggesting Ami1 does not play a role in directing PG synthesis 
to these sites. Following this, analysis of the intensities of BODIPY staining in the individual cells 
was conducted, using ImageJ, to determine whether specific regions of the cell are undergoing 
elevated levels of PG synthesis as depicted by increased levels of BODIPY-vanc localisation and 
subsequent fluorescence, Figure 3.9B.  This analysis revealed that in all three strains stain equally 
well at the poles and the septum. We also noted that staining intensity at both poles was not equal 
as one pole fluoresced more brightly, Figure 3.9B. These data confirmed the observations from a 
recent seminal study that reported that mycobacterial growth occurs through the greater 
incorporation of cell wall material at one pole (Botella et al., 2017). The chaining phenotype in the 
∆ami1 mutant was confirmed as demonstrated by the presence of multiple septa that stained with 
BODIPY-vanc. This confirmed that new PG was being incorporated at the septum in the mutant 
and that Ami1 played no role in this process Furthermore, in ∆ami1 chains, one septum appeared 
to fluoresce more than the others regardless of the number of septa suggesting the various septa 
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are synthesised in a successive manner. To further understand these findings, two parameters were 
quantified in these populations, the first being the proportion of cells displaying polar BODIPY-
vanc staining and the second evaluating the proportion of cells, within the polar staining 
population, which exhibit septal staining in addition to polar staining as an indicator of the 
proportion of cell undergoing cell division, Figure 3.10. 
 
Figure 3.8: Box-and-whisker analysis of the mc2155, ∆ami1 and ∆ami1::pSEami1 strains, showing the cell length and 
width of approximately 350 cells. (A) Comparison of the variation in cell length demonstrating a change in the 
distribution of mycobacterial cell length in the absence of Ami1. (B) Comparison of the variation in cell width 
depicting a change in the distribution of mycobacterial cell width in the absence of Ami1, p-values were obtained 
using the student’s t – test. ***: p < 0.001. Data represent three independent experiments. 
Analysis of ~ 200 cells indicated that 80 to 90 % of the cells displayed polar staining, with minor 
insignificant variations between the three strains. However, significant differences were observed 
when quantifying the proportion of cells displaying both polar and septal staining. In both the 
mc2155 and ∆ami1::pSEami1 populations 19 % and 16 %, respectively displayed septal staining; 
however, 90 % of the ∆ami1 population displayed septal staining confirming a high proportion of 
cells undergoing cell division. This is consistent with the high resolution SEM data which showed 
94 % of the ∆ami1 population contained cells with septa. 
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Figure 3.9: Microscopic analysis of the fluorescent BODIPY-vanc stained mc2155, ∆ami1 and ∆ami1::pSEami1 cells. 
A: Shown are the mc2155, ∆ami1 and ∆ami1::pSEami1 cells depicting the various staining patterns. B: Analysis of 
the BODIPY-vanc staining patterns in mc2155 and ∆ami1 through the quantification of fluorescence intensity in 
individual cells to elucidate sites of new PG synthesis. Red arrows indicate the cell poles, Purple arrows indicate cell 
septa and the blue arrows show the highly fluorescent septum in the ∆ami1 cell chain. 
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Figure 3.10: Histogram depicting the analysis of the fluorescent BODIPY-Vanc staining patterns. Shown is the 
proportion of bacterial cells that exhibit polar staining out of approximately 200 cells per strain, as well as the 
proportion of cells within the polar staining population which displays septal BODIPY-Vanc staining. p-values were 
obtained using the student’s t – test. ***: p < 0.001. Data represent three independent experiments. 
3.3.4 ∆ami1 can bypass stalled division through lateral growth 
Although the ∆ami1 strain exhibits significant division defects, the strain grew at the same rate as 
both mc2155 and ∆ami1::pSEami1 (data not shown). Thus to understand how this growth occurred, 
time lapse microscopy of the mc2155 and ∆ami1 strains was conducted. These strains were sent to 
the École polytechnique fédérale de Lausanne (EPFL) in Laussane, Switzerland where single cell 
time-lapse analysis was done. Thereafter, detailed analysis of the videos was conducted in this 
PhD, Figure 3.11. 
Time lapse microscopy of mc2155 revealed a typical growth pattern whereby the individual cells 
grow to a particular point followed by cell division resulting in the formation of two daughter cells. 
The ∆ami1 mutant cells displayed a number of deviations from the normal growth pattern. The 
most prominent defect in this mutant was the formation of viable lateral buds, which continue to 
elongate and function as new single cells. The lateral buds, led to branches that underwent cell 
division and appeared to function independent of the stalled ‘mother cell’. Furthermore, in some 
instances, these branches continue to form further aberrant buds, which then form branches 
resulting in a tree like form, Figure 3.11 and Appendix E, movies 3.1 to 3.6. Another notable defect 
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was the release of cell wall material from the septum, Figure 3.11 and Appendix E, movies 3.7 to 
3.9.  
 
I
II
III
IV
V
VI
mc2155
∆ami1
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Figure 3.11: Time-lapse microscopic analysis of the mc2155 and ∆ami1 strains. Cells were grown and imaged in 
7H9S media. I-III depicts three representative mc2155 micro-colonies, IV-VI depicts three representative ∆ami1 
micro-colonies showing cell budding and branch formation and VII-IX depicts three representative ∆ami1 micro-
colonies showing the release of cell wall material form the bacterial septum. Red arrows depict sites of cell division, 
blue arrows depict lateral budding and branch formation, yellow arrows depict polar budding and green arrows show 
cell wall material secretion. Movies were generated by N. Dhar then processed and analysed by the student (Senzani 
et al., 2017). 
3.3.5 Localisation of mycobacterial Ami1 
We next turned our attention to cellular localisation of Ami1. To assess cellular localisation, an 
Ami1-rsEGFP fusion protein was inserted into the mc2155 strain. The approach involved cloning 
of the ami1-rsEGFP fusion product downstream of the Pmyc-tet promoter (for constitutive 
expression of the fusion product), followed by the introduction of the vector into mc2155 and 
fluorescence microscopy.  
3.3.5.1 Construction of the pAmi1GFP vector 
PCR amplification was conducted to amplify the ami1 gene without the stop codon and the 
rsEGFP gene. The fragments were then cloned into pSE100 and clones were screened by 
restriction with EcoRI. A single positive clone was then selected and the genetic integrity of the 
vector was confirmed by extensive restriction profiling, shown in Figure 3.12. In all cases, all the 
fragment sizes observed corresponded to the vector map and expected sizes, confirming the genetic 
VII
VIII
IX
∆ami1 cell wall shedding 
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integrity of the vector. The genetic integrity of the vector was then further confirmed by sequencing 
of the cloned region, which revealed that no mutations had occurred during PCR and cloning 
processes (data not shown). This vector was then used for construction of the mc2155::pAmi1GFP 
strain. 
 
Figure 3.12: Restriction profile of pAmi1GFP. Shown are the different restriction nucleases used and the expected 
sizes in a table, which result from restriction digests of the pAmi1GFP vector. The predicted vector map of pAmi1GFP 
vector and agarose gel depicting the products of restriction digest of pAmi1GFP is also shown. For the agarose gel, 
Lane 1: Roche Marker IV, Lane 2: Uncut, Lane 3: BspHI, Lane 4: XhoI, Lane 5: EcoRI, Lane 6: PvuI, Lane 7: XmnI, 
Lane 8: SacI. 
3.3.5.2 Construction and screening of the mc2155::pAmi1GFP strain  
The pAmi1GFP vector was electroporated into the mc2155 strain (section 2.4.2); the 
transformation efficiency obtained from the electro-competent cells was 1.6 × 104 CFU/µg vector 
DNA (determined using the pSE100 control vector). Two clones were selected and screened by 
PCR using the ami1pSELF and the rsEGFPR primers (section 3.2.3) to determine the presence of 
the ami1-rsEGFP fusion DNA fragment (Appendix D, Figure D4).  
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Figure 3.13: Microscopic analysis of fluorescent Ami1-rsEGFP localisation in mc2155 cells. Cells were grown in 
7H9S and stained with FM4-64, which stains the plasma membrane, then mounted on agarose pads then images were 
captured using high resolution TIRF microscopy. Three different fields of view are shown above to provide a visual 
assessment of the localisation in the most of the cells assessed. White arrows indicate the division septum in cells 
undergoing cell division while blue arrows indicate individual puncta found across the elongating cell. Scale = 5 µm. 
3.3.5.3 Localisation of mycobacterial Ami1 
Following the construction of the mc2155::pAmi1GFP strain, high resolution TIRF microscopy 
was conducted to determine the cellular localisation of Ami1-rsEGFP. The cells were stained with 
the cell membrane strain FM4-64 to identify the membrane in the individual cells, Figure 3.13. 
Using TIRF microscopy, the Ami1-rsEGFP displayed punctate localisation throughout the 
longitudinal axis of the cell. In some instances septal localisation was observed, however, not all 
FM4-64 rsEGFP Composite
FM4-64 rsEGFP Composite
FM4-64 rsEGFP Composite
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septa displayed the presence of Ami1-rsEGFP. Thus, to further unpack these observations, the 
three basic localisation patterns observed were quantified, these were: 1, punctate localisation in 
cells with no septum; 2, non-septal lateral localisation in cells containing a septum and 3; Ami1-
rsEGFP septal localisation, Figure 3.14. 
 
Figure 3.14: Bar graph showing the analysis of Ami1-rsEGFP localisation patterns in the mc2155 strain. Shown is the 
proportion of the bacterial cells which exhibits various localisation patterns, out of approximately 200 cells, in both 
strains. White arrows indicate the division septum in cells undergoing cell division and blue arrows indicate individual 
puncta found across the elongating cell. Bar graph is a representative of two biological replicates. 
Quantification of these patterns revealed that 78 % of the population fell in the first localisation 
class, which was punctate localisation in cells with no-septum. Approximately 2 % of the 
population displayed non septal localisation in cells containing a septum and 20 % displayed septal 
Ami1-rsEGFP localisation, suggesting Ami1 could be recruited once the septum has formed. 
Furthermore, the analysis revealed that 22 % of the cells contained a septum, consistent with 
mc2155 SEM and BODIPY-vanc data suggesting the wild type strain was not affected by the 
overexpression of Ami1-rsEGFP. 
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3.3.5.4 Complementation of ∆ami1 with pAmi1GFP 
As the Ami1-rsEGFP localisation data revealed an unexpected pattern, it was prudent to determine 
whether the localisation was the result of a functional Ami1-rsEGFP derivative and not junk 
protein. To assess the functionality of the Ami1-rsEGFP, we genetically complemented the ∆ami1 
strain using the ami1-rsEGFP containing pAmi1GFP vector. 
3.3.5.4.1 Construction and screening of the ∆ami1::pAmi1GFP strain  
The pAmi1GFP vector was electroporated into the ∆ami1 strain (section 2.4.2); the transformation 
efficiency obtained from the electro-competent cells was 5.2 × 103 CFU/µg vector DNA 
(determined using the pSE100 control vector). Two clones were selected and screened by PCR 
using the ami1pSELF and the rsEGFPR primers (section 3.2.3) to determine the presence of the 
ami1-rsEGFP fusion DNA fragment (Appendix D, Figure D4).  
3.3.5.4.2 Analysis of ∆ami1::pAmi1GFP strain 
High resolution SEM was conducted on the ∆ami1::pAmi1GFP strain and same parameters were  
analysed as previously to determine whether the strain  ∆ami1::pAmi1GFP reverted to wild type 
physiological properties. Analysis of the SEM images suggested that the Ami-rsEGFP fusion 
protein displayed the ability to genetically complement the mutant. From the ~ 400 cells analysed 
per strain, 1.9 % of the of ∆ami1::pAmi1GFP population were in the form of chains, 10.4 % of the 
population contained septa and 4.4 % possessed abnormal septa, Figure 3.15. Additionally, the 
cell length of ∆ami1::pAmi1GFP ranged from 2 µm to 9 µm with a mean and median of 4.37 µm 
and 4.16 µm, which was similar to the wild type, thus confirming that the fusion protein was 
functional, Figure 3.15. 
3.3.6 Ectopic branch formation in the ∆ami1 mutant is mediated by DivIVA 
Thus far, we were able to establish that loss of Ami1 resulted in arrested cell division where septa 
were synthesised but were not degraded to allow for cell separation. Failure to complete cell 
separation resulted in the ectopic formation of lateral branches that continued to grow. We next 
sought to understand how this form of growth occurs and how these branches remain viable. To 
do this, four proteins involved in different parts of cell growth were evaluated. These were FtsZ,  
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Figure 3.15: Microscopic analysis of the complementation capacity of the Ami1-rsEGFP fusion protein. Shown are 
SEM images of the mc2155, ∆ami1 and ∆ami1::pAmi1GFP strains and the statistical analysis of the various ∆ami1 
associated phenotypes attained from approximately 400 cells per strains. p-values were attained using the student’s     
t – test. ***: p < 0.001. Red arrows point to unresolved septa in the ami1 mutant, a defect that was reverted in the 
strain complemented with Ami1-rsEGFP. Statistical analysis was conducted using data from three biological 
replicates. 
DivIVA (a marker for cell elongation, which will be discussed further in chapter 4.1), DnaN and 
ParB, the latter two are both essential components involved in chromosome replication and 
partitioning during cell division, respectively. These analyses were conducted through the 
localisation of these various proteins in order to determine how loss of Ami1 affects their tightly 
controlled subcellular localisation and ultimately their function. 
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3.3.6.1 Localisation of mycobacterial FtsZ 
As stated earlier, FtsZ is one of the initial proteins recruited to the site of cell division and plays 
an important role in the recruitment and anchorage of the bacterial cell division machinery. It also 
serves as a marker for division sites or future cell division sites (Eskandarian et al., 2017). With 
this in mind, it was essential to understand whether the mycobacterial cell division site 
determination mechanisms are affected by the loss of Ami1. To do this, a FtsZ-rsEGFP fusion 
protein was inserted in mc2155 and ∆ami1 strains to localise FtsZ. The approach adopted involved 
cloning of the ftsZ-rsegfp fusion product downstream its native promoter, followed by the 
introduction of the vector into mc2155 and ∆ami1 and time-lapse fluorescence microscopy.  
3.3.6.1.1 Construction of the pFtsZGFP vector 
PCR amplification was conducted to amplify the ftsZ gene, without the stop codon, containing a 
400 bp 5′ region upstream the transcriptional start codon and the rsEGFP wild type allele. The 
fragments were then cloned into pMV306(H) and clones were screened by restriction with EcoRI. 
A single positive clone was then selected and the genetic integrity of the construct was confirmed 
by extensive restriction profiling, shown in Figure 3.16. In all cases, the fragment sizes observed 
corresponded to the vector map and expected sizes, confirming the genetic integrity of the vector. 
The genetic integrity of the vector was then further confirmed by sequencing of the cloned region, 
which revealed that no mutations had occurred during PCR and cloning processes (data not 
shown). This vector was then used for construction of the mc2155::pAmi1GFP strain. 
3.3.6.1.2 Construction and screening of FtsZ localizing strains  
The pAmi1GFP construct was electroporated into the mc2155 strain and ∆ami1 (section 2.4.2), the 
transformation efficiency obtained from the electro-competent cells was 1.6 × 104 CFU/µg and 3.9 
× 104 CFU/µg vector DNA for mc2155 strain and ∆ami1, respectively (determined using the 
pSE100 control vector). Two clones were selected and screened by PCR using the rsEGFPF and 
the rsEGFPR primers (section 3.2.3) to determine the presence of the rsEGFP DNA fragment as 
the ftsZ-rsEGFP fragment was too large to check by PCR (Appendix D, Figure D5).  
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Figure 3.16: Restriction profile of pFtsZGFP. Shown are the different restriction nucleases used and the expected 
sizes in a table, which result from restriction digests of the pFtsZGFP vector. The predicted vector map of pFtsZGFP 
vector and agarose gel depicting the products of restriction digest of pAmi1GFP are also shown. For the agarose gels, 
Lane 1: Roche Marker IV, Lane 2: Uncut, Lane 3:BglII, Lane 4: XbaI, Lane 5: BamHI, Lane 6: EcoRI, Lane 7: PstI, 
Lane 8: KpnI. 
 
3.3.6.1.3 Localisation of mycobacterial FtsZ 
Following the construction of the FtsZ localizing strains, high resolution TIRF microscopy was 
conducted to determine the cellular localisation of FtsZ-rsEGFP. The cells were stained with the 
cell membrane stain FM4-64 to identify the membrane, Figure 3.17. 
The TIRF microscopic analysis of the mc2155::pFtsZGFP displayed the presence of four basic 
FtsZ-rsEGFP localisation patterns. These were; 1: no FtsZ-rsEGFP localisation, 2: Preseptal FtsZ-
rsEGFP localisation, wherein the FtsZ-ring has assembled but no septum has formed, 3: Septal 
FtsZ-rsEGFP localisation, wherein both the septum and FtsZ-ring have assembled at the same site 
and finally, 4: Daughter cell FtsZ-rsEGFP localisation, where the septal FtsZ-ring has  
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Figure 3.17: Microscopic analysis of fluorescent FtsZ-rsEGFP in mc2155 and ∆ami1 cells. Bacteria were grown in 
7H9 and stained with FM4-64, which stains the plasma membrane, then mounted on agarose pads followed by 
imaging. I-III depicts FtsZ-rsEGFP localisation in mc2155 and IV-VI represents FtsZ-rsEGFP localisation in the 
∆ami1 strain. White arrows indicate pre-septal FtsZ-rsEGFP localisation and blue arrows indicate septal FtsZ-rsEGFP 
localisation. 
disassembled and has begun to form in the two adjacent daughter cells, Figure 3.18. Analysis of 
FtsZ localisation in the Ami1 deficient strain revealed the presence of two additional classification 
patterns, which arose possibly as a result of the ∆ami1 division defects. These were 1: Daughter 
cell FtsZ-rsEGFP localisation in a chain, where all the cells in the chain displayed only localisation 
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with no septal localisation and 2: Multiple FtsZ-rsEGFP rings in a single daughter cell, where three 
or more FtsZ-rings assemble in a single daughter cell, Figure 3.17. 
Quantification of these patterns revealed relatively similar proportions in both populations 
displayed three localisation patterns which were, no FtsZ-rsEGFP localisation, Preseptal FtsZ-
rsEGFP localisation, and Septal FtsZ-rsEGFP localisation, with a high proportion of both 
populations displaying the Preseptal FtsZ-rsEGFP localisation pattern, 34.6 % for mc2155 and    
29.3 % for ∆ami1. The lack of significant differences in this regard suggested that the Z-ring was 
able to assemble properly in the absence of Ami1. There was, however, a significant difference 
between the populations displaying daughter cell FtsZ-rsEGFP localisation, in which case 36.7 % 
of the mc2155 population displayed this pattern while 21.4 % of the ∆ami1 population exhibited 
this pattern, Figure 3.18. Another difference related to the ∆ami1 associated localisation patterns, 
which were daughter cell FtsZ-rsEGFP localisation in a chain and multiple FtsZ-rsEGFP rings in 
a single daughter cell, these were noted in 6.9 % and 14.7 % of cells respectively in the 
∆ami1::pFtsZGFP strain, while none were found in the mc2155::pFtsZGFP strain, Figure 3.18. In 
addition to TIRF microscopy, time-lapse microscopy was conducted to elucidate the effect Ami1 
deficiency has on FtsZ placement and assembly, Figure 3.19 and Appendix E, movies 3.10 to 3.18. 
Time lapse microscopy of mc2155::pFtsZGFP revealed that the FtsZ-ring is dynamic and highly 
mobile, landing at the future cell division site. Also, the FtsZ-ring initially forms as two parallel 
rings close to the future cell division site these then eventually coalesce at the site of cell division 
resulting in constriction and cell division (Eskandarian et al., 2017). This two-ring confirmation of 
FtsZ is dysregulated in the ∆ami1 strain and instead of the two ring conformation, the FtsZ is 
predominantly found in the form of highly mobile puncta. These eventually merge to form a single 
FtsZ-ring. Furthermore, the Z-ring appears to be unstable as in some cases the ring disassembled 
when cell separation failed, presumably due to the lack of septum degradation, Figure 3.19 VII. 
This event was usually followed by Z-ring formation at the same site, which either disassembled 
again or proceeded through cell division.  Furthermore, in certain instances (25 of 84 micro-
colonies counted) cell separation failure resulted in the death of one daughter cell, predominantly 
the fast growing cell followed by the emergence of a new daughter cell at the failed septum (Figure 
3.19 IV to VI).    
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Figure 3.18: Histogram depicting the analysis of FtsZ-rsEGFP localisation patterns in the mc2155 and ∆ami1 strains. 
Shown is the proportion of bacterial cells which exhibit various localisation patterns, out of approximately 200 cells, 
in both strains white arrows show division septa. p-values were obtained using the student’s t – test. ***: p < 0.001. 
The bar graph is a representative of three biological replicates. 
3.3.6.2 Localisation of mycobacterial DivIVA 
DivIVA is an essential protein that functions as a marker for sites of mycobacterial cell elongation, 
which generally occurs at the poles (section 4.1). Given that the branching pattern of growth 
observed for the ami1 mutant suggested ectopic elongation on the lateral axis, we sought to 
understand how this protein localises in the ∆ami1 strain, particularly during branch formation. To 
do this DivIVA-rsEGFP fusion protein-containing mc2155 and ∆ami1 strains were created to 
localise DivIVA. The approach adopted involved the introduction of the plS220 construct, which 
is a pMV361 derivative containing a DivIVA-GFP fusion regulated by the hsp60 promoter, into 
mc2155 and ∆ami1 followed by time-lapse fluorescence microscopy (Santi et al., 2013).  
3.3.6.2.1 Construction and screening of the Δami1::plS220 strain  
The plS220 vector was electroporated into the mc2155 and ∆ami1 strain (section 2.4.2), the 
transformation efficiency obtained from the electro-competent cells was 2.6 × 104 CFU/µg and 1.7 
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× 104 CFU/µg vector DNA (determined using the pSE100 control vector) for mc2155 and∆ami1 
strains, respectively. Five clones were selected and screened by fluorescence microscopy to 
determine whether the strains exhibited DivIVA-GFP localisation (data not shown). Thereafter, 
one clone of each strain was used for further characterisation. 
3.3.6.2.2 Time-lapse microscopy to localise DivIVA 
Following the construction of the Δami1::plS220 and mc2155::plS220 strains, time-lapse 
microscopy was conducted to determine the cellular localisation of DivIVA-GFP, Figure 3.20 and 
Appendix E, movies 3.19 to 3.24. Time lapse microscopy in mc2155 revealed the previously 
reported DivIVA localisation pattern, where DivIVA localises only to the cell poles and the septum 
(Santi et al., 2013). In the case of the ∆ami1 strain, a number of differences, from the normal 
localisation pattern, were observed. In the ami1 mutant, DivIVA was recruited to the septum as 
with the wild type strain. However, failure of cells to separate after septum synthesis resulted in 
these septal DivIVA foci nucleating new cell pole synthesis at the septum, observed in 37 of 52 
micro-colonies examined, Figure 3.20 (panels IV-VI). From this, we were able to conclude that 
failure of cells to separate results in ectopic localisation of the cell elongation apparatus, leading 
to branch formation.  
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Figure 3.19: Time-lapse microscopic analysis of FtsZ-rsEGFP localisation in the mc2155 and ∆ami1 strains. Cells 
were grown and imaged in 7H9. (I-III) depicts three representative mc2155 micro-colonies showing the formation and 
ultimate fusion of two parallel FtsZ-rings to form a final division site followed by cell division. (IV-VI) depicts three 
representative ∆ami1 micro-colonies showing the formation and premature disassembly of the FtsZ-ring resulting in 
ultimate bacterial death and (VII to IX) depicts ∆ami1 micro-colonies stained with the membrane stain FM4-64 
showing the formation and disassembly of multiple FtsZ-rings at a single site (orange arrows), the formation of septal 
branches as a result of failed cell separation (red arrows) and the formation and growth of an ectopic branch followed 
by FtsZ-ring assemble within the branch indicating the presence of cell division machinery within ectopic branches 
(magenta  arrows). Movies were generated by N. Dhar and the student. The movies were processed and analysed by 
the student. The FM4-64 staining experiment was only done with the ∆ami1 mutant (Senzani et al., 2017). 
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In some cases DivIVA localised aberrantly at the longitudinal axis during cell elongation in the 
absence of a septum, resulting in the formation of a new growth pole and ultimate branch 
formation, observed in 12 of 52 micro-colonies examined, Figure 3.20. 
3.3.6.3 Localisation of mycobacterial DnaN and ParB 
Whilst assessing the spatial pattern of DivIVA localisation in the ami1 mutant, we noted that many 
of the ectopic branches, nucleated by DivIVA remained viable and were able to grow into long 
cells, which sometimes branched also. We next sought to study this further by determining whether 
chromosome partitioning was maintained in the ectopic branches. Hence, we localised DnaN (as 
a DnaN-GFP fusion) and ParB (as a ParB-mCherry fusion) in the ami1 mutant. These proteins 
play an essential role in chromosome replication and partitioning during cell division. DnaN, the 
clamp that anchors DNA-polymerases to the replication fork forms part of the chromosome 
replication machinery and ParB, which binds to parS sites on the origin of replication forms part 
of the chromosome partitioning machinery. Consequently, understanding how these proteins 
localise during bud formation and branch elongation was important to elucidate how lateral buds 
retain DNA. To do this, ami1 was deleted in the mc2155::ParBM-DnaNG background and the 
resulting strain was studied with time-lapse fluorescence microscopy to track both ParB-mCherry 
and DnaN-GFP in the knockout strain.  
3.3.6.3.1 Construction and screening of the ∆ami1::ParBM-DnaNG strain 
The p2ΔAmi1G19 knockout vector was electroporated into the mc2155::ParBM-DnaNG strain 
(section 2.4.2), the transformation efficiency obtained for the electro-competent cells was 4.9 × 
104 CFU/μg vector DNA determined using the pSE100 control. A single blue clone (SCO strain) 
was cultured and subjected to sucrose counter selection (section 3.2.4). White colonies were then 
screened by PCR to identify clones which possess only the deleted allele. Thereafter, Southern 
blot analysis was conducted to confirm the deletion of the wild type allele without imposing 
additional unintended chromosome rearrangements, Figure 3.21. 
PCR analysis revealed 3 possible deletion strains, clones 3, 4 and 5, indicated by the 327 bp mutant 
band, Figure 3.21. Genomic DNA from all was extracted and southern blot analysis was conducted 
to confirm the genotype of the ∆ami1::ParBM-DnaNG strain and to confirm correct site-specific 
integration of the deletion allele. The probe for Southern blotting was constructed by PCR and the 
primers used to amplify the upstream homologous region (MsmAmi1SF and MsmAmi1SR). 
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Figure 3.20: Time-lapse microscopic analysis of DivIVA-GFP localisation in the mc2155 and ∆ami1 strains. Cells 
were grown and imaged in 7H9. I-III depicts three representative mc2155 micro-colonies and IV-VI depicts three 
representative ∆ami1 micro-colonies. White arrows indicate the septal localisation of DivIVA, which became two 
new growth poles following cell separation. Yellow arrows depict septal localisation of DivIVA in the ∆ami1 strain, 
which resulted in the formation of two new growth poles leading to lateral budding and branch elongation and blue 
arrows indicate ectopic localisation of DivIVA in the ∆ami1 strain, which resulted in the establishment of a single 
growth pole leading to lateral budding and branch elongation. Scale = 5 µm. Movies were generated, processed and 
analysed by the student (Senzani et al., 2017). 
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Southern blot analysis using the restriction enzyme BamHI was conducted on the mc2155 and 
Δami1 strains, which would yield 7303 bp for mc2155::ParBM-DnaNG and 10185 bp for the 
∆ami1::ParBM-DnaNG strain. The corresponding expected sizes were observed, confirming 
successful deletion of ami1 in the ∆ami1::ParBM-DnaNG strain, Figure 3.21. 
3.3.6.3.2 Time-lapse microscopy of mycobacterial DnaN and ParB in a ami1 mutant 
Following the construction of the ∆ami1::ParBM-DnaNG strain, time-lapse microscopy was 
conducted to determine the cellular localisation of DnaN-GFP and ParB-mCherry, Figure 3.22 and 
Appendix E, movies 3.25 to 3.27. 
Time-lapse microscopy of ∆ami1::ParBM-DnaNG revealed a localisation pattern whereby DnaN 
is extremely dynamic, starting off near mid-cell and then localizing with the ¼ to ¾ region of the 
cell as the nucleoid replicates. ParB displays a similar pattern, beginning at mid-cell and moving 
to the ¼ and ¾ regions without disassembling (Santi et al., 2013). This suggests loss of Ami1 does 
not affect the mechanisms which replicate and partition the bacterial chromosome. This is also 
evidenced by the fact that this localisation pattern is maintained during ectopic bud and subsequent 
branch formation, whereby ParB localises at the point of bud formation (during bud formation and 
elongation) and moves towards the pole of the aberrant branch followed by DnaN. This suggested 
that chromosome replication occurs during branch formation, followed by ParB driven 
chromosome partitioning, resulting in the retention of the mycobacterial chromosome within the 
ectopic branch.  
3.3.7 Antibiotic susceptibility of the ∆ami1 mutant. 
Disruption of cell division enzymes in E. coli results in increased susceptibility to antibiotics either 
due to a weakened cell wall or failed division (Heidrich et al., 2001, Korsak et al., 2005). We 
sought to test whether a similar situation prevailed in mycobacteria with the deletion of ami1. To 
do this, antibiotic susceptibility assays were conducted on the mc2155, ∆ami1 and 
Δami1::pMVami1 strains (Appendix D, Table D1). This initial analysis, however, could not be 
used as the pMVami1 strain displayed increased resistance towards all antibiotics tested (data not 
shown). The basis for this was unknown and it was decided that a new complement strain using 
the episomal pSE100 vector as the backbone was required (section 3.3.1). Following construction  
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Figure 3.21:  Genotypic analysis of the ∆ami1::ParBM-DnaNG strain by PCR and Southern blot analysis.  The genomic map of the relevant locus is shown for the 
wild type mc
2
155 and ∆ami1::ParBM-DnaNG strain.  Also shown on the left is the PCR screen of possible ∆ami1::ParBM-DnaNG strains and southern blotting of 
a single positive clone is shown on the right. For PCR confirmation, chromosomal DNA was used to amplify the ami1 alleles from the wild type and mutant strains 
using the primers listed in Table 3.3 and indicated as red arrows above. The expected sizes of the amplicons are as follows: ami1, 608 bp and ∆ami1, 327 bp.  For 
the Southern blot analysis chromosomal DNA from the SCO, parental and mutant strain was digested with BamHI.  The probe used for hybridisation is shown as 
a solid green box and the expected sizes are indicated by the blue arrows.   
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of the new complementation strain (which was used in all the assays reported thus far) antibiotic 
susceptibility assays were repeated using antibiotics which target various cell wall, cytoplasmic 
and periplasmic components (Table 3.4). 
The antibiotic susceptibility assays revealed a reduction in the amount of antibiotic required to 
inhibit mycobacterial growth in most cases, with the exception of cefamandole, which displayed 
no change and D-cycloserine, in which case deletion of ami1 led to increased tolerance. There 
were cases wherein the reduction in MIC was more significant, these included, cefoxitin, 
cefotaxime and ceftraxone, which are all cephalosporins. We did not consider a two-fold change 
in antibiotic susceptibility significant as this falls within the experimental variation of this assay. 
The somewhat dramatic changes in antibiotic susceptibility to cell wall targeting antibiotics were 
suggestive of a defective cell wall in the ami1 mutant.  
To further understand this, an ethidium bromide (EtBr) diffusion assay was conducted to determine 
whether the increase in antibiotic susceptibility was associated with an increase cellular 
permeability, Figure 3.23. 
Analysis of the diffusion rate of EtBr in all three strains revealed elevated cell envelope 
permeability in the ∆ami1 strain, suggesting the reduction in antibiotic requirement could be a 
result of increased antibiotic penetrance. 
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Figure 3.22: Time-lapse microscopic analysis of ParB and DnaN in the ami1 mutant. Shown is the localisation ParB-
mCherry (red) and DnaN-GFP (green) localisation in the ∆ami1::ParBM-DnaNG strains. Cells were grown and 
imaged in 7H9. I-III depicts three representative ∆ami1::ParBM-DnaNG micro-colonies. Yellow arrows indicated the 
initiation of branch formation. White arrows track the movement of ParB-mCherry during branch elongation and 
Orange arrows track the movement of DnaN-GFP during branch elongation. Scale = 5 µm. Movies were generated by 
N. Dhar then processed and analysed by the student. 
Table 3.4: MIC of the mc2155, ∆ami1 and Δami1::pSEami1 strains 
Drug 
 MIC*  
mc2155 Δami1 Δami1::pSEAmi1 
Ampicillin 150 78  150 
Erythromycin 6.25 3.1 6.25 
Vancomycin 0.78 0.20 0,78125-1,5625 
Rifampicin 0.625 0.3125 0.625 
Cefamandole 500 500 500 
Cefoxitin 40 10 40 
Cefotaxime 93.75 23 93,75-187,5 
Ceftriaxone 250 62 250 
Cefapirin 50 25 50 
D-cycloserine 32 62 32 
*MIC in µg/ml,  
I
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Figure 3.23: EtBr diffusion in the ami1 mutant. Shown in a line graph depicting EtBr diffusion into the cytoplasmic 
space of the mc2155, ∆ami1 and Δami1::pSEami1 strains, as an indicator of cell envelope permeability.  Error bars 
determined using the standard error of the mean and p-values using the student’s t – test. ***: p < 0.001. The graph 
represents the average of three independent replicates. 
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3.4 Discussion 
Cell division is an essential component of the bacterial life cycle and understanding this process is 
important to designing effective inhibitors that target it. Much like a multitude of bacterial 
processes, the various components involved in cell division are carefully regulated in response to 
environmental conditions and other aspects of bacterial metabolism, an example of which is 
coordination of chromosome replication with cell wall growth (Egan and Vollmer, 2013). Many 
of the components involved in bacterial replication have been the subject of intense study and in 
this context, various divisome constituents, including Fts proteins, have been well characterised in 
model organisms. However, growth and division, particularly the role played by PG hydrolysing 
enzymes, still require further investigation in mycobacteria (Hett and Rubin, 2008). 
PG hydrolysing enzymes are important components of bacterial cell division as they play an 
central role in the coordinated breakdown of septal PG to facilitate daughter cell separation. Work 
conducted in various bacterial organisms, including E. coli, Pseudomonas aeruginosa, Neisseria 
gonorrhoeae and Staphylococcus spp. has highlighted the importance of two classes of PG 
hydrolysing enzymes in this process, the lytic transglycosylases and the cell wall amidases 
(Heidrich et al., 2002, Jorgenson et al., 2014, Yakhnina et al., 2015, Cloud and Dillard, 2004, 
Garcia and Dillard, 2006, Sugai et al., 1995, Stapleton et al., 2007). In E. coli deletion of three 
lytic transglycosylases or cell wall amidases resulted in the formation of chains consisting of 3 to 
9 or 6 to 24 cells, respectively, illustrative of cells that were unable to complete the final steps of 
cell division (Heidrich et al., 2002). Similarly in P. aeruginosa, depletion of the essential cell wall 
amidase, amiB, led to the formation of long cell chains, while deletion of lytic transglycosylase 
rlpA resulted in the formation of short chains consisting of 4 cells (Jorgenson et al., 2014, Yakhnina 
et al., 2015). This function is not only limited to rod shaped bacteria as deletion of either the lytic 
transglycosylase, ltgC, or cell wall amidase, amiC, in Neisseria gonorrhoeae, led to the formation 
of cell clusters attached to each other by septa (Cloud and Dillard, 2004, Garcia and Dillard, 2006). 
In addition, the deletion of lytic transglycosylase, sceD, or a cell wall amidase-containing major 
autolysin, atl, in Staphylococcus aureus, led to the formation of clusters (Sugai et al., 1995, 
Stapleton et al., 2007). Collectively, these observations suggest both enzyme classes conduct 
important and possibly non-redundant roles during cell division, as both are required for cell 
separation.  
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In mycobacteria, division mechanisms seem to have diverged somewhat. This is illustrated by the 
observation that deletion of all the lytic transglycosylases, in this case the resuscitation promoting 
factors (Rpfs), in M. smegmatis did not result in any significant cell division defects (Beukes, 
2014). This finding suggested that other PG hydrolysing enzymes such as cell wall amidases may 
be important in mycobacterial cell division. Thus, herein, we set out to characterise the role of the 
PG hydrolysing enzyme, Ami1, in the growth and division of M. smegmatis, with the intention of 
advancing the knowledge on the cell division machinery in mycobacteria. 
Bioinformatics analysis of the mycobacterial genome led to the identification of four cell wall 
amidases in Mtb (Senzani, 2014, Machowski et al., 2014). Further analysis of these revealed that 
two of them, Ami1 and Rv3915 (Ami2) were homologues to the E. coli cell division amidases, 
however, only one, Ami1, retained all the corresponding residues required for catalytic activity 
(Appendix D, Figure D1) (Machowski et al., 2014, Senzani, 2014). As such, Ami1 was selected 
for further study to assess the role this enzyme plays during cell division. The approach taken was 
to delete ami1 and subsequently characterise the resulting ∆ami1 strain to identify phenotypic 
changes that occurred (Appendix D, Figure D2) (Senzani et al., 2017, Senzani, 2014). Preliminary 
microscopic analysis of the ∆ami1 strain depicted a possible role for Ami1 during cell division. 
Much like in E. coli and P. aeruginosa, deletion of this enzymes resulted in the formation of chains 
consisting of multiple cells attached to each other by the septum (Senzani, 2014). This defect was 
further assessed in this PhD where microscopy and statistical analysis was conducted on the ∆ami1 
strain to determine whether the observed cell division defects were significant. This analysis 
demonstrated that 22 % of the cell population displayed the formation of cellular chains consisting 
of 3 to 8 cells. This was consistent with data on the E. coli ∆amiC mutant, which indicated that 
loss of AmiC led to the formation of chains consisting of 3 to 6 cells in 20 to 30 % of the population 
(Heidrich et al., 2001). Furthermore, we noted the presence of division septa in 94 % of the ∆ami1 
population, as opposed to 18 % in the mc2155 population, indicating a temporary yet significant 
stall during cell division, resulting in a high proportion of the population undergoing cell division 
at any given point. We hypothesise that this is due to a delay in cell separation rather than an 
increase in the frequency of cell division events in the ami1 mutant. This notion is based on the 
demonstrated role for amidases in the degradation of the septum to facilitate the last steps of cell 
division. Furthermore, BODIPY-vanc staining confirmed that PG synthesis occurs at the septum, 
resulting in the formation of mature septa that are not degraded.  
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Interestingly, this chaining phenotype has been reported previously in M. smegmatis, as a result of 
depletion of an unrelated PG hydrolysing enzyme. Mycobacteria possess a variety of PG 
hydrolysing enzymes and thus far, an interesting interaction between some of these enzymes, 
including RpfB, Rpf-interaction proteins A (RipA) and B (RipB), has been shown to be important 
for cell division (Hett et al., 2007, Martinelli and Pavelka, 2016). RipA and RipB are PG 
hydrolysing endopeptidases (Böth et al., 2011). These are operonic, redundant, essential proteins, 
which are individually dispensable for growth. However loss of both results in bacterial growth 
arrest (Martinelli and Pavelka, 2016). Deletion of either gene does not appear to affect bacterial 
cell division. However, depletion of both led to the formation of bacterial chains, containing lateral 
growth appendages (Hett et al., 2008, Martinelli and Pavelka, 2016). In this context, there is a 
striking similarity between the defects observed for the collective depletion of RipA-RipB and the 
deletion of ami1. This suggests that there might be an interplay between these septal degradation 
mechanisms, further supported by the fact that they degrade different bonds in the PG. RipA and 
RipB are endopeptidases that cleave within the stem peptide in PG whilst Ami1 cleaves between 
the stem peptide and the glycan backbone. The hypothesis that these enzymes have specialist 
function is further supported by the observations that deletion or depletion of either system is not 
compensated for by the remaining enzymes as clear cell division defects are manifested in both 
cases. Further interaction studies and real-time localisation of these different enzymes at the 
septum may help to unravel this interplay.  
As the Ami1 enzyme appeared to conduct an important role in cell separation, we sought to localise 
it and track the movement of Ami1 during growth to determine when this enzyme was recruited 
to the division septum. This was not possible as the Ami1GFP signal was unstable and single foci 
could not be tracked over time. Analysis of the localisation patterns using TIRF microscopy, 
however, showed that Ami1GFP localised as punctate foci during cell elongation and is recruited 
to the septum; perhaps late during division once the septum has formed, as indicated by the 
subpopulation of cells containing a division septum without the localisation of Ami1GFP. This 
type of localisation has been previously reported in E. coli where all three cells division amidases 
exhibit a diffused localisation pattern during elongation and are then recruited to the septum during 
cell division (Peters et al., 2011). It is also possible that the punctate localisation suggests a 
function for Ami1 during cell elongation, which would be the maintenance of bacterial cell shape 
as loss of ami1 not only resulted in the formation of thin cells but also the occurrence of cell bulges, 
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possibly due to the dysregulation of the systems which maintain the shape of the cell. However, 
this explanation is largely speculative and requires further investigation.  
Another striking observation was the influence of Ami1 in FtsZ-ring stability. Loss of Ami1 
resulted in some Z-ring defects, the first being the pattern at which the final Z-ring forms. In the 
presence of Ami1 the Z-ring formed as two concentric rings which oscillated to a final assembly 
point at the septum – presumably on either side of the septum of a dividing cell. However, in the 
∆ami1 strain this assembly mechanism does not occur, instead a single ring forms at the final site 
of cell division. FtsZ mobility is maintained in the ∆ami1 strain but the ring sometimes occurred 
in the form of disorganised foci rather than rings. Furthermore, in some cases the Z-ring formed 
and disassembles prior to septum synthesis. This generally led to the reassembly of the Z-ring at 
the same site, either resulting in septum synthesis or disassembly of the ring. The repeated 
formation and disassembly of the Z-ring at a single site suggests Ami1 does not influence the 
mechanism underpinning the site of Z-ring placement but the failure to separate does affect the 
stability of the Z-ring. How this is achieved is currently unclear, primarily as the localisation data 
suggested Ami1 is recruited later during cell division and the presence of a signal peptide in the 
Ami1 polypeptide suggests it resides outside the cytoplasmic space while FtsZ is a cytoplasmic 
component (Senzani, 2014). There is a possibility that Ami1 stabilises the Z-ring through 
interactions with an intermediary septum protein, which in turn functions to stabilise the Z-ring.  
Unlike the depletion of RipA-RipB, loss of Ami1, and the resulting cell division defects, was not 
associated with a reduction in bacterial growth in broth culture (Hett et al., 2008). This can be 
partially attributed to the mycobacterial growth cycle wherein cell elongation and division seems 
to be uncoupled; as such a halt in cell division does not result in the inhibition of cell elongation 
(Aldridge et al., 2012, Wachi and Matsuhashi, 1989, Fenton and Gerdes, 2013). This continued 
bacterial growth, in the absence of effective cell separation, appears to occur in numerous bacteria 
when cell division hydrolases are deleted/depleted. In this regard, with the exception of the 
essential cell wall amidase, amiB, in P. aeruginosa, loss of either a cell wall amidase or a lytic 
transglycosylase in the organisms listed above did not result in reduced bacterial growth (Heidrich 
et al., 2002, Jorgenson et al., 2014, Yakhnina et al., 2015, Cloud and Dillard, 2004, Garcia and 
Dillard, 2006, Sugai et al., 1995, Stapleton et al., 2007). How this growth continues to occur in 
these chains and clusters is not clear. As such, utilising single cell time lapse microscopy, we 
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sought to unpack how elongation continues in the presence of stalled cell division in the ∆ami1 
strain. 
Single cell analysis of the ∆ami1 strain revealed 2 key findings, the first being the formation of 
lateral branches, similar to those observed in the ripAB depletion strain and the second is the 
utilisation of these branches to bypass failed cell separation (Hett et al., 2008).  In addition to 
depletion of ripAB, this branched growth form was also observed in the overexpression of the 
growth pole determining component, DivIVA (Hett et al., 2008, Kang et al., 2008). As such it was 
hypothesised that the formation of these lateral branches in the ∆ami1 strain was a result of ectopic 
DivIVA recruitment, resulting in the formation of a growth pole at the septum. This was confirmed 
by single cell time-lapse microscopy of DivIVA localizing strains, wherein stalled cell division 
resulted in the establishment of the elongation machinery driven by DivIVA at the septum, in both 
daughter cells, resulting in septal cell elongation leading to lateral growth. Lateral growth, 
however, was also observed at non septal regions, in which case DivIVA was found to localise in 
an aberrant manner along the longitudinal axis during cell elongation in a similar manner to that 
seen in the filamentous Streptomyces coelicolor (Hempel et al., 2008). This suggested an 
additional role for Ami1 during elongation wherein it could function to inhibit ectopic DivIVA 
localisation. This hypothesis was further supported by the Ami1 localisation pattern which 
presented as ectopic foci during the cell elongation phase of growth. Both septal and ectopic 
branches resulted in viable cells, which elongated and subsequently underwent cell division. 
However, there were instances where these branches died, followed by the emergence of a new 
branch at the site of the previous branch, suggesting these cells could be anucleate and were not 
able to undergo successive replication cycles. These observations suggested that the DNA 
segregation machinery in the ∆ami1 strain was dysregulated leading to the formation of anucleate 
cells.  
To test this hypothesis, DnaN and ParB were localised in the ∆ami1 strain, these two components 
involved in chromosome replication/segregation. DnaN forms part of the DNA polymerase III 
holoenzyme responsible for DNA replication. ParB is the DNA binding component of the ParABS 
system, which is pulled to the opposite cell poles by ParA polymers, responsible for the segregation 
of the two newly synthesised genomes into the daughter cells, thus movement ParB would indicate 
the movement of a single genome (Burgers et al., 1981, Murray and Errington, 2008). Localisation 
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of both these proteins in the mc2155 background has demonstrated that chromosome replication 
and segregation begins at the midcell as both the DnaN and ParB foci were recruited to the midcell 
(Santi et al., 2013, Santi and McKinney, 2015). This is followed by the movement of the ParB foci 
to the opposite poles while DnaN remains at the midcell indicating that the replication machinery 
remains somewhat static and DNA is pulled through DNA polymerase III as the newly synthesised 
genome is pulled to the poles by the ParABS system (Santi and McKinney, 2015). A similar 
localisation pattern was observed in the ∆ami1 strain as the movement of ParB into lateral branches 
was observed indicating the movement of genetic material into these branches. Movement of 
DnaN into these branches was also observed in the ∆ami1 strain, suggesting a possible 
unidirectional ParABS pull in some of these branches which could result in polyploidy or 
guillotining of genomic material, resulting in irreparable DNA damage and possible cell death 
(Santi and McKinney, 2015).  
In addition to its involvement in cell elongation and division, Ami1 appears to play a role in 
antibiotic tolerance. This is demonstrated by the reduction in antibiotic tolerance of the ∆ami1 
strain relative to mc2155 to certain classes of antimicrobials. Similar observations have been noted 
in a number of bacterial organisms including P. aeruginosa, S. enterica and E. coli wherein the 
loss of various amidases led to antibiotic hypersensitivity, against PG targeting enzymes, partially 
attributed to the β-lactamase induction pathway in E. coli, which is regulated by cell wall amidases, 
and antimicrobial peptides (Korsak et al., 2005, Weatherspoon-Griffin et al., 2011, Jacobs et al., 
1995). This phenotype has been attributed to an increase in cell envelope permeability; however, 
the link between cell division defects and increased envelope permeability remains unclear. We 
sought to further investigate this by studying the permeability of the cell wall using EtBr and found 
enhanced EtBr penetration across the cell envelope in the absence of Ami1. This effect was 
reduced in both the mc2155 and ∆ami1::pMVami1 strains. In this case, the defect could be the 
possible outcome of a potential reduction in septum stability, confirmed by the extrusion of cell 
wall material from the septum in some cases. This could result in a weak point in the PG structure 
thus allowing for penetrance of more antimicrobial molecules.  
PG analysis of the ∆ami1 strain revealed an increase in the proportion of 3-3 stem peptide 
crosslinks, but more importantly between stem peptides which only possess three amino acids, 
when compared to the mc2155 strain (Senzani et al., 2017).  Though the abundance of 3-3 
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crosslinks in mycobacterium has been reported, the overwhelming presence of this specific 
confirmation in the ∆ami1 strain, suggests that the ∆ami1 septal PG may exist with 3-3 corsslinks, 
post synthesis conducted by PBPs removing the terminal D-alanines (Lavollay et al., 2008, 
Lavollay et al., 2011). Once this has occurred the resulting structure can no longer undergo 
modifications. One of the more striking observations from this study was the release of cell wall 
material from the division septum. Though the release of PG in not a new phenomenon, this is 
usually in the form of small molecules such as muropeptides (Templin et al., 1999, Goodell and 
Schwarz, 1985).  The release of large portions of cell wall material in the ∆ami1 strain, suggest a 
breakdown in the interplay between septal cell wall synthesis and degradation, possibly resulting 
in the overproduction and release of cell wall material.  
In conclusion, this section of the PhD dissertation represented the first extensive characterisation 
of a cell division amidase in the actinomycete family and serves to offer a broader understanding 
of amidase function in mycobacteria (a proposed model is given in Figure 3.24). Ami1 represents 
the first reported case of a single mycobacterial PG hydrolase being important for cell division. 
How this function relates to the biological role of other PG hydrolysing enzymes is an exciting 
area for future research.  
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Figure 3.24: Proposed model for Ami1 function in mycobacteria.  Shown is the role of Ami1 depicted by the mc2155 
branch, depicting the punctate localisation of Ami1 responsible for maintaining bacterial cell shape. Following septal 
synthesis, Ami1 is recruited to the septum resulting in septal cleavage. Deletion of ami1 results in the formation of 
cell chains, which are thinner than wild type bacteria, with aberrant cell growth/division modalities such as lateral 
budding. Defective division in cell chains also results in destabilisation of the FtsZ-ring, resulting in multiple cycles 
of FtsZ-ring assembly and collapse during a single division cycle. 
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Figure 4.1: Flow chart highlighting the focus of chapter 4. Highlighted is the portion of the study which will be addressed in the following chapter. The figure 
was drawn by S. Senzani. 
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4 The role of Ami 2 in cell elongation 
4.1 Introduction 
4.1.1 Bacterial cell elongation 
Much like cell division, elongation is an important part of the bacterial life cycle. With respect to 
the PG, this process entails the overall expansion of the bacterium, which involves remodelling of 
the PG sacculus to allow for this growth (Typas et al., 2011). Elongation requires the synthesis of 
new PG units, which occurs in the cytoplasm, using an extensive complement of biosynthetic 
genes to create the PG precursor molecule called Lipid II (Typas et al., 2011, Vollmer et al., 2008). 
Once synthesised, the molecule, which is membrane associated, is flipped into the periplasm where 
it gets incorporated into the existing PG sacculus by penicillin-binding proteins (PBPs). PBPs 
integrate the new precursor into the glycan strand and also crosslink the stem peptides to create a 
mesh-like structure. This entire process is carefully coordinated with a variety of PG synthases and 
hydrolases.  
4.1.1.1 Lipid II synthesis 
Lipid II is the building block for all bacterial PG. This component consists of a disaccharide 
backbone made up of GlcNAc and MurNAc linked by -1,4-glycosidic bonds (Vollmer et al., 
2008). Attached to this, via the MurNAc residue is a five amino acid stem peptide consisting of L-
alanine, D-glutamic acid, a meso-diaminopimelic acid (meso-DAP) moeity or L-lysine (depending 
on bacterial species) and two terminal D-alanines (Vollmer et al., 2008). The synthesis of this 
component occurs entirely in the cytoplasm and is conducted by a set of essential enzymes that 
possess various functions including; transferases, dehydrogenases and amino acid ligases 
(Barreteau et al., 2008). Metabolically, PG synthesis is dependent, to some extent on glycolysis, 
which yields the production of pyruvate and other intermediate metabolites such as fructose – 6 – 
phosphate (Barreteau et al., 2008). For PG biosynthesis, the resulting fructose – 6 – phosphate is 
processed by three proteins, the amidotransferase GlmS, the aminotransferase GlmM and the bi-
functional protein GlmU, yielding the production of UDP-GlcNAc (Barreteau et al., 2008). This 
is followed by the first committed step towards Lipid II synthesis, which is carried out by MurA, 
involving the attachment of enol-pyruvate to UDP-GlcNAc (Barreteau et al., 2008). Following 
this, is the reduction of the GlcNAc residue by MurB, converting it to UDP-MurNAc (McCoy et 
al., 2003, Brown et al., 1995, Benson et al., 1993, Typas et al., 2011). The amino acid stem peptide 
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is then attached to the MurNAc residue in a step wise manner by various amino acid ligases, 
beginning with MurC, which attaches the L-alanine (Typas et al., 2011, Barreteau et al., 2008). 
After this, a D-glutamic acid residue is added to the L-alanine and this is facilitated by MurD. 
Thereafter, the meso-DAP residue is added to D-glutamic acid by MurE (Typas et al., 2011, Akira 
et al., 2001). The final two residues are added to the stem peptide by MurF as a pair (Barreteau et 
al., 2008, Typas et al., 2011). This is a pair of D-alanines, obtained from the activity of two 
essential enzymes, the alanine racemase (Alr), which is responsible for the conversion of L-alanine 
to D-alanine and D-alanine-D-alanine ligase (Ddl), which ligates two D-alanines resulting in the 
production of the D-alanine pair (Typas et al., 2011, Barreteau et al., 2008). The resulting UDP-
MurNAc-pentapeptide molecule is then translocated to the cell membrane where the remainder of 
the process occurs (Barreteau et al., 2008, Typas et al., 2011). First, the PG monomer is linked to 
membrane-associated undecaprenol phosphate, a step catalysed by MraY, resulting in the 
formation of Lipid I (Barreteau et al., 2008, Typas et al., 2011). This is then finally processed by 
MurG, responsible for the addition of UDP-GlcNAc to Lipid I, leading to the production of 
membrane bound GlcNAc-MurNAc-pentapeptide also known as Lipid II, which is then 
translocated to the periplasm by RodA or FtsW where the rest of the PG synthetic steps can occur 
(Typas et al., 2011, Barreteau et al., 2008). A diagrammatic representation of this process is given 
in Figure 4.2. 
4.1.1.2 The periplasmic steps of PG biosynthesis 
Once in the periplasmic space, Lipid II is utilised by a group of enzymes collectively known as 
PBPs, initially named for their affinity to bind penicillin (Vollmer et al., 2008). There are three 
main proteins that utilise Lipid II to ultimately integrate this precursor into PG. These are class A, 
class B and low molecular weight (LMW) PBPs (Vollmer et al., 2008, Typas et al., 2011). Class 
A PBPs are high molecular weight PBPs, which contain both glycosyl transferase and 
transpeptidase activity (Bertsche et al., 2005, Born et al., 2006). These enzymes play a crucial role 
in the integration of Lipid II into pre-existing PG, by incorporating Lipid II into the sugar backbone 
and also by driving the formation of stem peptide crosslinks between newly incorporated PG units 
and pre-existing PG (Bertsche et al., 2005, Born et al., 2006). Deletion or reduction of these 
enzymes in B. subtilis results in the formation of thin long cells indicating a further role in 
determining bacterial cell shape (Popham and Setlow, 1995, Murray et al., 1996, McPherson and 
Popham, 2003). Similar to class A, class B PBPs are also high molecular weight penicillin-binding 
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proteins, however these only possess transpeptidase activity (Wei et al., 2003). In many organisms, 
there appears to be a redundancy of these proteins but their activity is essential for cell elongation, 
specifically in rod-shaped bacteria as evident by the formation of spherical cells in the absence of 
these enzymes (Wei et al., 2003). The final class of PBPs are the LMW PBPs, which possess 
carboxypeptidase activity (Nelson and Young, 2000). The main function for these enzymes is the 
removal of one terminal D-alanine from the pentapeptide stem (Pollock et al., 1974). Though the 
importance of this activity is currently unclear, the prevailing hypothesis is that the removal of the 
terminal alanine abrogates the ability to use that particular stem peptide to form a crosslink. 
Consequently, these PBPs are expected to regulate the level of PG crosslinking. Additionally, this 
function appears to have an important role in maintaining cell shape also as deletion of LMW PBPs 
in E. coli results in the formation of deformed bacterial cells (Nelson et al., 2002, Nelson and 
Young, 2001, Nelson and Young, 2000).  
An important aspect of PG biosynthesis is the spatial coordination of the process - it is important 
that PG synthesis is directed to the correct site of cell elongation. The composition of the 
elongation machinery, referred to as the elongasome, varies between different bacteria primarily 
because elongation occurs differently in various bacteria, thus the mechanisms controlling the 
process are not the same (Daniel and Errington, 2003). The most widely understood mechanisms 
utilised for directing the synthesis of PG is the MreB system. This functions much like the Fts 
system as it involves the recruitment of a polymerised anchor (MreB) to the inner membrane, 
which then recruits other components required for the association of PBPs and lytic enzymes 
essential for PG synthesis (Errington, 2015). MreB is an actin like protein that forms filaments in 
the presence of ATP or GTP and plays an important role during elongation, as depletion of MreB 
results in a halt in cell elongation, and an increase in cell width, which ultimately leads to cell lysis 
in E. coli (Maeda et al., 2012, Kruse et al., 2005).
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Figure 4.2: Diagrammatic representation of PG biosynthesis, depicting the various cytoplasmic and periplasmic steps. Shown are the different enzymes and the 
reactions that they catalyse, as well as the various periplasmic reactions catalysed by PBPs (Red arrows and lines). Also indicated are the various PG hydrolases 
shown to be essential for PG synthesis in different organisms (blue arrows) (adapted from Typas et al, 2012). Figure drawn by S. Senzani. 
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MreB was initially thought to direct PG synthesis through the formation of long helical filaments 
along the longitudinal axis of the bacterium thus directing synthesis in a helical manner. However, 
subsequent studies have demonstrated that MreB filaments localise as patches, which then move 
in a somewhat helical manner synthesizing PG as they move (Garner et al., 2011, Dominguez-
Escobar et al., 2011, van Teeffelen et al., 2011). MreB attachment to the inner membrane and 
rotation appears to be directed by one of the MreB interacting partners, the cell shape determinant, 
RodZ (Morgenstein et al., 2015). This motion is not only essential for elongation but also plays an 
important role in maintaining the integrity of the rod shape, as the loss of RodZ leads to the 
formation of ovococcoid cells (Alyahya et al., 2009, Morgenstein et al., 2015). These defects could 
be partially complemented with specific mutations in the mreB gene, indicating a potential to 
bypass the need for RodZ (Shiomi et al., 2013). The impact of these mutations in MreB localisation 
and movement has yet to be described. MreB forms a complex with two other components, MreC 
and MreD (Kruse et al., 2005, Leaver and Errington, 2005). These are both membrane-associated 
proteins that play an essential role in the recruitment of PBPs and lytic transglycosylases, required 
to hydrolyse the PG backbone allowing for the insertion of new PG material (Leaver and Errington, 
2005). Additionally, the Mre complex interacts with a number of the components that comprise 
the cytoplasmic PG synthesis machinery including MurB, MurC, MurE, MurF and MraY, 
suggesting this complex serves as a central hub for all steps in PG synthesis (White et al., 2010). 
The Mre complex is essential in all rod-shaped bacteria that possess the gene coding for MreB 
(Daniel and Errington, 2003). However, there are rod-shaped bacteria which do not possess the 
Mre system, primarily the actinomycetes (Singh et al., 2010). In these organisms, a different 
approach is adopted due to the absence of this canonical system and also because of the differences 
in the modalities of cell growth. Bacteria which use the Mre system to grow do so by the insertion 
of new PG material along the longitudinal axis of the cell. However, actinomycetes such as 
streptomyces and mycobacteria grow by inserting PG material at the poles, more specifically in a 
ring-like conformation in sub-polar space (Meniche et al., 2014). This polar growth is driven by 
the tropomyosin-like protein DivIVA, which localises to the bacterial subpolar region, due to its 
affinity to bind areas of negative curvature (Meniche et al., 2014). The biological function of 
DivIVA is a subject of much ongoing research. Depletion and/or over-expression studies 
conducted in mycobacteria and various other organisms has demonstrated the importance of this 
protein during cell elongation, as depletion lead to the formation of short, wide cells while 
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overexpression resulted in long, branched cells indicating elevated activity of the elongation 
machinery (Kang et al., 2008). Furthermore, recent studies have shown interaction between 
DivIVA and RodA, implicating the latter protein in the regulation of cell elongation in 
actinobacteria (Sieger and Bramkamp, 2015).  
In addition to DivIVA, another enzyme has been shown to play an important role in cell elongation, 
which is the high molecular weight PBP, PonA1 (Kieser et al., 2015). The mycobacterial PonA1 
is a bi-functional PG synthase which contains both transglycosylation and transpeptidation activity 
as such, it possesses the capability to insert new PG precursors into the cell wall. Work conducted 
by Keiser et al, 2015, has shown PonA1 is essential for growth in M. smegmatis (Kieser et al., 
2015). The essential nature of PonA1 was primarily linked to the transglycosylation activity, as 
deletion of this transglycosylase domain could not yield viable bacteria, while deletion of the 
transpeptidase domain resulted in shorter but viable cells (Kieser et al., 2015). Though PonA1 is 
not essential for growth in Mtb, this enzyme has been shown to play an important role in bacterial 
survival during infection as deletion of PonA1 in Mtb led to a reduction in the CFUs found in the 
lungs and spleen of infected mice (Kieser et al., 2015). Much like DivIVA, PonA1 localises at the 
bacterial poles and septum suggesting a possible interaction between the two, which is plausible 
considering overexpression of PonA1 results in phenotypes similar to those observed when 
overexpressing DivIVA, this interaction however remains to be confirmed (Kieser et al., 2015, 
Kang et al., 2008). 
During elongation, PG hydrolysing enzymes are expected to be important for the insertion of new 
PG subunits as the cell elongates. As such, a recent study conducted in mycobacteria has shown 
an essential cell wall amidase (MSMEG_6935) (herein referred to as Ami2, also referred to CwlM) 
plays an important role in the synthesis of PG at the poles. The importance of Ami2 in cell 
elongation does not appear to be PG hydrolysis, allowing for insertion of new PG, but rather the 
activation of PG synthesising components. Work conducted by Boutte et al., 2016, has 
demonstrated that depletion of Ami2 resulted in the formation of short cells, suggesting a possible 
role during cell elongation (Boutte et al., 2016). Furthermore, it was shown that Ami2 interacts 
with PknB. This interaction results in the phosphorylation of the Ami2 C terminal tail, which in-
turn phosphorylates MurA (Boutte et al., 2016). This phosphorylation results in the activation of 
MurA, and consequently the initiation of Lipid II synthesis thus promoting bacterial growth. 
Therefore, Ami2 serves as an important intermediate between PknB signalling and bacterial 
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elongation (Boutte et al., 2016).  Cytoplasmic signal transduction is not new to cell wall amidases, 
as it occurs in E. coli; however, the direct phosphorylation of downstream elements has never been 
shown. Unlike mycobacteria, E. coli conduct this function indirectly through the activity of AmpD. 
AmpD much like Ami2 is a cytoplasmic cell wall amidase which plays an important role in PG 
recycling and the regulation of β-lactamase (ampC) expression (Jacobs et al., 1995). AmpD 
conducts this function through the hydrolysis and deactivation of muropeptides, by-products of 
PG remodelling, which possess the ability to induce a signal cascade resulting in the expression of 
ampC (Jacobs et al., 1995).  Consistent with these findings, preliminary work conducted at our lab 
demonstrated that depletion of Ami2 results in the formation of short cells (Senzani, 2014). In this 
section of the PhD research, we aimed to expand on these findings.   
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Hypothesis: Ami2 is important for polar elongation of cells and, therefore, localises to the cell 
poles during growth. Depletion of Ami2 will be lethal for mycobacterial cells, an effect resulting 
from stalled cell elongation and defective PG turnover. 
Preliminary work prior to this PhD. As part of an MSc study (Senzani, 2014) an Ami2 depletion 
strain was generated and a preliminary phenotypic characterisation was carried out.  
Aims and objectives: The main aim of this section of the PhD was to carefully characterise the 
existing Ami2 depletion strain to establish a biological function for this enzyme. Given the 
demonstrated role for Ami2 in cell elongation, we also aimed to study the cellular localisation of 
this protein. As such, the specific objectives included: 
1. Characterisation of the ami2 depletion strain using growth assays, microscopy and single-
cell time-lapse microscopy.  
2. Confirmation that Ami2 is essential for growth in M. smegmatis through the deletion of the 
native ami2 allele in the presence of a second copy of ami2 integrated at the attB site. 
3. Construction of the Ami2 localisation strain, mc2155::pAmi2GFP and cellular localisation 
of Ami2GFP. 
4. Confirming Ami2GFP functionality through the deletion of the native ami2 allele in a strain 
carrying ami2-rsEGFP integrated at the attB site. 
5. Construction of the Ami2-N and C- terminally FLAG tagged strains, mc2155::pFAmi2N 
and mc2155::pFAmi2C, followed by cell fractionation and localisation of the Ami2-FLAG 
variants. 
 
 
 
 
 
 
 
96 
 
4.2 Methods 
4.2.1 Demonstrating the essentiality of ami2 
The method adopted to prove ami2 is essential, is a modified version of the method used by Gomez 
and Bishai, 2000, which involved the creation of a merodiploid strain. This entailed the 
construction of an ami2 SCO strain followed by insertion of an additional ami2 gene at a secondary 
site, driven off the native promoter, resulting in a strain containing two full-length ami2 alleles and 
a truncated version (Appendix D, Figure D6) (Gomez and Bishai, 2000). This was then followed 
by the resolution of the SCO to a DCO resulting in either the deletion of the ami2 gene located at 
the native allele or the removal of the truncated version resulting in a strain possessing two full 
length ami2 genes (Gomez and Bishai, 2000). 
4.2.1.1 Construction of the mc2155::pMVami2 strain 
Primers were designed; ami2pMVCF and ami2pMVCR listed in Table 4.3, to amplify the ami2 
gene as well as 400 bp upstream the transcriptional start codon. PCR amplification of the respective 
fragments was carried out using Phusion polymerase, using an annealing temperature of 60 °C for 
ami2 and an elongation time of 1 min to allow for complete amplification of the ami2 fragment, 
which is 1619 bp. The PCR products were purified using the Nucleospin PCR purification Kit. 
Thereafter, 3 µg of pMV306 (H) was digested with HindIII and PvuII and the PCR product was 
restricted with HindIII. The pMV306 (H) restriction product was then treated with FastAP 
phosphatase for 30 min. The restriction products were separated on a 0.8 % agarose gel and the 
respective bands [4258 bp for pMV306 (H) and 1598 bp for ami2] were excised from the gel and 
purified using the Nucleospin gel purification kit. These were then quantified using the NanoDrop 
spectrophotometer and ligations were set up containing 50 ng of pMV306 (H) and varying molar 
ratios of ami2. The fragments were ligated using Fermentas T4 ligase for 1 h, transformed into 
DH5α cells and plated on LAHyg200. Thereafter, 10 possible clones were selected and screened by 
restriction digest with BamHI, which would yield two fragments, a 3560 bp and a 2304 bp band. 
A single positive clone was grown in 50 ml LBHyg200 overnight then bulk vector extraction was 
carried out using the Nucleobond bulk vector extraction kit. Extracted vector DNA was quantified 
and restricted with a variety of enzymes to profile the ami2 complementation construct 
(pMVami2), then the vector was sent for sequencing to check for the presence of mutations within 
the amplicon (data not shown). After confirmation, 1 µg of pMVami2 was electroporated into 
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electrocompetent mc2155 cells, plated on 7H10Hyg50 and incubated at 37 ºC for 5 days to create the 
mc2155::pMVami2. A single clone was then selected and used for the construction of the 
∆ami2::pMVami2 
Table 4.1: Bacterial strains created/used in this study 
Strain 
 
Genotype 
 
Reference 
 
mc2155 High frequency transformation mutant of M. 
smegmatis ATCC 607 
(Snapper et al., 1990) 
Δami1 Derivative of mc2155 carrying an unmarked, out-
of-frame deletion in ami1 
(Senzani, 2014) 
mc2155::pMVami2 Derivative of mc2155 carrying pMVami2 
integrated at the bacterial attB phage attachment 
site, HygR 
This study 
Δami2::pMVami2 Derivative of mc2155::pMVami2 carrying an 
unmarked, out-of frame deletion of ami2 
This study 
ami2KDP Derivative of SRS carrying pSEAmi2P integrated 
in the upstream promoter region of ami2 to allow 
for ATc-regulation, KanR, HygR 
(Senzani, 2014) 
mc2155::pAmi2GFP Derivative of mc2155 carrying an episomal 
pSAmi2GFP vector, HygR 
This study 
mc2155::pMAmi2GFP Derivative of mc2155 carrying pMAmi2GFP 
integrated at the attB bacterial phage attachment 
site, HygR 
This study 
Δami1::pAmi2GFP Derivative of Δami1 carrying episomal 
pAmi2GFP, HygR 
This study 
mc2155:: pAmi2NFLAG Derivative of mc2155 carrying an episomal 
pAmi2NFLAG vector, HygR 
This study 
mc2155:: pAmi2NFLAG Derivative of mc2155 carrying an episomal 
pAmi2NFLAG vector, HygR 
This study 
mc2155::pFAmi2N Derivative of mc2155 carrying an episomal 
pFAmi2N vector, HygR 
This study 
mc2155::pFAmi2C Derivative of mc2155 carrying an episomal 
pFAmi2C vector, HygR 
This study 
KanR: Kanamycin Resistance, HygR: Hygromycin Resistance 
4.2.1.2 Construction of the ∆ami2::pMVami2 strain 
To construct the p2ΔAmi2G17 vector used to make the ∆ami2::pMVami2 strain, the 
p2ΔAmi2G19 vector and pGOAL17 were restricted with PacI. The p2ΔAmi2G19 restriction 
product was then phosphatased using FastAP phosphatase for 30 min. The restriction products 
were separated on 0.8 % agarose and the respective bands (6754 bp for p2ΔAmi2G19 and 6359 
bp for pGOAL17) were excised from the gel and purified using the Nucleospin gel purification 
kit. These were then quantified using the NanoDrop spectrophotometer and ligations were set up 
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containing 50 ng of p2ΔAmi2G19 and varying molar ratios of pGOAL17. The fragments were 
ligated using 
Table 4.2: Vectors created and/or used in this study 
Vectors Genotype 
 
Reference 
p2NILΔAmi2 Derivative of p2NIL carrying the Δami2 deletion allele, 
with a 1021 bp internal deletion; KanR 
This study 
p2ΔAmi2G17 Derivative of p2NILΔAmi2 carrying the lacZ, sacB and 
hyg genes from pGOAL17, KanR 
This study 
pMVAmi2 Derivative of pMV306(H) carrying a functional ami2 
gene and the upstream native promoter region HygR 
This study 
pAmi2GFP Derivative of pSE100 carrying the ami2-rsEGFP fusion 
gene downstream the Pmyc-tet HygR 
This study 
pAmi2GFPN Derivative of pMV306(H) carrying a functional ami2-
rsEGFP gene and the upstream native promoter region 
HygR 
This study 
pAmi2NFLAG Derivative of pFLAGEM carrying a functional ami2 gene 
and the upstream native promoter region HygR 
This study 
pAmi2CFLAG Derivative of pFLAGEM carrying a functional ami2 gene 
and the downstream native promoter region HygR 
This study 
pFAmi2C Derivative of pMV306(H) carrying a functional ami2 
gene, upstream the FLAG tag HygR 
This study 
pSEAmi2P Derivative of pSE100 carrying the first 350 bp region of 
the ami2 gene and the panC ribosomal binding site HygR 
This study 
p2ΔAmi2G19 Derivative of p2NIL carrying the lacZ, sacB and hyg 
genes from pGOAL19, KanR 
This study 
KanR: Kanamycin Resistance, HygR: Hygromycin Resistance, AmpR: Ampicillin Resistance 
 
Fermentas T4 ligase for 10 min, transformed into DH5α cells and plated LAKan50. Thereafter, 10 
possible clones were selected and screen by restriction with EcoRI, which would yield five 
fragments, a 4988 bp, 3594 bp, 2747 bp, 1863 bp and a 766 bp band. A single positive clone was 
grown in   50 ml LBKan50 overnight then bulk vector extraction was carried out using the 
Nucleobond bulk vector extraction kit. Extracted vector DNA was quantified and restricted with a 
variety of enzymes to profile the ami2 deletion construct (p2ΔAmi2G17). 
Using the p2ΔAmi2G17 vector generated previously, 1, 3 and 5 µg of  DNA was electroporated 
into electrocompetent mc2155::pMVami2 cells and plated on 7H10 containing Kan, Hyg and 
0.004 % X-gal, then incubated at 37 ˚C for 7 days to create SCOs. A single blue colony was then 
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cultured in 2×TY supplemented with Kan and Hyg at 37 ºC; this was then sub-cultured in 2 × TY 
without antibiotic. The resulting cells were subjected to sucrose counter  
Table 4.3: List of primers used in the M. smegmatis, ami2 study 
Gene primers Amplicon 
ami2pMVCF GCGCGCGCCAGCTGGCCGGTGCTGGTCGATTT 1619 bp ami2 amplicon 
including  400 bp upstream 
the ami2 start codon 
ami2pMVCR GCCGCCGCAAGCTTTCAGGCGCCGCGGCCGGC 
ami2KOSCF CAGGACGCGCTTGGCGTT ami2 screening primers 
which produce either a 429  
bp wild type amplicon or a 
231 bp ∆ami2 amplicon 
ami2KOSCR1 TGCCTGTGAATTCAGGTCAG 
ami2KOSCR2 TGTAGAAGCCGAGGTCCTG 
ami2RTF GCTGTACTTCCTCGGCTCAC qPCR which amply a 112 
bp region within the ami2 
ORF  
ami2RTR  ATCGATGATGACCCGCTTAC 
ami2RTR2 AGGATGTCGGCCTCACTGAT RT-PCR conversion primer 
SigARTF GGGCGTGATGTCCATCTCCT qPCR which amply a 122 
bp region within the sigA 
ORF  
SigARTR GTATCCCGGTGCATGGTC 
ami2pFLNF GCGCGCGGTACCATGTCGAGTCTGCGTCGC 1215 bp ami2 amplicon 
excluding the 
transcriptional stop codon 
ami2pFLNR GCCGCCAAGCTTAAAGGTTGCGGTTCAGGG 
ami2pFLCF GCGCGCGGATCCATGTCGAGTCTGCGTCGC 1212 bp ami2 amplicon 
excluding the 
transcriptional stop codon 
ami2pFLCR GCCGCCTGTACAGGCGCCGCGGCCGGCCTG 
ami2pSELF GCGCCGCCGCATGCCTGGAGGGGCCCCGTATG 1219 bp ami2 amplicon 
excluding the 
transcriptional stop codon 
ami2pSELR GCGCGCGCGAATTCGGCGCCGCGGCCGGCCTG 
ami2pSELNF CGCGCGTCTAGAGCCGGTGCTGGTCGATTT 1616 bp ami2 amplicon 
including  400 bp upstream 
the ami2 start codon 
ami2pSELNR GCGCGCGCGAATTCGGCGCCGCGGCCGGCCTG 
rsEGFPF CGCGCGGAATTCATGGTGAGCAAGGGCGAGGA 720 bp rsEGFP amplicon  
rsEGFPR1 GCGCGCCTGCAGAGGAGTCCAAGCTCAGCTAA 
rsEGFPR2 GCGCGCAAGCTTAGGAGTCCAAGCTCAGCTAA When used in conjunction 
with rsEGFPF, produces a 
720 bp rsEGFP amplicon 
used for cloning in 
pMV306(H)  
*red: restriction endonuclease site 
selection by plating 100 μl of a 10-fold serial dilution series onto media containing sucrose, Hyg 
and X-gal.  
The plates were incubated for 3 - 5 days until blue and white colonies emerged. White colonies 
represent strains, which have undergone the second cross over event at the ami2 locus to yield 
either a reversion to wild type or a mutant strain and blue colonies represent strains, which have 
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incurred a mutation in sacB to render them resistant to the toxic effects of sucrose. Subsequently 
10 white colonies were selected and PCR screens were conducted on these using the ami2KOSCF, 
ami2KOSCR1 and ami2KOSCR2 primers, which would yield a 429 bp band in the case of wild 
type and a 231 bp band for the ∆ami2::pMVami2 strain. 
4.2.2 Construction of the Ami2 localisation strains 
Localisation of Ami2 was conducted using the rsEGFP fluorescent tag. The approach involved 
PCR amplification of the rsEGFP tag and the ami2 gene, with and without the native promoter 
region. The amplification would be followed by three way cloning of the ami2 and rsEGFP 
fragment into pSE100 downstream the Tet operator resulting in a construct wherein the Pmyc-tet 
regulates the expression of an amidase gene which contains a C-terminal rsEGFP tag or 
pMV306(H) in which case expression of the ami2-rsEGFP product is regulated by the 
mycobacterial ami2 promoter.  
Primers were designed, ami2pSELF and ami2pSELR for ami2, ami2pSELNF and ami2pSELNR 
for ami2 containing the native promoter, and rsEGFPF and rsEGFPR1 for the rsEGFP tag used 
cloning into pSE100 and rsEGFPR and rsEGFPR2 for the rsEGFP tag used for cloning into 
pMV306(H) listed in Table 4.3. In the case of the amidase primers, these were designed to amplify 
a product which does not contain the transcriptional stop codon allowing for the transcription of 
the C-terminal rsEGFP tag. PCR amplification of the respective fragments was carried out using 
Phusion polymerase, using an annealing temperature of 60 ºC and an elongation time of 1 min to 
allow for complete amplification of the ami2 fragment. The PCR products were purified using the 
Nucleospin PCR purification Kit. Thereafter, pSE100 and the PCR products were then restricted. 
To create the Pmyc-tet regulated construct, pSE100 was restricted with SphI and PstI, the ami2 
fragment, without the native promoter, was restricted with SphI and EcoRI and the rsEGFP 
fragment was restricted with EcoRI and PstI. The pSE100 was then phosphatased using FastAP 
phosphatase for 10 min. The restriction products were separated on a 0.8 % agarose gel and the 
respective bands (5498 bp for pSE100, 1194 bp for ami2 and 698 bp for rsEGFP) were then cut 
from the gel and purified using the Nucleospin gel purification kit. Thereafter, these were 
quantified using the NanoDrop spectrophotometer and ligations were set up containing 50 ng of 
pSE100 and varying molar ratios of ami2 and rsEGFP fragment. The fragments were ligated using 
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Fermentas T4 ligase for 10 min, transformed into DH5α cells and plated on LAHyg200. Ten possible 
clones were selected and screened by restriction with EcoRI, which would yield four fragments, a 
2857 bp, 2306 bp, 1538 bp and a 760 bp band. A single positive clone (pAmi2GFP) was grown in 
50 ml LBHyg200 overnight then bulk vector extraction was carried out using the Nucleobond bulk 
vector extraction kit. Extracted DNA was quantified and restricted with a variety of enzymes to 
profile the rsEGFP tagged amidase construct. The second construct, which contains a ami2-
rsEGFP fusion regulated by the mycobacterial ami2 promoter, was created using pMV306(H). 
For this, pMV306(H) was restricted with XbaI and HindIII, the ami2 fragment, containing the 
native promoter, was restricted with XbaI and EcoRI and the rsEGFP fragment was restricted with 
HindIII and EcoRI. The restricted pMV306(H) vector was then phosphatased using FastAP 
phosphatase for 10 min. The restriction products were separated on a 0.8 % agarose gel and the 
respective bands (4238 bp for pMV306(H), 1611 bp for ami2 and 673 bp for rsEGFP) were then 
cut from the gel and purified using the Nucleospin gel purification kit. Thereafter, these were 
quantified using the NanoDrop spectrophotometer and ligations were set up containing 50 ng of 
pMV306(H) and varying molar ratios of ami2 and rsEGFP fragment. The fragments were ligated 
using Fermentas T4 ligase for 10 min, transformed into DH5α cells and plates on LAHyg200. Ten 
possible clones were selected and screened by restriction with EcoRI, which would yield two 
fragments, a 3577 bp, and a 2981 bp band. A single positive clone (pAmi2GFPN) was grown in 
50 ml LBHyg200 overnight then bulk vector extraction was carried out using the Nucleobond bulk 
vector extraction kit. Extracted vector DNA was quantified and restricted with a variety of 
enzymes to profile the rsEGFP tagged amidase construct. The vectors were also sent for 
sequencing to check for mutations which might have occurred during PCR amplification process 
(data not shown). Finally, 1 µg of the pAmi2GFP construct was then electroporated into 
electrocompetent mc2155 and ∆ami1 cells, plated on 7H10Hyg50 and incubated at 37 ºC for five 
days to create the mc2155::pAmi2GFP and ∆ami1::pAmi2GFP.  Clones were selected; colony boil 
was conducted followed by PCR screening using the ami2pSELF and the rsEGFPR primers to 
determine whether clones possessed the full length ami2-rsEGFP fusion fragment. PCR products 
were separated on a 0.8 % agarose gel. The pAmi2GFPN construct was electroporated into 
electrocompetent mc2155, screened as stated above then the native ami2 allele was deleted as in 
section 4.2.1.2. 
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4.2.3 Construction of Ami2-FLAG tagged strains 
Primers were designed, ami2pFLNF, ami2pFLNR, ami2pFLCF and ami2pFLCR listed in Table 
4.3, to amplify the ami2 gene. PCR amplification of the respective fragments was carried out using 
Phusion polymerase, using an annealing temperature of 60 °C for ami2 and an elongation time of 
1 min to allow for complete amplification of the ami2 fragments, which were 1215 bp and          
1212 bp. The PCR products were purified using the Nucleospin PCR purification Kit. Following 
this, 3 µg of pFLAGEM was restricted with HindIII and KpnI for the Ami2 N-terminal FLAG 
tagged construct and BamHI and BsrGI for the Ami2 C-terminal FLAG-tagged construct. The 
PCR products were then restricted with HindIII and KpnI for the, ami2pFLNF and ami2pFLNR 
product and BamHI and BsrGI for the ami2pFLCF and ami2pFLCR product respectively. The 
pFLAGEM restriction products were then phosphatased using FastAP phosphatase for 30 min. 
The restriction products were separated on a 0.8 % agarose gel and the respective bands (5602 bp 
and 5591 bp pFLAGEM fragments for N and C terminal tagging, respectively and 1197 bp and 
1194 bp ami2 fragments for N and C terminal tagging, respectively) were excised from the gel and 
purified using the Nucleospin gel purification kit. These were then quantified using the NanoDrop 
and ligations were set up containing 50 ng of pFLAGEM and varying molar ratios of ami2. The 
fragments were ligated using Fermentas T4 ligase for 1 h, transformed into DH5α cells and plated 
on LAHyg200. Thereafter, possible clones were selected and screened by restriction with EcoRI, 
which would yield two fragments, a 4523 bp and a 2306 bp for the N-terminal tag construct and    
4479 bp and 2306 bp for the C-terminal tag construct. A single positive clone, per vector, was 
grown in 50 ml LBHyg200 overnight then bulk vector extraction was carried out using the 
Nucleobond bulk vector extraction kit. Extracted vector DNA was quantified and restricted with a 
variety of enzymes to profile the ami2 FLAG tagged constructs (pAmi2NFLAG and 
pAmi2CFLAG) and the vector was sent for sequencing to check for the presence of mutations 
within the amplicon. After sequence confirmation, 1 µg of the pAmi2NFLAG and pAmi2CFLAG 
constructs were electroporated into electrocompetent mc2155 cells, plated on 7H10Hyg50 and 
incubated at 37 ºC for five days to create the mc2155:: pAmi2NFLAG and mc2155:: 
pAmi2CFLAG. A single hyg resistant colony per strain was selected and used for cell wall 
fractionation studies. 
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4.2.4 Mycobacterial cell fractionation 
The mycobacterial cell was fractionated into the cell wall, cell membrane and cytoplasmic fraction 
using a protocol by Rezwan et al., 2007. Mycobacterial cultures were grown to OD600nm = 0.8 in a 
50 ml volume. Cultures were centrifuged at 3500 × g for 10 min. The supernatant was discarded 
and pellet was resuspended in lysis buffer (0.05 M potassium phosphate, 0.022 % mercaptoethanol, 
pH 6.5). The cells were sonicated three times for 20 min then centrifuged at 1000 × g for 10 min 
to remove unbroken cells. The lysate was then centrifuged at 27000 × g, 5 times for 40 min. The 
supernatant and pellet were separated and the supernatant was stored at 4 °C for future use. The 
pellet was sonicated once and centrifuged at 27000 × g for 40 min, and then the resulting 
supernatant was pooled with the stored supernatant. The pellet, which is the PG fraction, was stored 
at 4 °C. The supernatant was centrifuged at 100 000 × g for 1 h and the pellet (cell membrane) and 
supernatant (cytoplasm) were separated and stored at 4 °C (Rezwan et al., 2007). 
4.2.5 Acrylamide gel electrophoresis 
Acrylamide gel electrophoresis was conducted using acrylamide gels made using the TGX stain 
free fastcast acrylamide Kit (Bio-Rad laboratories) as per the manufacture’s instruction. Various 
proteins samples were prepared by mixing with equal volume 2 × loading buffer (0.1 M Tris-HCl 
pH 6.8, 4 % SDS, 20 % glycerol [v/v], 25 % β-mercaptoethanol [v/v] and 0.05 % bromophenol 
blue) and incubated at 95 ˚ C for 2 min prior to loading. Electrophoresis was carried out in resolving 
buffer (Appendix B) at 80 – 100 V for 2 h in Mini protean tetra cell tanks (Bio-Rab laboratories). 
PageRuler Plus prestained protein ladder (Thermo fisher) was separated on the same gel to indicate 
the molecular weight of the samples examined. To visualise proteins, gels were stained with 
Coomasie blue overnight, shaking at room temperature subsequently destained until protein bands 
became visible.  
4.2.6 Western blot analysis 
Proteins samples were separated on an acrylamide gel at 80 V for 2 to 4 h. The gel was then washed 
in transfer buffer (Appendix B). This was then overlaid with polyvinylidene fluoride (PVDF) 
membrane, sandwiched between four Whatman filter papers and six sponges, then pre-soaked in 
transfer buffer. The sandwich was carefully placed in a gel cassette (Bio-Rad Laboratories) and 
transferred to an SB10 tank (Bio-Rad Laboratories) containing transfer buffer. Samples were 
transferred to the PVDF membrane at 400 mA for 2 h. The membrane was incubated in blocking 
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solution containing 2 % skim milk for 30 min at room temperature. Thereafter, the membrane was 
incubated in 20 ml of primary antibody solution (20 ml 1 × blocking solution and 10 µg/ml ANTI-
FLAG M2 monoclonal antibody [Sigma]) for 30 min with gentle agitation at room temperature, 
followed by rinsing three times for 5 min in TBST (Appendix B). The membrane was incubated 
in 20 ml of secondary antibody solution (1:25 000 dilution of Rabbit Anti-Mouse IgG, Peroxidase 
Conjugate [Sigma] in 20 blocking solution) for 1 h with gentle agitation at room temperature, 
followed by five washes for 5 min in TBST (Appendix B). The membrane was placed in a 
hybridisation bag and 1 ml chemiluminescent peroxidase substrate (CPS) was aliquoted onto the 
membrane and incubated at room temperature for 10 min, the excess CPS was then removed, the 
hybridisation bag was sealed. The membrane was exposed to X-ray film (Kodak Biomax Light or 
CL-Xposure™ Film-Thermo Scientific) for 30 seconds to 5 min, to attain the desired band 
intensity and the film was developed using an automated Axim developer. 
Figure 4.3 illustrates the basic outline of the research undertaken in this chapter, with reference to 
the specific methods.  
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Figure 4.3: Flow chart depicting the experimental layout for the M. smegmatis ami2 research. 
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4.3 Results 
4.3.1 Demonstrating the essentiality of ami2 
Numerous attempts to delete ami2 proved unsuccessful (data not shown, Senzani, 2014) and 
considering this, we hypothesised that it was essential for M. smegmatis growth. Consistent with 
this, was the prediction that the Mtb counterpart was predicted to be essential by saturating 
transposon mutagenesis (Griffin et al., 2011, Sassetti and Rubin, 2003). To demonstrate this, a 
merodiploid strain was constructed, that carried two copies of ami2 and we attempted to delete the 
gene in this background. This involved the construction of an SCO in a strain containing two copies 
of Ami2 followed by the subsequent deletion of the native allele (Appendix D, Figure D6). 
4.3.1.1 Construction of the mc2155::pMVami2 strain  
PCR amplification was conducted to amplify the ami2 gene and 400 bp upstream the 
transcriptional start codon. The fragments were then cloned into pMV306 (H) and clones were 
screened by restriction digest with BamHI. A single positive clone was then selected and the 
genetic integrity of the construct was confirmed by extensive restriction profiling, shown in Figure 
4.4. In all cases, the fragment sizes observed corresponded to the vector map and expected sizes, 
confirming the genetic integrity of the vector. The genetic integrity of the vector was then further 
confirmed by sequencing of the cloned region, which revealed that no mutations had occurred 
during PCR and cloning processes (data not shown). This vector was then used for construction of 
the mc2155::pMVami2 strain. For this, the vector was electroporated into the mc2155 strain 
(section 2.4.2); the transformation efficiency obtained from the electro-competent cells was          
7.2 × 103 CFU/µg vector DNA (determined using the pSE100 control vector). A single hyg 
resistant clone was then selected and used for the construction of the ∆ami2::pMVami2 strain. 
4.3.1.2 Construction and screening of the ∆ami2::pMVami2 strain 
The pGOAL17 cassette and ami2 p2NIL deletion fragments were excised from pGOAL17 and 
p2ΔAmi2G19 vectors respectively, then cloned together to create the p2ΔAmi2G17 vector. The 
smaller PacI cassette, without the hyg gene, was required so that hyg could be used as a selectable 
marker for the merodiploid copy. The resulting clones were screened using EcoRI and a single 
positive clone was then selected and the genetic integrity was confirmed by extensive restriction 
profiling, shown in Figure 4.5. 
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Figure 4.4: Restriction profile of pMVami2. Shown are the different restriction nucleases used and the expected sizes 
in a table, which result from restriction digests of the pMVami2 vector. The predicted vector map of the pMVami2 
vector and agarose gel depicting the products of restriction digest of pMVami2 are also shown. Lane 1: Roche Marker 
IV, Lane 2: Uncut, Lane 3: MscI, Lane 4: BamHI, Lane 5: MluI, Lane 6: BglII, Lane 7: XhoI, Lane 8: MluI and EcoRI. 
All the observed sizes were as expected with the exception of the EcoRI, 766 bp band which was 
smaller than expected. As the homologous regions were sequenced, with no mutations detected 
(data not shown), we expect that this difference was related to a restriction site in the vector. The 
p2ΔAmi2G17 knockout vector was electroporated into the mc2155::pMVami2 strain (section 
2.4.2); the transformation efficiency obtained for the electro-competent cells was 9.2 × 104 CFU/μg 
vector DNA determined using the pSE100 control. A single blue clone (SCO strain) was cultured 
and subjected to sucrose counter selection (section 4.2.3). White colonies were then screened by 
PCR to identify clones which possess only the deleted allele, and then southern blot analysis was 
conducted to confirm the second homologous event removed the wild type allele without imposing 
additional unintended chromosome rearrangements, Figure 4.6.  
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Figure 4.5: Restriction profile of p2ΔAmi2G17. Shown are the different restriction nucleases used and the expected 
sizes in a table, which result from restriction digests of the p2ΔAmi2G17 vector. The predicted vector map of the 
p2ΔAmi2G17 vector and agarose gel depicting the products of restriction digest of p2ΔAmi2G17 are also given. Lane 
1: Roche Marker IV, Lane 2: Uncut, Lane 3: BamHI, Lane 4: EcoRI, Lane 5: EcoRV, Lane 6: HindIII, Lane 7: BsrGI, 
Lane 8: BglII. Fragments below 1000 bp were difficult to visualise.  
Southern blot analysis using the restriction enzyme PvuII was conducted on the mc2155, the SCO 
strain and the ∆ami2::pMVami2 strains, which would yield 4386 bp for mc2155::pMVami2  and 
3364 bp for the ∆ami2::pMVami2 strain. All the expected sizes were observed, confirming the 
genetic integrity of the merodiploid knockout. These results confirmed that ami2 is essential as a 
mutant was only obtained in the presence of a second copy of the gene. 
4.3.2 Ami2 is essential for bacterial cell elongation  
Preliminary work conducted in M. smegmatis pointed to a possible role for Ami2 in cell elongation, 
as shown by the presence of short cells  and cells with polar bulges when Ami2 was depleted 
(Appendix D, Figure D7) (Senzani, 2014). Additionally, defects in sliding motility and colony 
morphology were observed further indicating a possible role during cell growth (Appendix D, 
Figure D8).
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Figure 4.6:  Genotypic analysis of the ∆ami2::pMVami2 strain by PCR and Southern blot analysis.  The genomic map of the relevant locus is shown for the wild 
type mc
2
155 and ∆ami2::pMVami2 strain which also depict the integration of a functional ami2 gene at the attB site. Also shown on the left is the PCR confirmation 
of the genotype and southern blotting is shown on the right. For PCR confirmation, chromosomal DNA was used to amplify the ami2 alleles from the wild type 
and mutant strains using the primer pairs described in Table 3 and indicated as red arrows above. The expected sizes of the amplicons are as follows: ami1, 429 bp 
and ∆ami1, 231 bp.  For the Southern blot analysis, chromosomal DNA from the SCO, parental and mutant strain was digested with PvuII.  The probe used for 
hybridisation is shown as a solid green box and the expected sizes are indicated by the blue arrows.  The figures are not drawn to scale. 
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To confirm this, an in-depth analysis was conducted to assess the effects of ami2 depletion. The 
ami2 depletion strain (ami2KDP), previously created by promoter replacement of the native ami2 
promoter with the Pmyc-tet operator, Figure 4.7, was used to assess the essentiality of ami2. In this 
case, ami2 gene expression is under the control of the Pmyc-tet operator such that addition of the 
inducer, anhydrotetracycline (ATc), allows for gene expression. In the absence of ATc, the ami2 
gene expression is repressed. Using this system, we tested the essentiality of ami2 by growing the 
ami2KDP strain in the presence of various concentrations of the inducer, Figure 4.7. This analysis 
demonstrated a retarded growth rate in cultures containing no or low ATc concentrations (0 ng/ml 
and 0.001 ng/ml). Bacterial growth rates increased in the presence of higher concentrations of ATc. 
However, early growth rates never reached the level of mc2155 and all strains eventually plateaued 
at the same density in stationary phase. 
To determine whether the changes in growth rate corresponded to the expression levels of ami2, 
transcriptional analysis was conducted 6, 12 and 18 h post initiation of the growth curve, Figure 
4.7. In the absence of inducer, we were able to achieve a 40 % reduction in ami2 transcript levels 
when compared to wild type, Figure 4.7B. This expression increased moderately in the presence 
of 0.001 ng/ml of ATc and was restored to levels similar to that of the wild type in the presence of 
0.05 ng/ml ATc. Addition of higher levels of ATc, at 1 ng/ml and 50 ng/ml, resulted in moderate 
overexpression with ami2 mRNA peaking at levels 3-fold higher than that of mc2155. Analysis of 
ami2 expression levels 18 h post induction revealed an overall reduction in the expression of ami2, 
with the higher ATc concentrations displaying expression levels similar to that of mc2155, 
suggesting possible ATc degradation over time. 
Thus far, we were able to demonstrate that in the ami2KDP strain, repression of ami2 led to a ca. 
40 % reduction in gene expression, which was associated with retardation of growth. To further 
assess the impact of ami2 depletion in bacterial physiology, high resolution SEM was conducted 
on samples taken 12 h post induction, as the greatest difference with regards to bacterial growth 
was noted at this time point. SEM was conducted on mc2155, the ami2KDP strain grown with         
0 ng/ml and 0.05 ng/ml ATc. Bacterial length was also measured to determine whether ami2 
depletion affected the overall bacterial size, Figure 4.8 and Figure 4.9. From the ~ 400 cells 
analysed per sample, 13 % of the ami2-depleted population were shorter than 3 µm, while only  
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Figure 4.7: Growth analysis of mc2155 and ami2KDP strains. (A) Growth kinetics analysis of mc2155 and ami2KDP 
strains at different ATc concentrations establish varying levels of ami2 expression. (B) shows the CFU/ml counts from 
the mc2155 and the Ami2KDP cultures containing 0 ng/ml and 0.05 ng/ml ATc. (C) shows the transcriptional analysis 
of samples taken at different time points from the growth kinetics analysis depicting the impact of different ATc 
concentrations on ami2 transcript abundance. Shown are the ami2 transcript levels first normalised to sigA (to account 
for differences in RNA between reactions) and subsequently normalised to levels found in the wild type strain. The 
data represents three biological replicates Statistical analysis was conducted using the student’s t-test, ***: p < 0.001 
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Figure 4.8: Microscopic analysis of the mc2155 and ami2KDP strains. Shown are SEM images of the mc2155, 
ami2KDP strain grown in the presence of 0 ng/ml and 0.05 ng/ml ATc. Samples were taken from the growth kinetics 
analysis at time point 12 h, then fixed, dehydrated, carbon coated and imaged using high resolution SEM. Red arrow 
depict cells shorter than 3 µm and yellow arrows indicated polar cell bulges. Data are representative pictures from 
three independent experiments. 
mc2155
ami2KDP 0 ng/ml ATC
ami2KDP 0.05 ng/ml ATC
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Figure 4.9: Statistical analysis of the defects associated with repression of ami2. (A) Bar graph showing the 
quantification of the various Ami2-associated phenotypic defects. Displayed are the two distinctive phenotypes which 
emerged as a result of ami2 depletion and the proportions in which they were observed in the mc2155, ami2KDP 
strains growth with 0 ng/ml and 0.05 ng/ml ATc. (B) Box-and-whisker analysis of the mc2155, ami2KDP strains 
grown with 0 ng/ml and 0.05 ng/ml ATc, comparing the variation in cell length. The analysis demonstrated a change 
in the distribution of cell length in the in the presence of diminished Ami2. Graphs were generated using 3 biological 
replicates, counting a total of approximately 400 cells per strain, p-values were attained using the student’s t – test. 
***: p < 0.001. 
2.7 % and 4.6 % of the mc2155 and ami2KDP, grown with 0.05 ng/ml ATc, populations displayed 
this phenotype, respectively. Additionally, repression of ami2 gave rise to cells with a bulge at a 
single pole, 12 % of the ami2 depleted population contained a bulge at a single pole, while only 
0.9 % and 3.1 % of the mc2155 and ami2KDP, grown with 0.05 ng/ml ATc, populations displayed 
this phenotype, respectively. Further analysis of bacterial cell length revealed the ami2 depleted 
strain was shorter than the mc2155 and ami2KDP, grown with 0.05 ng/ml ATc, counterparts. The 
ami2 depleted population displayed cells lengths of between 1.2 µm to 9.5 µm with a mean and 
median of 4.22 µm and 4.31 µm respectively. The mc2155 and ami2KDP, grown with 0.05 ng/ml 
ATc, populations both fell within a cell length range of 2.1 µm to 9.5 µm with a mean and median 
of 5.01 µm and 4.66 µm for the mc2155 population and 5.12 µm and 4.77 µm for the 
∆ami1::pSEami1 population, Figure 4.9.  
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As Ami2 has been shown to initiate PG synthesis through the activation of MurA (Boutte et al., 
2017), samples were taken from log phase ami2KDP log phase cultures containing no ATc and 
BODIPY-vanc staining was conducted to determine whether PG synthesis continued to occur 
primarily at the poles when ami2 was depleted (Figure 4.10). 
 
Figure 4.10: Microscopic analysis of the fluorescent BODIPY-Vanc (green) and FM4-64 (red) stained depleted 
ami2KDP cells depicting polar staining of both bulged and miniature cells. White arrows indicate polar BODIPY-
Vanc staining, yellow arrows indicate polar bulges and blue arrows indicate miniature cells. The images are 
representatives of biological replicates. Scale = 2 µm. 
As Shown by figure 4.10 both miniature and bulged cells retained polar vancomycin staining, 
indicating PG synthesis, under conditions of depleted ami2, continued to occur at the cell poles. 
4.3.3 Single-cell analysis of the effects of ami2 gene depletion. 
Though growth was retarded when ami2 was repressed, the bacterial culture was able to grow to a 
significant biomass in stationary phase. This suggested that mutants that escaped ATc regulation 
may have arisen during growth. To further assess the effects of ami2 gene repression, we 
conducted single-cell time-lapse microscopy to assess individual micro-colonies. The individual 
bacteria imaged, was incubated in the presence of ATc resulting in growth. However, removal of 
the inducer, ATc, resulted in stalled growth and apperant death, depicted by the loss of membrane 
staining, Figure 4.11, Appendix E, movies 4.1 to 4.3. These observations illustrated that repression 
of ami2 led to cessation of growth and most likely, death of cells. We observed this effect in 37/59 
micro- colonies assessed. In 22/59 micro-colonies, we noted that bacteria continued to grow, 
suggesting that these cells represented escape mutants.  
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Figure 4.11: Time lapse microscopic analysis showing the effects of ami2 depletion in M. smegmatis. Shown in panel 
I to III are Cells initially grown on the presence of ATc (On) for 12 h resulting in bacterial growth and cell division 
depicted by the blue and white arrows, respectively (slides 1-5), followed by removal of the inducer (Off) resulting in 
an immediate stall in bacterial growth and loss of membrane stain in the M. smegmatis ami2KDP strain (slide 6 – 10). 
Green stain is FM4-64 which stain the bacterial cell membrane (green bar = 5 µm)  
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III
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To further test this, growth curve analysis was conducted on mc2155 and the ami2KDP strain in 
the absence of ATc, where cells were allowed to reach stationary phase then a sample of the 
stationary phase culture, that was repressed from initation of growth, was used to start a secondary 
growth curve. This analysis showed similar retarded growth patterns upon a second round of ami2 
gene repression, suggesting that escape, whilst a notable phenomenon, did not distort the readout 
of ami2 essentiality in broth culture, Figure 4.12. The lower growth rate observed with the 
ami2KDP strain in the absence of inducer, instead of complete cessation of growth, may have been 
due to the ability to repress ami2 further at a transcriptional level. 
 
Figure 4.12: Growth analysis of mc2155 and ami2KDP strains. Shown is the growth kinetics analysis of mc2155 and 
ami2KDP growth with 0 ng/ml and 0.05 ng/ml ATc. The first phase was conducted as per the previous growth curve 
then a sample from the 0 ng/ml ATc ami2KDP population was used as a pre-culture to inoculate the 0 ng/ml and 0.05 
ng/ml cultures in the second phase. Both growth phases displayed a similar growth pattern suggesting the growth of 
the ami2KDP strain was a result of residual ami2 expression, rather than the emergence of large numbers of escape 
mutants. The graphs are a representation of three biological replicates. 
4.3.4 Localisation of mycobacterial Ami2 
As the ami2 strain displayed the formation of bulges at the pole we sought to determine whether 
this protein is associated with the cell pole. A recent report on Ami2 (CwlM) function in M. 
smegmatis confirmed a role for this amidase in activating PG biogenesis at the cell pole. However, 
localisation of Ami2 was not assessed. Therefore, an Ami2-rsEGFP fusion protein-containing 
mc2155 and ∆ami1 strain was created in this study to localise Ami2. The approach involved 
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cloning of the ami2-rsegfp fusion product downstream the Pmyc-tet promoter (for constitutive 
expression of fusion product), followed by the introduction of the construct into M. smegmatis.  
4.3.4.1 Construction of the pAmi2GFP vector 
PCR amplification was conducted to amplify the ami2 gene without the stop codon and the 
rsEGFP gene. The fragment was then cloned into pSE100 and clones were screened by restriction 
with EcoRI. A single positive clone was then selected and the genetic integrity of the construct 
was confirmed by extensive restriction profiling, Figure 4.13. 
 
Figure 4.13: Restriction profile of pAmi2GFP. Shown are the different restriction nucleases used and the expected 
sizes in a table, which result from restriction digests of the pAmi2GFP vector. The predicted vector map of pAmi2GFP 
vector and agarose gel depicting the products of restriction digest of pAmi2GFP are also shown. Lane 1: Roche Marker 
IV, Lane 2: Uncut, Lane 3: BspHI, Lane 4: XhoI, Lane 5: EcoRI, Lane 6: PvuI, Lane 7: XmnI, Lane 8: SacI. 
In all cases, all the fragment sizes observed corresponded to the vector map and expected sizes, 
confirming the genetic integrity of the vector, with the exception of PvuI which displayed a        
7462 bp band, which was a result of incomplete restriction endonuclease digestion. Also, there 
was an unexpected small band in the XhoI digest, the result of an unmapped vector site. The genetic 
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integrity of the vector was then further confirmed by sequencing of the cloned region, which 
revealed that no mutations had occurred during PCR and cloning processes (data not shown). This 
vector was then used for construction of the mc2155::pAmi2GFP and ∆ami1::pAmi2GFP strain. 
4.3.4.2 Construction of the pAmi2GFPN vector 
PCR amplification was conducted to amplify a fragment containing the 400 bp region upstream 
the ami2 transcriptional start codon and the ami2 gene without the stop codon. The fragments were 
then cloned into pPV306(H) and the resulting clones were screened by restriction with BamHI. A 
single positive clone was then selected and the genetic integrity of the construct was confirmed by 
extensive restriction profiling, Figure 4.14. 
All the sizes observed on the agarose gel were as expected which the exception of BamHI and PstI 
digests, which displayed additional bands that can be attributed to partial vector digestion by the 
enzymes and HindIII, possibly as a result of star activity. 
4.3.4.3 Construction and screening of the mc2155::pAmi2GFP and ∆ami1::pAmi2GFP strain  
The pAmi2GFP construct was electroporated into the mc2155 and the ∆ami1 strains (section 
2.4.2), the transformation efficiency obtained from the electro-competent cells was                             
7.2 × 104 CFU/µg and 1.9 × 103 CFU/µg vector DNA, respectively (determined using the pSE100 
control vector). Given that the ami1 mutant displayed severe cell division defects, we sought to 
assess how Ami2 would localise under these conditions. Two clones were selected and screened 
by PCR using the ami2pSELF and the rsEGFPR primers (section 4.2.4) to determine the presence 
of the ami2-rsEGFP fusion DNA fragment (Appendix D, Figure D9).  
4.3.4.4 Construction of the ∆ami2::pAmi2GFPN strain  
To determine whether the Ami2-rsEGFP fusion protein is functional, a merodiploid strain was 
constructed containing the ami2-rsEGFP fusion, integrated at the attB site, regulated by the native 
promoter. To do this, the pAmi2GFPN construct was electroporated into the mc2155 strain to 
create the mc2155::pAmi2GFPN strain (section 2.4.2). The transformation efficiency obtained  
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Figure 4.14: Restriction profile of the pAmi2GFPN vector. Shown are the different restriction nucleases used and the 
expected sizes in a table, which result from restriction digests of the pAmi2GFPN vector. The predicted vector map 
of pAmi2GFPN vector and an agarose gel depicting the products of restriction digest of pAmi2GFPN are also shown. 
Lane 1: Roche Marker III, Lane 2: Uncut, Lane 3: BamHI, Lane 4: EcoRI, Lane 5: HindIII, Lane 6: MluI, Lane 7: 
PstI, Lane 8: PvuI. 
from the electrocompetent mc2155 cells was 5.3 × 104. A single clone was selected then the 
p2ΔAmi2G17 knockout vector was electroporated into mc2155::pAmi2GFPN strain (section 
2.4.2), the transformation efficiency obtained for the electrocompetent cells was   3.1 × 104 
CFU/μg vector DNA determined using the pSE100 control. A single blue clone (SCO strain) was 
cultured and subjected to sucrose counter selection (section 4.2.3). White colonies were then 
screened by PCR to identify clones which possess only the deleted allele, and then southern blot 
analysis was conducted to confirm the second homologous event removed the wild type allele 
without imposing additional unintended chromosome rearrangements, Figure 4.15.  
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Figure 4.15:  Genotypic analysis of the ∆ami2::pAmi2GFPN strain by PCR and Southern blot analysis.  The genomic map of the relevant locus is shown for the 
wild type mc
2
155 and ∆ami2::pAmi2GFPN strain which also depict the integration of a functional ami2rsEGFP fusion at the attB site.  Also shown on the left is 
the PCR confirmation of the genotype and southern blotting is shown on the right. For PCR confirmation, chromosomal DNA was used to amplify the ami2 alleles 
from the wild type and mutant strains using the primer pairs described in Table 4.3 and indicated as red arrows above. The expected sizes of the amplicons are as 
follows: ami1, 429 bp and ∆ami1, 231 bp.  For the Southern blot analysis, chromosomal DNA from the SCO, parental and mutant strain was digested with PvuII.  
The probe used for hybridisation is shown as a solid green box and the expected sizes are indicated by the blue arrows. The figures are not drawn to scale. 
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4.3.4.5 Localisation of mycobacterial Ami2 
Following the construction of the Ami2 localisation strains, high resolution TIRF microscopy was 
conducted to determine the cellular localisation of Ami1-rsEGFP. The cells were stained with the 
cell membrane strain FM4-64 to identify the membrane, Figure 4.16. 
The TIRF microscopy revealed a polar localisation pattern for Ami2-rsEGFP, with the majority of 
cells displayed distinct polar focus. Furthermore, this pattern was maintained in the 
∆ami1::pAmi2GFP strain where the Ami2-rsEGFP fusion protein maintained the polar localisation 
pattern with no septal localisation observed, confirming that Ami2 plays an important role in the 
polar elongation of mycobacterial cells. To further analyse these observations, the 6 basic 
localisation patterns observed were quantified, these were: 1, No Ami2-rsEGFP localisation, 2, 
Ami2-rsEGFP localisation in the larger daughter cell 3, Ami2GFP localisation in the smaller 
daughter cell, 4, Ami2-rsEGFP localisation on single pole in a chain, 5, Ami2-rsEGFP localisation 
on both poles and 6, Ami2-rsEGFP localisation on a single pole.  
Quantification of these patterns revealed relatively a high proportion, 60.15 %, of the mc2155 
population displayed the single pole localisation pattern of Ami2, Figure 4.17. As the majority of 
the population is not undergoing cell division, these were not classified under the daughter cell 
classification groups which depict dividing cells, Figure 4.17. In the ∆ami1 mutant, the majority 
of this population, 48.67 %, displayed the Ami2-rsEGFP localisation in the larger daughter cell. 
This was expected as a majority of this population is undergoing cell division as a result of the 
previously reported division arrest. A small proportion of both populations displayed localisation 
at the smaller of the two daughter cells suggesting that Ami2 preferentially localises at the old 
pole. Furthermore, in 14 % of the ∆ami1 population, polar Ami2 localisation in a chain was 
observed. At this point, it is unclear how this localisation pattern in the ami1 mutant is mediated 
and further work is required to resolve this.  
 
122 
 
 
Figure 4.16: Cellular localisation of Ami2-rsEGFP in mc2155 and ∆ami1 cells. Bacteria were grown in 7H9 and 
stained with FM4-64 which stains the plasma membrane then mounted on agarose pads followed by imaging. I-II 
depicts Ami2-rsEGFP localisation in mc2155 and III-IV represents Ami2-rsEGFP localisation in the ∆ami1 strain 
showing the localisation of a single Ami2-rsEGFP foci in individual cells and in ∆ami1 chains. White arrows indicate 
polar Ami2-rsEGFP localisation.  
FM4-64 rsEGFP Composite
FM4-64 rsEGFP Composite
I
II
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FM4-64 rsEGFP CompositeIV
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Figure 4.17: Histogram depicting the analysis of the Ami2-rsEGFP localisation patterns in the mc2155 and ∆ami1 
strains. Shown is the proportion of bacterial cells which exhibit various localisation patterns in both strains white 
arrows show polar Ami2-rsEGFP localisation and blue arrow indicate division septa, The bar graph was generated 
using data from 3 biological replicate counting a total of approximately 350 cells. P-values were attained using the 
student t – test. ***: p < 0.001. 
To further investigate Ami2 localisation in wild type, time-lapse microscopy was conducted on 
the mc2155::pAmi2GFP strain. Time-lapse microscopy of the mc2155::pAmi2GFP strain 
confirmed Ami2 polar localisation, Figure 4.18, Appendix E, movies 4.4 to 4.6, which seemed to 
occur after the cells had initiated polar elongation. The cells retained the single pole localisation 
pattern until the conclusion of cell division at which point the daughter cell possessing Ami2 
continued to grow from that pole. Ami2 was then only recruited to the new pole after the 
establishment of growth at the pole, Figure 4.18. 
4.3.5 Association of Ami2 with the cell membrane 
Unlike Ami1, Ami2 does not possess a signal peptide for translocation to the periplasm. However, 
as Ami2 is predicted to be a PG hydrolysing enzyme, we sought to determine whether it was 
translocated to the periplasm or remains in the cytoplasm to conduct its function. For this, N- and 
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C- terminally FLAG-tagged variants of Ami2 were constructed and introduced into mc2155 
followed by cell fractionation and western blot analysis to determine the location of Ami2. 
 
Figure 4.18: Time lapse microscopic analysis of Ami2-rsEGFP localisation in the mc2155 strain. Cells were grown 
and imaged in 7H9S. I-III depicts three representative mc2155 micro-colonies. White arrows indicate the polar 
localisation of Ami2, which emerge on a single as the cell begins to elongate and remains at the same pole throughout 
multiple division cycles. Scale = 5 µm 
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4.3.5.1 Construction of the pAmi2NFLAG and pAmi2CFLAG vectors 
PCR amplification was conducted to amplify two variants of the ami2 gene, one full length gene 
for N-terminal tagging and one without the stop codon for C-terminal tagging. The fragments were 
then cloned into pFLAGEM and clones were screened by restriction with EcoRI. A single positive 
clone was then selected and the genetic integrity of the vector was confirmed by extensive 
restriction profiling, Figure 4.19 and Figure 4.20. 
In all cases, all the fragment sizes observed corresponded to the vector map and expected sizes, 
confirming the genetic integrity of the vector (Fig 4.19 and Fig 4.20). The genetic integrity of the 
vector was then further confirmed by sequencing of the cloned region, which revealed that no 
mutations had occurred during PCR and cloning processes (data not shown). This vector was then 
used for construction of the mc2155::pAmi2NFLAG and mc2155::pAmi2CFLAG strains. 
4.3.5.2 Determining the subcellular localisation of Ami2 
The pAmi2NFLAG and pAmi2CFLAG vectors were electroporated into the mc2155 strain (section 
2.4.2); the transformation efficiency obtained from the electro-competent cells was                            
5.6 × 104 CFU/µg (determined using the pSE100 control vector). A single clone per strain was 
selected. This was cultured, fractionated and western blot analysis was conducted to determine the 
possible export of Ami2 through cellular fraction association, section 4.2.4 and 4.2.5. 
As shown in Figure 4.21, both N- and C- terminally tagged Ami2 products associated with the cell 
wall fraction. Furthermore the detection of both variants of the same size, in the same type of 
fraction, in two distinct strains suggests that the protein is not cleaved during localisation. This 
was unexpected,  
 
126 
 
 
Figure 4.19: Restriction profile of pAmi2NFLAG, Shown are the different restriction nucleases used and the expected 
sizes in a table, which result from restriction digests of the pAmi2NFLAG vector. Predicted vector map of 
pAmi2NFLAG vector and agarose gel depicting the products of restriction digest of pAmi2NFLAG. Lane 1: Roche 
Marker IV, Lane 2: Uncut, Lane 3: RcaI, Lane 4: EcoRI, Lane 5: XhoI, Lane 6: BglII, Lane 7: NruI, Lane 8: HindIII 
and KpnI. 
as ami2 does not possess a signal peptide and was shown to be a cytoplasmic protein (Boutte et 
al., 2016). The co-localisation of Ami2FLAG could be a result of protein PG interactions during 
sample preparation. Furthermore, the lack of relevant control antibodies for each fraction makes it 
difficult to confirm that each fraction contained only cell wall, cell membrane or cytoplasmic 
material. 
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Figure 4.20: Restriction profile of pAmi2CFLAG. Shown are the different restriction nucleases used and the expected 
sizes in a table, which result from restriction digests of the pAmi2CFLAG vector. The predicted vector map of 
pAmi2CFLAG vector and agarose gel depicting the products of restriction digest of pAmi2CFLAG are also shown. 
Lane 1: Roche Marker IV, Lane 2: Uncut, Lane 3: RcaI, Lane 4: EcoRI, Lane 5: XhoI, Lane 6: BglII, Lane 7: NruI, 
Lane 8: HindIII and KpnI. 
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Figure 4.21:  Western blot analysis of N- and C- terminally Flag-tagged Ami2. (A) Shown is a flow chart representing 
the protocol used to fraction the cell into three fractions; the cell wall, cell membrane and cytoplasmic content. (B) 
Shows western blot analysis conducted on the three cell fractions to detect Flag tagged Ami2 in the three fractions. 
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4.4 Discussion 
In the previous chapter, we demonstrated that Ami1 plays an important role in cell division, more 
specifically, in daughter cell separation. Our initial bioinformatics analysis identified Ami2 as the 
second amidase_3-domain-containing PG hydrolase in mycobacteria. Whilst the amidase_2 
domain was generally conserved, some of the conventional catalytic residues were replaced with 
non-canonical amino acids, suggesting a possible divergence in function or substrate specificity, 
Appendix D, Figure D1. Consistent with this, our analysis of this enzyme confirmed a role in cell 
elongation. Elongation in mycobacterial cells occurs through polymerisation of new PG at the cell 
poles (Botella et al., 2017). Little is known about the role of PG hydrolases in cell elongation; 
however, one class of enzymes which has been well characterised in this context are the PBPs. 
This is a class of enzymes consisting of various sub-groups conducting different enzymatic 
reactions, including transglycosylases (which polymerise the glycan strand), transpeptidases 
(which crosslink the stem peptides) and two groups of hydrolases, which are, the endopeptidases 
and carboxypeptidases, both responsible for cleaving various peptide bonds within the stem 
peptide (Hett and Rubin, 2008). The role of carboxypeptidases in cell growth has remained 
enigmatic, work conducted in E. coli has suggested a possible role in cell shape maintenance, as 
deletion of multiple DD-caboxypepetidases resulted in the formation of long, fat cells containing 
lateral and polar branches (Nelson and Young, 2001). With regards to endopeptidases. however, 
it is clear these enzymes are important for cell elongation. Several reports in E. coli and B. subtilis 
has demonstrated that deletion of multiple PG endopeptidases results in the formation of short cells 
which ultimately lyse resulting in bacterial death (Singh et al., 2012, Hashimoto et al., 2012, 
Meisner et al., 2013). In M. smegmatis, depletion of the bi-functional, essential, PBP (ponA1), 
which conducts both transpeptidase and transglycosylase activity, results in a phenotype similar to 
that observed in the M. smegmatis ami1 deletion strain (Kieser et al., 2015, Senzani et al., 2017), 
indicating this enzyme is essential for cell division (Kieser et al., 2015). 
Similar to PonA1, Ami2 was also predicted to be essential for growth of Mtb and we sought to 
determine whether this essentiality was linked to any role in cellular growth or division (Sassetti 
and Rubin, 2003, Griffin et al., 2011). This initial prediction of essentiality in Mtb was proven 
using TraSH (Sassetti and Rubin, 2003, Griffin et al., 2011). This technique possesses certain 
limitations including secondary effects on downstream genes resulting in false annotations of 
essentiality and it also relies on negative screening whereby the lack of growth is viewed as 
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essentiality (Sassetti and Rubin, 2003, Nisa et al., 2010, Ginda et al., 2013). These limitations may 
give rise to an incorrect assumption of essentiality, as demonstrated for the MoaA1-MoaD1 operon 
in Mtb, which was initially predicted to be essential by TraSH but later proven to be dispensable 
(Williams et al., 2011). To address these limitations, a merodiploid technique was adopted to try 
and prove essentiality (Appendix D, Figure D6). The ami2 knockout vector was constructed and 
the ability to knockout ami2 in mc2155 was tested, this yielded only wild-type and SCOs, the latter 
carrying a loss of function mutation in the sacB and lacZ genes (Senzani, 2014). These data were 
consistent with the predicted essentiality of Ami2 (Sassetti and Rubin, 2003, Griffin et al., 2011). 
To further explore this, a second copy of the ami2 gene, driven off the native promoter was inserted 
at the attB site, and the two-step allelic exchange mutagenesis was attempted again. This yielded 
two amidase knockout strains, out of 10 possible clones, demonstrating that an additional copy the 
gene was required for mutagenesis. While we were conducting our analysis, another group also 
demonstrated the essentiality of ami2 by adopting a merodiploid approach (Boutte et al., 2016). 
The depletion of ami2 led to a reduction in bacterial growth when compared to mc2155. In broth 
culture, this did not result in complete cessation of growth in the absence of the inducer. Our data 
in this regard are in contrast to that reported by Boutte et al, 2016, who demonstrated complete 
cessation of growth upon depletion of Ami2 (Boutte et al., 2016). We expect that this is due to the 
leaky nature of the tetO regulated system, which in our case only allowed for a 40% reduction in 
gene expression under conditions of gene depletion (Ehrt et al., 2005a, Blokpoel et al., 2005). This 
reduced expression was sufficient to facilitate low level bacterial growth and provided the 
opportunity to study the effects of ami2 depletion. Microscopic analysis demonstrated that a 
reduction in ami2 levels led to the formation of short cells containing bulges at the polar region, 
confirming that Ami2 is crucial for cell elongation. This was consistent with findings that Ami2 
played an important role during cell elongation through the activation of MurA and the initiation 
of lipid II biosynthesis (Boutte et al., 2016). Therefore, the depletion of Ami2 would lead to the 
inhibition of lipid II biosynthesis and retarded cellular growth (Figure 4.22). 
We also considered the possibility that escape mutants emerged during growth to bypass the lethal 
effects of ami2 repression. Consistent with this, Boutte et al 2016 also demonstrated the occurrence 
of escape mutant strains in the phospho-ablative Ami2 strains, in which case Ami2 does not 
possess the ability to activate MurA (Boutte et al., 2016). In these strains, point mutations found 
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in murA resulted in a seemingly constitutively active form of the enzyme rendering, the MurA 
activation function of Ami2, non-essential for growth (Boutte et al., 2016). To address this issue 
in our experiments, a sample from the culture, wherein gene depletion was carried out, was used 
to start a secondary growth kinetics analysis. The hypothesis here was that if the emerging 
organisms were escape mutants, growth of the secondary culture would resemble the mc2155 
culture, and would not be responsive to ATc depletion. This was not the case as retarded growth 
was observed again, in a manner similar to the initial growth curve, confirming the ability to 
regulate growth using ATc. This indicated that in our experiments, the reduced growth seen upon 
ami2 gene depletion was due to leaky expression rather than loss of Pmyc-tet regulation. 
As Ami2 appears to be essential for the initiation of PG biosynthesis, BODIPY-vanc staining was 
conducted on ami2KDP to evaluate whether PG synthesis continues to occur at the poles when 
Ami2 is depleted. In this regard, it was demonstrated that Ami2 plays an important role in 
regulating the activity of MurA during starvation and stationary phase (Boutte et al., 2016). 
Furthermore, it has been suggested that a reduction in PG biosynthesis, as a result of stationary 
phase or starvation, led to the delocalisation of the elongasome and in this context, we expected 
that depletion of Ami2 would lead to diffused BODIPY-vanc staining (Hayashi et al., 2018). This 
was not the cases as the ami2KDP strain retained polar BODIPY-vanc staining when ami2 was 
depleted, this suggests the elongasome remained at the poles and low level ami2 expression is 
sufficient as to allow for the synthesis of lipid II.  
As PG biosynthesis seemed to be occurring at the cell poles in the ami2KDP strain, single cell 
microscopy was conducted to evaluate how these strains were growing. This revealed that 
depletion of ami2 did in-fact result in substantive growth inhibition, an effect that was noted in a 
substantive number of micro-colonies analysed. Given the dramatic loss of FM4-64 staining 
observed in cells where ami2 was depleted, we assumed that depletion resulted in death but this 
would need to be further confirmed with live/dead staining techniques or by re-introduction of 
ATc to the system. Despite these limitations, our data seem consistent with previous reports of 
ami2 essentiality (Boutte et al., 2016). 
Depletion of ami2 also resulted in the formation of polar bulges. This phenotype has been reported 
with a number of essential M. smegmatis cell elongation components including a divIVA depletion 
strain, where depletion resulted in short cells which contain bulges and ponA1, where deletion of 
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the transpeptidase domain results in short cells containing polar bulges (Kang et al., 2008, Kieser 
et al., 2015). However, unlike the ami2 depletion strain the bulges in both the ∆ponA1 mutant and 
divIVA depletion strains, originate from the septum, during cell division (Kang et al., 2008, Kieser 
et al., 2015, Hett et al., 2010). This does not appear to be the case in the ami2KDP strain as only   
2 of the 64 bulges observed were septal in nature and in both instances the septum seemed to be 
misplaced and was adjacent to the pole.  
A comparable phenotype was also noted with the overexpression of pknB (Kang et al., 2005). 
Elevated levels of pknB resulted in the formation of short, wider cells, which contained bulges 
identical to those observed in the ami2KDP strain (Kang et al., 2005). This could be the result of 
altered Ami2 activity, a hypothesis that is supported by the demonstrated interaction between 
Ami2 and PknB, which results in Ami2 phosphorylation and PknB dephosphorylation (Boutte et 
al., 2016). However, it is unusual that pknB overexpression would result in the formation of long 
cells (Kang et al., 2008). One possible reason for this is the broad substrate specificity of PknB, 
which phosphorylates a multitude of proteins including RshA (Prisic et al., 2010, Park et al., 2008). 
RshA is an anti-sigma factor which regulates the activity of SigH by binding and inhibiting the 
expression of stress responsive genes (Song et al., 2003). This interaction is regulated by PknB, as 
it was demonstrated that phosphorylation of RshA by PknB hinders the interaction between SigH 
and RshA, leading to transition to a stress tolerant form, possibly similar to that observed in the 
PknB overexpression strain (Song et al., 2003, Park et al., 2008, Kang et al., 2005, Shleeva et al., 
2010). This would suggest Ami2 and PknB regulate each other, thus a reduction in Ami2 would 
not only result in a decrease in active MurA, but also an increase in active PknB resulting in the 
formation of short cells with polar bulges (Figure 4.22). 
As localisation of both DivIVA and PonA1 was shown to be both polar and septal in nature, we 
sought to determine whether Ami2 localises in a similar manner (Hett et al., 2010, Kang et al., 
2008). Our localisation data indicated that Ami2 localises exclusively to the pole, furthermore it 
appears to be recruited once the leading pole is established as shown by the late arrival of Ami2 to 
the growing pole. Although, it is difficult time Ami2 localisation accurately in the absence of other 
markers of cell division. This pattern of Ami2GFP localisation was observed in approximately half 
the cells examined using live cell microscopy, however images acquired with TIRF microscopy 
indicated approximately 80 % of the population contained localisation foci at the poles. This 
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discrepancy in the proportion of cells localizing Ami2GFP could be due to the higher sensitivity 
of TIRF microscopy enabling it to detect fluorescent signals with lower intensity (Mattheyses et 
al., 2010). Furthermore, analysis of the TIRF acquired ∆ami1::pAmi2GFP data revealed a similar 
localisation pattern in a ∆ami1 chain, consisting of three or more cells indicating that failure to 
separate did not affect the localisation pattern. How Ami2 is directed to the cell pole is still unclear.  
Cell fractionation analysis of the C- and N-terminally FLAG-tagged Ami2 suggested the 
association of Ami2 with the cell wall fraction. This was unexpected as the polypeptide does not 
contain a translocation signal sequence; furthermore, it has been demonstrated that Ami2 is 
cytoplasmic in nature (Boutte et al., 2016). One possible answer to this is the presence of a 
mycobacterial fraction which consists of a tightly associated plasma and cell membrane (PM-CW) 
fraction (Hayashi et al., 2016, Morita et al., 2005). Work conducted by Hayashi et al., 2016, 
indicated the association of Ami2 which the PM-CW fraction (Hayashi et al., 2016). This 
association is perhaps stronger with the CW component of this fraction, as Ami2 possesses two 
cell wall binding domains and no plasma membrane binding domain (Hayashi et al., 2016, 
Machowski et al., 2014). This study and observations by Hayashi et al, 2016 suggest the possible 
translocation of Ami2 to the cell wall; however, the mechanism involved is unknown. This is 
plausible as a number of mycobacterial proteins without a signal sequence have been shown to be 
secreted (De Souza et al., 2011). That said, caution should be used when intepreting these 
experiments and as a result, we sought an alternate explanation. There is the possibility where due 
to the presence of the cell wall binding domains, Ami2 possesses the ability to bind PG, as such 
this interaction could have occurred during fraction preparation resulting in the co-precipitation of 
the Ami2-FLAG protein with the PG fraction (Machowski et al., 2014). Furthermore the lack of 
specific antibodies to differentiate the three fractions, using enzymes demonstrated to precipitate 
with each fraction, makes it difficult to confirm the validity of the fractionation approach. We are 
actively seeking alternatives to determine cellular localisation of this protein. 
Collectively, herein we confirm the essentiality of Ami2 for polar elongation of mycobacterial 
cells. We demonstrated that depletion of this enzyme results in a dramatic reduction in growth at 
a single-cell levels and substantive morphological defects including short cells and the presence 
of bulges. We also show that Ami2 localises the cell pole, the mechanism that supports this has 
yet to be unravelled.  
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Figure 4.22: Proposed model for the role of Ami2 during cell growth in mycobacteria. PknB phosphorylates Ami2, 
which in turn phosphorylates MurA, resulting in the activation of MurA, followed by PG synthesis and cell 
elongation. Ami2 phosporylation also regulates the level of active PknB thus indirectly regulating the activity of 
SigH. When Ami2 is depleted this results in an increase in active PknB, which then phosphorylates RshA, leading to 
increased SigH activity causing a bacterial switch to a stress tolerant form. The reduction of Ami2 results in a 
reduced levels of active MurA in the cell leading to retarded growth and the formation of short cell with bulges at 
the poles (figure drawn by S. Senzani). 
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Figure 5.1: Flow chart highlighting the focus of chapter 5. Highlighted is the portion of the study which will be addressed in the following chapter. (figure drawn 
by S. Senzani) 
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5 Mtb amidases in bacterial growth and survival 
5.1 Introduction 
As bacteria constantly find themselves under stressful conditions, survival is critically reliant on 
the ability to sense the environment and respond to changes (Justice et al., 2008). In addition to 
playing a vital structural role, bacteria are able to use their cell walls to sense environmental 
changes and respond appropriately. Within the cell wall, the PG layer is a dynamic and fluid 
structure, continuously undergoing remodelling for various purposes and as has been discussed, 
many of these related to cell growth and division (Horcajo et al., 2012, Alvarez et al., 2014). Some 
PG modifications, however, are important for responding to stress. In many cases, deletion of PG 
remodelling enzymes generally results in elongation or division defects, which are generally severe 
and obfuscate any role these enzymes play in responding to stress (Heidrich et al., 2001, Korsak 
et al., 2005). One example of how PG remodelling is critical for responding to stress is illustrated 
in Bacillus subtilis during spore formation.   
 
5.1.1 The role of amidases in B. subtilis 
B. subtilis possesses 10 cell wall amidases, five of these are amidase_2 domain containing enzymes 
designated as CwlH, CwlA, XlyA, XlyB and BlyA (Smith et al., 2000). From an evolutionary 
perspective, some of the amidase_2 domain containing enzymes are predicted to be of viral origin, 
as their expression is regulated by viral elements (Nugroho et al., 1999, Longchamp et al., 1994, 
Mizuno et al., 1996, Regamey and Karamata, 1998). The biological role of the entire bacillus 
amidases_2 domain containing enzymes and how they are related to each other is unknown; 
however, the catalytic activity has been demonstrated (Nugroho et al., 1999, Longchamp et al., 
1994, Mizuno et al., 1996, Regamey and Karamata, 1998). B. subtilis also contains five amidase_3 
domain containing amidases designated CwlD, YqiI, LytC, CwlC and CwlB, which seem to be 
required for sporulation, protection against high osmolarity and cell division. These will be 
discussed further in detail below. 
Sporulation is an adaptive process carried out by members of the bacillus species under conditions 
of stress such as nutrient starvation (Errington, 1993). This process entails the formation and 
release of an endospore, which remains dormant until conditions become favorable for growth. 
Sporulation begins with the formation of asymmetric division septa (Piggot and Hilbert, 2004). 
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This is followed by phagocytosis of the miniature cell by the adjacent mother cell (Piggot and 
Hilbert, 2004). The engulfed cell is then coated with an additional PG layer, termed the spore 
cortex, finally followed by lysis of the mother cell resulting in spore release (Piggot and Hilbert, 
2004). Cell wall amidases play a role at various stages along the sporulation process, beginning 
with spore cortex maturation. Formation of this polymer is facilitated by CwlD (Sekiguchi et al., 
1995). Analysis of strains lacking this amidase revealed the formation of spores which were unable 
germinate under nutrient rich conditions (Sekiguchi et al., 1995). The authors hypothesise that 
CwlD plays an important role in the hydrolysis of the spore cortex resulting in the release of the 
endospore leading to bacterial growth. CwlD expression analysis, however, showed that this gene 
is only expressed during spore formation, suggesting that an alternate mechanism must prevail 
(Sekiguchi et al., 1995). Analysis of spore cortex PG from ΔcwlD spores revealed the absence of 
a δ-lactam structure on the NAM residues (Smith et al., 2000, Popham et al., 1996, Atrih et al., 
1996). This NAM - δ-lactam structure is found in approximately 50 % of the spore cortex PG and 
plays an important role in spore germination, as spore lacking this structure fail to germinate 
(Popham, 2002, Popham et al., 1996). Thus, CwlD most likely modifies the peptide stem in the 
spore cortex, which subsequently allows the formation of the δ-lactam structure. 
Three cell wall amidases LytC, CwlC and CwlB are also involved in mother cell lysis (Smith and 
Foster, 1995). In this case, deletion of each amidase individually has no impact on mother cell 
lysis; however, deletion of two or more resulted in abrogation of mother cell lysis (Smith et al., 
2000). Furthermore, double mutants containing a cwlC knockout displayed a higher proportion of 
unlysed mother cells, indicating CwlC plays the major role during mother cell lysis, possibly in 
synergy with LytC and CwlB (Smith and Foster, 1995). 
B. subtilis amidases also play a role in maintaining bacterial osmolarity (Fischer and Bremer, 
2012). Deletion of any amidase_3 domain-containing amidase resulted in retarded growth in media 
containing high salt concentration (Fischer and Bremer, 2012). The exact mechanism for osmotic 
tolerance is unknown. However it is predicted that amidases play a role in remodeling the cell wall 
to yield a conformation that allows for minimal water loss (Fischer and Bremer, 2012). As deletion 
of multiple cell wall amidases did not exacerbate the phenotype, the authors predict the presence 
of an osmolarity pathway involving all the B. subtilis amidase_3 amidases, each possessing a 
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specific role, where deletion of a single amidase would result in the collapse of the pathway 
(Fischer and Bremer, 2012). 
Unlike in E. coli, the amidases do not appear to play a major role in cell division in B. subtilis. 
LytC is the only amidase demonstrated to play a role during cell division (Blackman et al., 1998). 
This function is conducted in synergy with the glucosaminidase LytD, as deletion of LytC 
individually does not induce any septation defects. However, the lytC lytD double mutant is 
characterised by the formation of abnormally long chains (Blackman et al., 1998). 
5.1.2 Amidases in other organisms 
Cyanobacterium Anabaena PCC 7120 a filamentous, photosynthetic prokaryotic organism, which 
forms specialised cells, called heterocysts from vegetative cells (Berendt et al., 2012). Heterocysts 
are nitrogenase containing cells, which are responsible for filamentous nitrogen assimilation 
(Berendt et al., 2012). These cells are morphologically different from vegetative cells, as they 
possess a thick PG layer to allow for protection of oxygen sensitive nitrogenases from the O2 
produced by vegetative photosynthetic cells (Berendt et al., 2012). Heterocyst formation is tightly 
regulated to ensure the formation of a single heterocyst for every 10 to 20 vegetative cells (Berendt 
et al., 2012, Golden and Yoon, 2003). Deletion of amidases in these organisms resulted in a 
reduction in the amount of heterocyst cells formed (Berendt et al., 2012). This led to the hypothesis 
that amidases are required to actively remodel the PG layer resulting in the formation of the thick-
walled conformation. Further research, however, uncovered another role for the C. anabaena 
amidase, wherein it was demonstrated that this amidase plays an important role in the formation 
and maturation of septal pores, which allow for exchange between adjacent cells (Zheng et al., 
2017). Deletion of this amidase resulted in the formation of pores which are smaller in diameter 
possibly limiting the movement specific elements (Zheng et al., 2017). This exchange could 
include intercellular markers, which target specific cells for heterocyst formation and reduction in 
the movement of these markers could reduce the amount of heterocysts formed. This hypothesis 
requires further investigation. 
5.1.3 Amidase response to host immune associated stress 
The constant remodelling associated with PG results in the release PG breakdown products, which 
can be used by neighbouring cells for various purposes including metabolism and as signalling 
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molecules (Shah et al., 2008, Goodell, 1985). With regards to signalling, PG is important in 
inducing certain immune responses during infection (Takeda and Akira, 2005). This is discussed 
in further detail below. 
5.1.3.1 Why bacteria release PG fragments? 
Muropeptides are strong inducers of the immune system. However, these molecules also have an 
important role in bacterial signalling (Shah et al., 2008, Nikitushkin et al., 2013). The release of 
muropeptides can occurs as a by-product of active bacterial growth. As such, these molecules can 
be used by non-replicating organisms as cues to signal the presence of growth permissive 
conditions (Shah et al., 2008, Nikitushkin et al., 2013). In B. subtilis it has been shown that 
muropeptides have the capacity to induce the germination of dormant spores (Shah et al., 2008). 
This capacity was only present when the muropeptide possessed a three or more amino acid stem 
peptide, with the meso-DAP being the third amino acid (Shah et al., 2008). Treatment of these 
muropeptides with cell wall amidases eliminated the ability to induce germination, indicating that 
amidase activity, as is the case with the host immune system, is important for modulating the 
stimulatory properties of muropeptides (Shah et al., 2008). The mechanism, in this case, involves 
signalling through serine threonine protein kinases. It is also possible that a similar phenomenon 
occurs through the function of lytic transglycosylase like proteins, resuscitation promoting factors 
(Rpfs), which are required for muropeptide formation, in combination with an endopeptidase RipA 
(Mukamolova et al., 2006, Cohen Gonsaud et al., 2005, Nikitushkin et al., 2013). Though 
mycobacteria do not form dormant spores, they have been shown to possess the capacity to enter 
a state of non-culturability (Parrish et al., 1998, Wayne, 1994). It is widely thought this ability may 
contribute to the establishment of latent TB infection, thus helping the organism persist under 
hostile conditions (Parrish et al., 1998, Wayne, 1994, Barry et al., 2009). However, it is emerging 
that latent TB infection is characterised by a dynamic immune response, suggestive of a similarly 
dynamic underlying bacterial population (Barry et al., 2009, Russell et al., 2009). Various studies 
have demonstrated that Rpfs play an important role in the growth stimulation of viable but non-
culturable bacteria (Nikitushkin et al., 2013, Kana et al., 2008, Russell-Goldman et al., 2008, 
Downing et al., 2005, Tufariello et al., 2006). The ability of muropeptides to stimulate the growth 
of non-replicating mycobacteria has been tested, with equivocal results, suggesting that an 
alternate mechanism may prevail in these organisms (Nikitushkin et al., 2013, Mir et al., 2011).  
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5.1.3.2 Host responses to PG 
As PG is unique to bacteria, eukaryotic hosts have developed various mechanisms to identify 
organisms possessing this structure in order to detect possible invasion by bacteria (Palaniyar et 
al., 2010). Two main pathways are important for this, including the TLR and nucleotide-binding 
oligomerisation domain (Nod) system. Both are constituents of the innate immune response 
(Takeda and Akira, 2005). The TLR system consists of various cytoplasmic and cell membrane 
bound receptors tasked with the responsibility of identifying various foreign components, ranging 
from cellular organelles to RNA (Takeda and Akira, 2005). This comprises 11 receptors containing 
two domains an external TLR domain and an Internal Toll/IL-1 receptor (TIR) domain (Takeda 
and Akira, 2005). The TLR domain is the primary ligand binding component, which associates 
with different elements including PG, this leads to the activation of the TIR domain, resulting in a 
signalling cascade that induces a response (Takeda and Akira, 2005, Takeuchi et al., 2000). In the 
case of PG, it has been shown TLR2 is an important receptor for binding. Binding of PG to TLR2 
leads to TIR domain activation, resulting in the recruitment TIR domain-containing adaptor protein 
(TIRAP), which in-turn recruits MyD88 (Yamamoto et al., 2002). MyD88 then binds interleukin-
1 receptor-associated kinase - 4 (IRAK-4) (Takeda and Akira, 2005). IRAK–4 phosphorylates 
IRAK – 1, which associates with tumor necrosis factor receptor-associated factor 6 (TRAF6), 
resulting in the activation of two distinct signalling pathways. The first involves activation of AP-
1 transcription factors through the activation of MAP Kinases and second involves activation of 
the TAK1/TAB complex (Takeda and Akira, 2005, Gray et al., 2006). Activation of TAK1/TAB 
complex leads to enhanced IκB Kinase (IKK) complex activity, which phosphorylates IκB, leading 
to subsequent degradation (Takeda and Akira, 2005, Gray et al., 2006). This results in the release 
and nuclear translocation of NF-κB transcription factors and subsequent transcription of pro-
inflammatory cytokines such as TNF-α and IL-12 (Gray et al., 2006). This mechanism is illustrated 
in Figure 5.2. In Drosophila, some of the TLR2 activated NF-κB factors include Dif and Dorsal, 
which induce the expression of antimicrobial peptides that target fungal and bacterial organisms 
(Lemaitre et al., 1997). 
The second system that utilises the identification of PG derivatives as indicators of bacterial 
invasion is the Nod system. Nod recognizes the presence of cytoplasmic muropeptides as an 
indicator of bacterial invasion. It consists of two essential elements Nod1 and Nod2, which 
recognize different muropeptide structures (Inohara et al., 2003, Girardin et al., 2003b, Girardin et 
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al., 2003a, Chamaillard et al., 2003). Nod1 recognizes muropeptides containing a minimum of 
three peptides on the stem peptide with the third peptide being a Meso-Dap subunit while Nod2 
recognizes a stem peptide containing 2 peptides (Inohara et al., 2003, Girardin et al., 2003a, 
Chamaillard et al., 2003, Coulombe et al., 2009, Girardin et al., 2003b). 
Muropeptides binding to either Nod1/Nod2 induce oligomerisation of Nod proteins resulting in 
the recruitment of the serine/threonine kinase RICK (Kanneganti et al., 2007, Inohara and Nunez, 
2003). This in turn results in the recruitment of the IKK complex, which subsequently 
phosphorylates IκB leading to subsequent degradation (Kanneganti et al., 2007). IκB degradation 
results NF-κB translocation and subsequent gene expression (Takeda and Akira, 2005, Deshpande 
et al., 1997, Gerondakis et al., 1999). In this case, NF-κB Relish is activated and leads to the 
transcription of antimicrobial agents such a diptericin (Lemaitre et al., 1997). The overall 
mechanism is shown in Figure 5.2. 
Both the Toll and Nod systems are central to induce an immune response and as with all immune 
responses, these systems require careful regulation (Fukata et al., 2009). In light of this, eukaryotic 
organisms have developed mechanisms to regulate the level of PG mediated immune induction 
through the modification of the PG ligands. This is achieved by a class of eukaryotic proteins 
called PG recognition proteins (PGRPs) (Palaniyar et al., 2010, Dziarski, 2004). PGRPs are a 
group of proteins that have the ability to bind to bacterial PG (Dziarski, 2004, Palaniyar et al., 
2010). These are essential for various cellular processes including phagocytosis, activation of   
Toll-mediated immune response, antimicrobial activity and reduction of PG mediated                    
pro-inflammatory response (Dziarski, 2004, Palaniyar et al., 2010). The regulatory capacity of 
these proteins is due to the function of eukaryotic PG amidases, found in both vertebrate and 
invertebrate organisms (Palaniyar et al., 2010, Dziarski, 2004). Similar to the counterparts found 
in bacteria, these enzymes act by cleaving the stem peptides from PG, thus rendering the ligand 
inept, inactivating PG mediated pro-inflammatory responses (Palaniyar et al., 2010, Dziarski, 
2004). 
With the evolution of muropeptide directed immune responses, pathogenic bacterial have 
developed countermeasures to evade these systems. These mainly include the modification of the 
glycan backbone of PG such as, glycolylation and deacetylation of the sugars and modification of 
the stem peptide, primarily the substitution of specific amino acids (Humann and Lenz, 2009). The 
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role that amidases play in this process is not clear though they have been found to be essential for 
pathogenesis in various species such as Neisseria gonorrhoeae and Helicobacter pylori, where 
deletion of these enzymes resulted in reduced pathogenicity (Chaput et al., 2006, Garcia and 
Dillard, 2008, Melly et al., 1984). Furthermore, transposon mutagenesis of Ami1 in Mtb resulted 
in a dissemination defect, localizing the infection to the lungs (Sassetti and Rubin, 2003).  
The role of mycobacterial PG associated enzymes in the ability to adapt to changes in the 
environment is currently limited with anecdotal evidence provided by the ability of Rpfs to respond 
to stressful conditions during reactivation of infection in mice (Tufariello et al., 2006). The role of 
Mtb amidases in any of these processes is also currently unknown. Here, we assess the role of the 
Mtb amidases, Ami1and Ami4, in growth, cell division and bacterial responses to environmental 
stress. We chose Ami1 as it was the direct counterpart of Ami1 in M. smegmatis and was 
demonstrated to be important in cell division. Attempts to generate an ami2 knockdown in Mtb 
were fraught with challenges and due to time limitations, this was not pursued further. Upon 
surveying the literature Ami4 emerged as an enzyme that would potentially be important in 
responding to stress conditions, as it was identified through transposon mutagenesis as 1 of 18 
proteins important for tolerance to reactive oxygen species (Mestre et al., 2013). Hence, we 
selected this enzyme for further study.  
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Hypothesis: As with M. smegmatis, Ami1 in Mtb plays and important role in cell division and 
deletion thereof will result in growth and morphological defects. Deletion of ami4 will result in 
reduce the ability of the tubercle bacillus to respond to stress.  
Preliminary work prior to this PhD. Vectors for deleting ami1 and ami4 in Mtb were constructed 
and confirmed by M. Chengalroyen. 
Aims and objectives: The main aim of this section was to construct and characterise mutants of 
Mtb that were defective for Ami1 and Ami4. Given limited time, what follows herein is a 
prelimenary characterisation of these enzymes in Mtb. The specific objective included: 
1. Confirmation of existing knockout vectors. 
2. Construction and confirmation of ami1 and ami4 deficient strains, H37∆ami1S and 
H37∆ami4S. 
3. Construction and confirmation of ami1 and ami4 complementation vectors, pAmi1TB and 
pAmi4TB. 
4. Genetic complementation of H37∆ami1S and H37∆ami4S using pAmi1TB and pAmi4TB 
vectors, respectively. 
5. Characterisation of growth of amidase deficient strains in rich and minimal media. Growth 
was also conducted under stress conditions. 
6. Elucidating antibiotic susceptibility the H37∆ami1S and H37∆ami4S strains. 
7. Elucidating the survival of H37∆ami1S and H37∆ami4S strains in macrophages. 
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Figure 5.2: Diagrammatic representation of both the Toll and Nod PG-mediated immune responses. Shown is the 
stepwise progression of the cascade from ligand binding to cytokine expression (adapted from Inohara and Nunez, 
2003, Takeda and Akira, 2005). Figure drawn by S. Senzani. 
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5.2 Methods 
5.2.1 Bacterial Strains, vectors and primers 
All the bacterial strains, vectors and primers used and/created in this study are listed on Table 
5.1, Table 5.2 and Table 5.3, respectively. 
Table 5.1: Bacterial strains created/used in this study 
Strain 
 
Genotype 
 
Reference 
 
Escherichia coli DH5α SupE44 ΔlacU169 hsdR17 recA1 endA1 gyrA96 
thi-1 relA1 
Promega, Madison, WI 
H37RvS Virulent laboratory isolate ATCC 25618 Laboratory Stock 
H37∆ami1S Derivative of H37RvS carrying an unmarked, in-
frame deletion in ami1, containing 96 bp of the 5′ 
and 78 bp 3′ regions, lacking 551 bp of the ami1 
gene  
This Study 
H37∆ami1S::pAmi1TB Derivative of H37Δami1 carrying pAmi1TB 
integrated at the bacterial attB phage attachment 
site, HygR 
This Study 
H37∆ami4S Derivative of H37RvS carrying an unmarked, in-
frame deletion in ami4, containing 39 bp of the 5′ 
and 82 3′ regions, lacking 707 bp of the ami4 gene  
This Study 
H37∆ami4S::pAmi4TB Derivative of H37Δami4 carrying pAmi4TB 
integrated at the bacterial attB phage attachment 
site, HygR 
This Study 
   
KanR: Kanamycin Resistance, HygR: Hygromycin Resistance 
Table 5.2: Vectors created and/or used in this study 
Vectors Genotype 
 
Reference 
p2H37ΔAmi1G17 Derivative of p2NIL carrying a truncated derivative of the 
H37RvS ami1 gene and the lacZ and sacB genes from 
pGOAL17, KanR 
M. Chengalroyen 
pAmi1TB Derivative of pMV306(H) carrying a functional H37RvS 
ami1 gene and the upstream native promoter region HygR 
This study 
p2H37ΔAmi4G17 Derivative of p2NIL carrying a truncated derivative of the 
H37RvS ami4 gene and the lacZ and sacB genes from 
pGOAL17, KanR 
M. Chengalroyen 
pAmi4TB Derivative of pMV306(H) carrying a functional H37RvS 
ami4 gene and the upstream native promoter region HygR 
This study 
KanR: Kanamycin Resistance, HygR: Hygromycin Resistance, AmpR: Ampicillin Resistance 
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Table 5.3:  List of primers used in the Mtb, ami1 study 
Gene primers Amplicon 
H37ami1pMVF GCGCGCGCAAGCTTGCCATCTTCGTCACCTGC 1126 bp ami1 amplicon 
including  400 bp upstream 
the ami1 start codon H37ami1pMVR GCCGCCGCGTTAACCTAACGCGCCTGGCCCTG 
H37ami4pMVF GCGCGCGCAAGCTTCGGCCTCGCCCGTCCGAC 1311 bp ami4 amplicon 
including  400 bp upstream 
the ami4 start codon H37ami4pMVR GCCGCCGCGTTAACCCGGTTGACATCGTTGCA 
H37ami1KOUSF GTGAAGCTTGCCGCATTACCAGCTATGAC 1577 bp amplicon the 5′ 
region of the ami1 gene and 
96 bp of the ami1 gene 
H37ami1KOUSR GTGTCTAGAGTCGATGAAGACGACCATGC 
H37ami1KODSF GTGTCTAGACGAGGGCAGGCAAAAATAC 1579 bp amplicon the 3′ 
region of the ami1 gene 
including 78 bp of the ami1 
gene 
H37ami1KODSR GTGGGTACCGCCATCAACCTCCAGTAGACA 
H37ami4KOUSF GTGAAGCTTACCGGCAAGACTGCATAAC 1557 bp amplicon the 5′ 
region of the ami4 gene and 
39 bp of the ami4 gene 
H37ami4KOUSR GTGTCTAGACACCTCCTCGAGCCAAATC 
H37ami4KODSF GTGTCTAGACGAGCTCGGCAATAAGGTC 1530 bp amplicon the 3′ 
region of the ami1 gene 
including 82 bp of the ami1 
gene 
H37ami4KODSR GTGGGTACCCGATCCGCTGTGACAATAGA 
*red: restriction endonuclease site 
 
5.2.2 Construction of the H37∆ami1S and H37∆ami4 strains  
To construct the H37∆ami1S and H37∆ami4 strains, the native ami1 and ami4 genes were deleted 
using homologues recombination. Using the p2H37ΔAmi1G17 and p2H37ΔAmi4G17 vectors 
generated previously, 1, 3 and 5 µg of  DNA was electroporated into electrocompetent H37RvS 
cells and plated on 7H11 containing Kan and 0.004 % X-gal, then incubated at 37 ˚C for 6 weeks 
to create SCOs. A single blue colony per gene was then cultured in 7H9 supplemented with Kan 
at 37 ºC then sub-cultured in 7H9 without antibiotic. The resulting cells were subjected to sucrose 
counter selection by plating 100 μl of a 10-fold serial dilution series onto media containing sucrose 
and X-gal. The plates were incubated for 5 - 6 weeks until blue and white colonies emerged. White 
colonies represent strains that have undergone the second cross over event to yield either a 
reversion to wild type or a mutant strains and blue colonies represent strains, which have incurred 
a mutation in sacB to render them resistant to the toxic effects of sucrose. Subsequently, 10 white 
colonies were selected and colony boils and PCR were conducted on these using the 
H37ami1pMVF and H37ami1pMVR primers for ami1 which would yield a 1126 bp band in the 
H37RvS strain and a 580 bp band in the H37∆ami1S strain and H37ami4pMVF and 
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H37ami4pMVR primers for ami4 which would yield a 1311 bp band in the H37RvS strain and a 
580 bp band in the H37∆ami4S strain. 
5.2.3 Construction of the H37∆ami1S::pAmi1TB and H37∆ami4S::pAmi4TB strains 
Primers were designed, H37ami1pMVF and H37ami1pMVR for ami1 and H37ami4pMVF and 
H37ami4pMVR for ami4, listed in Table 5.3, to amplify the TB ami1 and ami4 genes respectively, 
as well as 400 bp upstream the transcriptional start codon. PCR amplification of the respective 
fragments was carried out using Phusion DNA polymerase, using an annealing temperature of      
60 °C for ami1 and an elongation time of 1 min to allow for complete amplification of both the 
ami1and ami4 fragments. The PCR products were purified using the Nucleospin PCR purification 
Kit. Thereafter, 3 µg of pMV306 (H) and PCR product was then restricted with HindIII and HpaI. 
The pMV306 (H) restriction product was then phosphatased using FastAP phosphatase for 30 min. 
The restriction products were separated on a 0.8 % agarose gel, the respective bands (4248 bp for 
pMV306 (H), 1102 bp for ami1 and 1293 bp for ami4) were excised from the gel and purified 
using the Nucleospin gel purification kit. These were then quantified using the NanoDrop 
spectrophotometer and ligations were set up containing 50 ng of pMV306 (H) and varying molar 
ratios of the amidase fragments. The fragments were ligated using Fermentas T4 ligase for 1 h, 
transformed into DH5α cells and plated on LAHyg200. Following this, five possible clones per gene 
were selected and screen by restriction digest with BamHI, which would yield two fragments, a 
3560 bp and a 1822 bp band for pAmi1TB and a 3560 bp and a 1822 bp band for pAmi4TB. A 
single positive clone was selected, grown in 50 ml LBHyg200 overnight and bulk vector extraction 
was carried out using the Nucleobond bulk vector extraction kit. Vector DNA was quantified and 
digested with a variety of enzymes to profile the amidase complementation constructs, then the 
vectors were sent for sequencing to check for the presence of mutations within the amplicon. The 
pAmi1TB and pAmi4TB vectors were electroporated in the H37∆ami1S and H37∆ami4S strains 
respectively, 10 colonies were selected and PCR was conducted on these using the H37ami1pMVF 
and H37ami1pMVR primers which would yield a 1126 bp band representing the presence of a full 
length ami1 gene and the H37ami4pMVF and H37ami4pMVR primers which would yield a      
1311 bp band representing the presence of a full length ami4 gene. 
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5.2.4 Bacterial survival in macrophages 
5.2.4.1 Culturing of J774 Mouse macrophage cells 
A single 1 ml frozen stock of J774 cells was thawed at room temperature and inoculated in 20 ml 
macrophage media consisting of 10 % Fetal Bovine Serum (FBS) in Dulbecco's Modified Eagle's 
Medium (DMEM). The cells were then harvested through centrifugation at 200 × g for 10 min.  
Thereafter, they were gently resuspended in 500 µl fresh media and inoculated into 10 ml of fresh 
media in a 50 ml cell culture flask and incubated at 37 ˚C in 5 % CO2 for 4 h. The media was then 
discarded and replaced with 10 ml fresh media and incubated overnight. The attached macrophage 
population was assessed daily using an inverted microscope and the media was replaced until the 
macrophage cell completely covered the bottom of the cell culture flask.  
Once the culture was ready, the media was discarded and the attached cells were washed with 10 
ml cold PBS.  A 2 ml aliquot of accutase was added to the cells and this was incubated at 37 ˚C 
for 5 min to allow the cells to detach. The cells were then dislodged by vigorously snapping the 
flask onto the palm of the hand four to five times. The suspension was then transferred into a fresh 
falcon tube, 10 ml of fresh DMEM was added to the flask, swirled and transferred into the cell 
suspension to remove remaining cells. The suspension was adjusted to 25 ml using fresh DMEM 
and the cells were harvested by centrifugation at 200 × g for 10 min. The cells were resuspended 
in 500 µl fresh DMEM, the volume was adjusted to 50 ml using and transferred into a 550 ml cell 
culture flask and incubated at the 37 ˚C for 4 h to allow for cell attachment.  Thereafter, the media 
was discarded and replaced with 50 ml fresh media and incubated overnight. The attached 
macrophage population was assessed daily using an inverted microscope and the media was 
replaced daily until the macrophage cell completely covered the bottom of the cell culture flask.  
5.2.4.2 Preparing plates for infections 
Once the macrophage culture was ready the media was discarded and the cells were washed with 
20 ml cold PBS, harvested as before and the 500 µl final cell suspension was then placed on ice. 
A 2 µl aliquot of the cell suspension was inoculated into 98 µl of 0.4 % trypan blue solution. A   
10 µl aliquot of this solution was then spotted on a hemocytometer and unstained cells were 
counted, these represented viable macrophage cells. The concentration of viable cells was 
calculated using the following equation: 
 
  Number of cells/ml = Number of viable cells × 5 × 105 
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The cell suspension concentration was then adjusted to make a 1 × 105 cells/ml suspension using 
fresh DMEM and 1 ml of this was inoculated into 24 well tissue culture plates and incubated at   
37 ˚C overnight.  
5.2.4.3 Macrophage infections 
Bacterial cells were grown to an OD600 of 0.5, which approximates to a concentration                            
5 × 108 CFU/ml. using this as a framework, bacterial cells were adjusted to 5 × 105 CFU/ml using 
fresh DMEM media and stored at room temperature. The 24 well plates were checked for 
macrophage attachment using an inverted microscope and if confluent, a 1 ml aliquot of the 
DMEM bacterial suspension was inoculated into the 24 well plates, in duplicate, per strain for each 
time point. Two samples per time point were inoculated with DMEM media to serve as the 
uninfected controls. These were incubated at 37 ˚C for 4 hours to allow for bacterial phagocytosis. 
The supernatant was then discarded, the cells were washed twice in PBS then, 1 ml fresh 
macrophage media was aliquoted into each well and incubated at 37 ˚C, sacrificing two wells per 
time point to determine bacterial survival. 
5.2.4.4 Determining bacterial survival through CFU calculation 
The macrophage supernatant was filtered in 0.2 µm filters and stored at – 80 ˚C for future analysis. 
The wells containing infected macrophages where then washed twice with PBS and lysed with    
0.1 % SDS in PBS. A serial dilution of the lysate was conducted from 10-1 to 10-4 and plated on 
7H11 media. This was incubated at 37 ˚C for four to five weeks. The same was conducted for the 
uninfected control to ensure macrophages were not contaminated. 
5.2.5 Growth assays 
A bacterial culture was grown to an OD600nm of 0.5. This was then washed and re-suspended in      
1 ml 7H9 containing ADS as a substitute for Middlebrook OADC. The cells were then diluted to 
a final OD600nm of 0.005 in media and incubated at 37 ˚C. CFU analysis was then conducted 0 and 
24 h post incubation. 
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Figure 5.3 illustrates the basic outline of the research undertaken in this chapter, with reference to 
the specific methods.  
 
 
 
Figure 5.3: Flow chart depicting the experimental layout for the Mtb ami1and ami4 research. 
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5.3 Results 
5.3.1 Construction of the H37∆ami1S strain 
The p2H37ΔAmi1G17 and p2H37ΔAmi4G17 vectors obtained from Dr. M. Chengalroyen and 
extensive restriction profiling was conducted to ensure genetic integrity, Figure 5.4 and Figure 5.5. 
 
Figure 5.4: Restriction profile of p2H37ΔAmi1G17. Shown are the different restriction nucleases used and the 
expected sizes in a table, which result from restriction digests of the p2H37ΔAmi1G17 vector. The predicted vector 
map of p2H37ΔAmi1G17 vector and agarose gel depicting the products of restriction digest of p2H37ΔAmi1G17 are also 
shown. Lane 1: Roche Marker IV, Lane 2: Uncut, Lane 3: BamHI, Lane 4: EcoRI, Lane 5: EcoRV, Lane 6: HindIII, 
Lane 7: PstI, Lane 8: SphI. Fragments below 1000 bp were difficult to visualise. 
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Figure 5.5: Restriction profile of p2H37ΔAmi4G17. Shown are the different restriction nucleases used and the 
expected sizes in a table, which result from restriction digests of the p2H37ΔAmi4G17 vector. The predicted vector 
map of p2H37ΔAmi4G17 vector and agarose gel depicting the products of restriction digest of p2H37ΔAmi4G17 are also 
shown. Lane 1: Roche Marker IV, Lane 2: Uncut, Lane 3: BamHI, Lane 4: EcoRI, Lane 5: EcoRV, Lane 6: HindIII, 
Lane 7: PstI, Lane 8: SphI. Fragments below 1000 bp were difficult to visualise. 
In both cases, with p2H37ΔAmi1G17 and p2H37ΔAmi4G17 knockout vectors, all the expected 
sizes were observed upon restriction profiling. Hence, these vectors were electroporated into the 
H37RvS strain (section 2.4.2); the transformation efficiency obtained for the electro-competent 
cells was 4.9 × 105 CFU/μg vector DNA determined using the pSE100 control. A single blue clone 
(SCO strain) was cultured and subjected to sucrose counter selection (section 5.2.2). White 
colonies were then screened by PCR to identify clones which possess only the deleted allele, and 
then Southern blot analysis was conducted to confirm the second homologous event removed the 
wild type allele without imposing additional unintended chromosome rearrangements, Figure 5.6 
and Figure 5.7). 
5.3.2 Complementation of the H37∆ami1S and H37∆ami4S strains 
The complementation of the H37∆ami1S and H37∆ami4S strains was conducted to serve as a 
control. These strains were used to show all phenotypic variations which arose in the 
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Figure 5.6: Genotypic analysis of the H37∆ami1S strain by PCR and Southern blot analysis.  The genomic map of the relevant locus is shown for the wild type 
mc
2
155 and H37∆ami1S strain.  Also shown on the left is the PCR confirmation of the genotype and Southern blotting is shown on the right. For PCR confirmation, 
chromosomal DNA was used to amplify the ami1 alleles from the wild type and mutant strains using the primers H37ami1pMVF and H37ami1pMVR described 
in Table 5.3 and indicated as red arrows above. The expected sizes of the amplicons are as follows: ami1, 1126 bp and ∆ami1, 580 bp.  For the Southern blot 
analysis chromosomal DNA from the parental and mutant strain was digested with ApaI.  The probe used for hybridisation is shown as a solid green box and the 
expected sizes are indicated by the blue arrows.  The figures are not drawn to scale.  
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Figure 5.7: Genotypic analysis of the H37∆ami4S strain by PCR and Southern blot analysis.  The genomic map of the relevant locus is shown for the wild type 
mc
2
155 and H37∆ami4S strain.  Also shown on the left is the PCR confirmation of the genotype and Southern blotting is shown on the right. For PCR confirmation, 
chromosomal DNA was used to amplify the ami4 alleles from the wild type and mutant strains using the primers H37ami4pMVF and H37ami4pMVR described 
in Table 6.3 and indicated as red arrows above. The expected sizes of the amplicons are as follows: ami4, 1311 bp and ∆ami4, 460 bp.  For the Southern blot 
analysis chromosomal DNA from the parental and mutant strain was digested with ApaI.  The probe used for hybridisation is shown as a solid green box and the 
expected sizes are indicated by the blue arrows.  The figures are not drawn to scale. 
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H37∆ami1S and H37∆ami4S strains can be reversed through the re-introduction of the full length 
amidase 
5.3.2.1 Construction of the pAmi1TB and pAmi4TB vectors 
PCR amplification was conducted to amplify the amidase genes and 400 bp upstream the 
transcriptional start codon. The fragments were then cloned into pMV306 (H) and clones were 
screened by restriction with BamHI. A single positive clone was then selected and the genetic 
integrity of the vector was confirmed by extensive restriction profiling (Fig 5.8 and Fig 5.9). 
 
Figure 5.8: Restriction profile of pAmi1TB. Shown are the different restriction nucleases used and the expected 
sizes in a table, which result from restriction digests of the pAmi1TB vector. The predicted vector map of 
pAmi1TB vector and agarose gel depicting the products of restriction digest of pAmi1TB are shown. Lane 1: 
Roche Marker III, Lane 2: Uncut, Lane 3: BclI, Lane 4: PstI, Lane 5: BglII, Lane 6: HindIII, Lane 7: HpaI, Lane 
8: BamHI. 
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Figure 5.9: Restriction profile of pAmi4TB. Shown are the different restriction nucleases used and the expected 
sizes in a table, which result from restriction digests of the pAmi4TB vector. The predicted vector map of 
pAmi4TB vector and agarose gel depicting the products of restriction digest of pAmi4TB are also shown. Lane 
1: Roche Marker III, Lane 2: Uncut, Lane 3: BclI, Lane 4: PstI, Lane 5: BglII, Lane 6: HindIII, Lane 7: HpaI, 
Lane 8: BamHI. 
 
In all cases, the fragment sizes observed corresponded to the vector map and expected sizes, 
with the exception of the PstI in which case the 905 bp band in pAmi1TB was missing while 
the 3518 bp band in both the pAmi1TB and pAmi4TB vectors was bigger. This was mapped 
back to a mutation in the PstI next to the oriE resulting in a loss of the restriction (Fig 5.8 and 
Fig 5.9). The genetic integrity of the vector was then further confirmed by sequencing of the 
cloned region, which revealed that no mutations had occurred during PCR and cloning 
processes (data not shown). This vector was then used for construction of the 
H37∆ami1S::pAmi1TB and H37∆ami4S::pAmi4TB strains as previously described.  
5.3.3 Deletion of Ami1 or Ami4 does not affect bacterial growth in nutrient rich media 
To assess the role of Ami3 and Ami4 on bacterial growth, growth kinetics analysis was 
conducted on the H37RvS, H37∆ami1S, H37∆ami1S::pAmi1TB, H37∆ami4S and 
H37∆ami4S::pAmi4TB strains in Middlebrook 7H9, Figure 5.10. No Significant difference 
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was observed in the growth kinetics of the amidase deficient strains, when compared to the 
parental strain, similar to observations in broth culture upon deletion of ami1 in M. smegmatis.  
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Figure 5.10: Growth analysis of H37RvS, H37∆ami1S, H37∆ami1S::pAmi1TB, H37∆ami4S and 
H37∆ami4S::pAmi4TB strains. Shown is the growth kinetics analysis of H37RvS, H37∆ami1S, 
H37∆ami1S::pAmi1TB, H37∆ami4S and H37∆ami4S::pAmi4TB in Middlebrook 7H9 containing Middlebrook 
OADC at 37 ˚C, assessed over 15 days. The data represent an average of three independent experiments.  
Deletion of the M. smegmatis ami1 gene resulted in a robust, detrimental impact on bacterial 
cell division. Thus, to determine whether the same occurs upon deletion of the Mtb homologs, 
SEM was conducted on the H37RvS, H37∆ami1S, H37∆ami1S::pAmi1TB, H37∆ami4S and 
H37∆ami4S::pAmi4TB strains, to elucidate whether deletion of ami1 or ami4 in Mtb resulted 
in similar defects to that observed in M. smegmatis, Figure 5.11A and Figure 5.11B. 
SEM revealed no significant changes in bacterial cell division in the absence of either amidase, 
suggesting that these enzymes do not play a role in this process. Analysis of bacterial cell length 
revealed a general reduction in Mtb size when compared to M. smegmatis, observed in all the 
strains examined, with sizes ranging from 0.43 µm to 10.05 µm and a mean of ~ 3.5 µm, Figure 
5.11B. No difference was observed between the sizes of the amidase deficient stains and wild 
type. 
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Figure 5.11: Microscopic analysis of the H37RvS, H37∆ami1S, H37∆ami1S::pAmi1TB, H37∆ami4S and 
H37∆ami4S::pAmi4TB strains. (A) Shown are SEM images of the H37RvS, H37∆ami1S, 
H37∆ami1S::pAmi1TB, H37∆ami4S and H37∆ami4S::pAmi4TB strains. Strains were grown in 7H9 to log phase 
then fixed, dehydrated, carbon coated and imaged using high resolution SEM, shown are normal Mtb cells 
depicted by the red arrows.. (B) Box-and-whisker analysis of the H37RvS, H37∆ami1S, H37∆ami1S::pAmi1TB, 
H37∆ami4S and H37∆ami4S::pAmi4TB strains, showing the various cell lengths of the respective strains 
generated approximately 300 cells per strain.  
5.3.4 Ami1 plays a role in bacterial growth under nutrient starved conditions 
As both Ami1 and Ami4 did not appear to play a significant role in cell division in Mtb, the 
role of these enzymes on bacterial growth under nutrient limited conditions was assessed. This 
was assessed through growth kinetic analysis in Sauton’s and Modified M. phlei (MPL) media, 
which both utilise glycerol as the sole carbon source and ammonium and sodium nitrate as the 
sole nitrogen source, respectively (Fig 5.12).  
In both cases, the H37∆ami1S strain displayed retarded growth rate as well as a reduction in 
biomass in stationary phase. This phenotype was more severe in the MPL media. In the case 
of the H37∆ami4S strain, however, no significant difference was observed in the growth 
kinetics of the H37∆ami4S strain when compared to the parental strain in all conditions tested, 
suggesting Ami4 plays no role during bacterial growth, Figure 5.12. To further assess the defect 
in the ami1 defective mutant, SEM was conducted to evaluate physiological changes which 
arise in the H37RvS, H37∆ami1S, and H37∆ami1S::pAmi1TB, Figure 5.13. The ami4 
defective strains were also included, Figure 5.13. 
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Figure 5.12: Growth analysis of H37RvS, H37∆ami1S, H37∆ami1S::pAmi1TB, H37∆ami4S and 
H37∆ami4S::pAmi4TB strains in Sauton’s minimal media and MPL media. Shown is the growth kinetics analysis 
of H37RvS, H37∆ami1S, H37∆ami1S::pAmi1TB, H37∆ami4S and H37∆ami4S::pAmi4TB strains in Sauton’s 
minimal media at 37 ˚ C, assessed over 13 days (A) and MPL media over 23 days (B). Graphs represent 3 biological 
replicates. Statistical analysis was conducted comparing H37RvS and the H37∆ami1S strains using the student t-
test, ***: p < 0.001. 
In the case of the H37∆ami1S strain grown in MPL media, the formation of lateral branches 
similar to those observed in the M. smegmatis ∆ami1 strain were observed, with 16.8 % of the 
population displaying this phenotype, Figure 5.13A and C. Analysis of bacterial cell length 
revealed a general increase in size when compared to strains grown in 7H9T, observed in all 
the strains examined, with sizes ranging from 2.01 µm to 10.69 µm and a mean of ~ 6 µm, 
similar to the size of M. smegmatis grown in 7H9T, Figure 5.13B. However, no differences in 
cell size were observed between the mutant strains and the wild type. 
5.3.5 Ami1 and Ami4 play a role in bacterial tolerance to external stress 
The role of Ami1 and Ami4 on bacterial tolerance to stress was analysed using two forms of 
stress, nitrosative and oxidative stress, using survival assays (Section 5.2.5). In the case of  
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Figure 5.13: Microscopic analysis of MPL grown H37RvS, H37∆ami1S, H37∆ami1S::pAmi1TB, H37∆ami4S 
and H37∆ami4S::pAmi4TB strains. (A) Shown are SEM images of the H37RvS, H37∆ami1S, 
H37∆ami1S::pAmi1TB, H37∆ami4S and H37∆ami4S::pAmi4TB strains. Strains were grown in MPL, sampled 
at day 15 (log phase) then fixed, dehydrated, carbon coated and imaged using high resolution SEM.                           
(B) Box-and-whisker analysis of the H37RvS, H37∆ami1S, H37∆ami1S::pAmi1TB, H37∆ami4S and 
H37∆ami4S::pAmi4TB strains, showing the various cell lengths of the respective strains. (C) Bar graph showing 
the proportion Mtb containing lateral branches. Data is representative of 3 biological replicates and graphs were 
generated by counting a total of approximately 200 cells per strain. Statistical analysis was conducted using the 
student’s t-test **: p < 0.01 
nitrosative, stress the H37RvS, H37∆ami1S, H37∆ami1S::pAmi1TB, H37∆ami4S and 
H37∆ami4S::pAmi4TB strains were incubated in 7H9, pH 5.3 containing various 
concentration of sodium nitrite, ranging between 0 to 96 mM creating various levels of 
nitrosative stress 24 h, Figure 5.14. While in the case of oxidative stress, the strains were 
incubated in 7H9 containing 5 mM hydrogen peroxide for 48 h, Figure 5.15. 
In the case of both sodium nitrite and hydrogen peroxide the H37∆ami1S strain displayed 
higher susceptibility to both stresses. With regards to oxidative stress, the H37∆ami1S strain 
exhibited faster death, when compared to both the parental and complemented strains. In terms 
of the nitrosative stress, the H37∆ami1S strain required less sodium nitrite to induce death, 
indicating and increased susceptibility to nitrosative stress. This was not the case with regards 
to the H37∆ami4S strain as it was not affected by nitrosative stress. The H37∆ami4S strain, 
however, displayed resistance to oxidative stress, which was partially complemented in the 
H37∆ami4S::pAmi4TB strain. 
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5.3.6 Ami1 is important for survival under immune assault 
Following the observation that Ami1 has an impact on the ability to tolerate both oxidative and 
nitrosative stress, we sought to assess survival of the amidase defective mutants in 
macrophages, where these stresses are thought to prevail. To do this, resting and activated J774  
Figure 5.14: Line graph showing survival of H37RvS, H37∆ami1S, H37∆ami1S::pAmi1TB, H37∆ami4S and 
H37∆ami4S::pAmi4TB strains exposed to nitrosative stress. Depicted is the percentage survival of the various 
bacterial strains, calculated using CFU/ml count determined at 0 and 24 hours post inoculation into media, pH 
5.3, containing 0, 1.5, 3, 6, 12 and 24 mM sodium nitrite, the graph is a representative of 3 biological replicates. 
Statistical analysis was conducted comparing H37RvS and the H37∆ami1S strains using the student’s t-test *: p 
< 0.1 and **: p < 0.01 
 
 
Figure 5.15: Bar graph showing survival of H37RvS, H37∆ami1S, H37∆ami1S::pAmi1TB, H37∆ami4S and 
H37∆ami4S::pAmi4TB strains exposed to oxidative stress. Depicted is the Log percentage survival of the various 
bacterial strains, calculated using CFU/ml count determined 0, 24 and 48 hours post inoculation into media 
containing 5 mM hydrogen peroxide, the graph is a representative of three biological replicates. Statistical analysis 
was conducted using the student’s t-test *: p < 0.1, *: p < 0.01 and ***: p < 0.001 
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macrophages were infected with the H37RvS, H37∆ami1S and H37∆ami1S::pAmi1TB strains, 
these were incubated at 37 ˚ C and macrophage samples were sacrificed at various time intervals 
to record bacterial load, Figure 5.16.  
 
Figure 5.16: Bar graph showing survival of H37RvS, H37∆ami1S, H37∆ami1S::pAmi1TB, H37∆ami4S and 
H37∆ami4S::pAmi4TB strains in J774 macrophages. Depicted is the log percentage survival of the various 
bacterial strains, calculated using CFU/ml count determined at various time point throughout the macrophage 
infection. (A) Resting macrophages were infected with the various bacterial strains for 4 hours, macrophages were 
washed and sacrificed at day 0, 1, 2 and 3 then supernatant was plated to determine the amount of viable 
intracellular bacteria, the bar graph is a representative of three biological replicates. (B) Amidase deficient strains 
grown in activated macrophages, which were activated through treatment with LPS and INF-γ for 16 hours 
followed by infection for 4 fours. Macrophages were washed and sacrificed at day 0, 3, 5 and 7 then supernatant 
was plated to determine the amount of viable intracellular bacteria, the bar graph is a representative of a single 
experiment. Statistical analysis was conducted on resting macrophage samples using the student’s t-test *: p < 0.1 
and **: p < 0.01. 
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Loss of Ami1 did not affect bacterial ability to persist in the naive macrophage environment, 
as the bacterial population did not decline over time. However, rapid killing of the H37∆ami1S 
strain was observed when macrophages were activated with LPS and IFN-γ, suggesting that 
Ami1 plays an important role in colonisation of macrophages (Fig 5.16B). This defect was 
reversed in the genetically complemented derivative. Due to time limitations, this experiment 
was only conducted once; further repetitions are required to make definitive conclusions. 
Similarly, loss of Ami4 does not significantly affect bacterial ability to persist in the resting 
macrophage environment, as the bacterial population did not decline at a significantly higher 
rate over time when compared to the parental strain. A minor increase in bacterial killing of 
the H37∆ami4S strain was observed when macrophages were activated with LPS and IFN-γ, 
which was less severe than that observed in the ami1 deficient strain. An unexpected 
observation that was noted in both the naïve and activated macrophage infection was that the 
genetically complemented strain was rapidly cleared in activated macrophages, suggesting that 
ectopic expression of ami4 is detrimental to the cell. 
5.3.7 Ami4 regulation in the complemented strain 
As the macrophage and oxidative damage data suggested aberrant survival/growth of the ami4 
complemented, RT-qPCR was conducted to check the expression of ami4 in both the H37RvS 
and H37∆ami4S::pAmi4TB strains to check for differences in gene expression, the 
H37∆ami4S strain was included to serve as a negative control (Fig 5.17). 
As shown by figure 5.17, there was no difference in the expression of ami4 in both the H37RvS 
and H37∆ami4S::pAmi4TB strains, suggesting the phenotypic variations observed were not 
due to the mis-regulation of ami4 in the H37∆ami4S::pAmi4TB strain. 
5.3.8 Antibiotic susceptibility of  H37∆ami1S and H37∆ami4S  
We next assessed antibiotic susceptibility to determine whether deletion of ami1 or ami4 led 
to a change in tolerance towards antibiotic treatment. To do this, antibiotic susceptibility assays 
were conducted on the H37RvS, H37∆ami1S, H37∆ami1S::pAmi1TB, H37∆ami4S and 
H37∆ami4S::pAmi4TB strains, using antibiotics that target the cell wall, Table 5.4. 
The antibiotic susceptibility assay revealed a reduction in the amount of antibiotic required to 
inhibit mycobacterial growth of the H37∆ami1S for some antibiotics tested. We did not 
consider a two-fold reduction significant. Hence, treatment with cefoxitin and vancomycin, 
which target various components of the cell, resulted in significant increases in drug  
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Figure 5.17: Bar graph showing the ami4 expression levels in the H37RvS, H37∆ami4S and 
H37∆ami4S::pAmi4TB strains. Cultures were grown to an OD600nm of between 0.7 - 0.8, mRNA was extracted 
and qPCR was conducted to determine the level of ami4 transcript in all three strains. The constitutively expressed 
sigA gene was used to normalise the various samples the graph is a representative of three biological replicates. 
Statistical analysis was conducted using the student’s t-test ***: p < 0.001 
susceptibility. We also noted increased susceptibility to RIF and erythromycin, indicating the 
reduction in bacterial tolerance to antibiotics was not limited to cell wall antibiotics. This was 
not the case with the H37∆ami4S strain, there was no significant change observed.  
As loss of ami1 resulted in elevated bacterial sensitivity to a number of external stress factors 
tested. Kill curves were conducted to determine whether this increases sensitivity was a result 
of the inability to form persiters. To do this, survival assays were conducted as per section 5.2.5 
with a few exceptions; 1. Cells were resuspended in 7H9T containing 32 µg/ml isoniazid,          
2. Cells were incubated at 37 ˚C shaking at 100 rpm. CFUs were then taken daily to track 
bacterial survival as per de Steenwinkel et al, 2010 (Fig 5.18) (de Steenwinkel et al., 2010). 
Isoniazid was used instead of the enzymes listed on Table 5.4, as the study by de Steenwinkel 
et al., 2010, showed treatment with this antibiotic consistently resulted in persister formation 
whilst other antibiotics tested in the study resulted in bacterial death (de Steenwinkel et al., 
2010). 
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The kill curve revealed a lack in the ability to form a persister population in the strain lacking 
ami1 suggesting Ami1 plays an important role in the ability to form a persister population, 
while no significant difference in persister formation was observed in the population lacking 
ami4, indicating Ami4 plays no role in this phenomenon.   
Table 5.4: MIC of the H37RvS, H37∆ami1S, H37∆ami1S::pAmi1TB, H37∆ami4S and 
H37∆ami4S::pAmi4TB strains 
Drug 
  MIC*   
H37RvS H37∆ami1S 
H37∆ami1S::
pAmi1TB 
H37∆ami4S 
H37∆ami4S::
pAmi4TB 
Ethambutol 3.13 1.6 1.6-3.13 3.13 3.13 
Erythromycin 250 15.6-31.3 125-250 125 250 
Vancomycin 6.25-12.5 0.78-1.56 12.5 6.25-12.5 6.25-12.5 
Rifampicin 0.003 0.0008 0.003-0.006 0.003 0.003 
Streptomycin 0.39 0.1-0.2 0.1-0.2 0.05-0.1 0.05-0.2 
Cefoxitin 80-160 10-20 80-160 80-160 80-160 
D-cycloserine 6.25-12.5 3.125-6.25 6.25-12.5 6.25 6.25-12.5 
MIC in µg/ml,  
 
Figure 5.18: Line graph showing survival of H37RvS, H37∆ami1S, H37∆ami1S::pAmi1TB, H37∆ami4S and 
H37∆ami4S::pAmi4TB strains exposed to isoniazid. Depicted is bacterial survival, over seven days in media 
containing antibiotics, calculated using CFU/ml count determined at 0 and 1, 2, 3, 4 and 7 days post inoculation 
into media, containing 32 µg/ml isoniazid. The graph is a representative of three biological replicates. Statistical 
analysis was conducted comparing H37RvS and the H37∆ami1S strains using the student’s t-test, ***: p < 0.001. 
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5.4 Discussion 
One of the key contributing factors to the survival of any living species is the ability to adapt 
and persist in a changing environment. There are two main ways in which this can be achieved; 
the first being random genetic mutations followed by the selection and propagation of fit 
mutants which confer a survival benefit in the prevailing environment and the second being 
phenotypic plasticity, which entails the ability to adopt a different phenotype in response to a 
change in the environment (Justice et al., 2008, Cava and de Pedro, 2014). Both these systems 
are prevalent in the bacterial world and are used constantly as survival tools leading to the 
formation of drug tolerant strains (Justice et al., 2008, Cava and de Pedro, 2014, Levin et al., 
2000). Drug tolerance has been well documented in Mtb; however, the mechanisms driving 
this plasticity remain a mystery (Morris et al., 1995). Understanding how these organisms 
navigate harsh conditions is a key component in identifying essential elements required for 
survival in the host under constant bombardment by the immune system. Herein, we set out to 
characterise the role of mycobacterial amidases in cell division in Mtb but instead, noted an 
interesting role for these enzymes in modulating tolerance. We present a very preliminary 
analysis of the biological function of amidases in Mtb, due to the primary focus on M. 
smegmatis for this PhD and appending time constraints.  
Unlike in M. smegmatis, both Ami1 and Ami4 in Mtb do not appear to participate in cell 
division and bacterial growth under nutrient rich conditions, as deletion of either did not result 
in the formation of notable cell division defects such as the formation of chains or an increase 
in the formation of cell division septa. This suggests that the function of these amidases is not 
conserved between these closely related species. Cell wall amidases have been shown to be 
important for processes that are distinct from cell division in other organisms including              
B. subtilis and C. anabaena, where in both instances they appear to play an essential role in the 
formation of stress tolerant cells through cell wall modification (Blackman et al., 1998, Smith 
et al., 2000, Piggot and Hilbert, 2004, Berendt et al., 2012).  
In Mtb, loss of ami1 resulted in reduced growth under nutrient limited conditions as depicted 
by the retarded growth in both Sautons and MPL media. This phenotype was exaggerated in 
MPL media possibly because MPL contains less glycerol than Sautons, thus exerting a higher 
starvation pressure. SEM analysis of cells cultured in MPL revealed a general increase in 
bacterial cell size from an average of ~3.5 µm seen in 7H9T to ~ 6 µm. This was unexpected 
as the OD doubling time in 7H9T was ~ 22 h and 48 h in MPL. The longer doubling time would 
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predict a slower growth rate of individual cells, possibly leading to the presence of smaller cells 
in MPL, as the mycobacterial cell cycle is time dependent where cells divide at constant time 
intervals, regardless of cell size (Aldridge et al., 2012). Under these conditions, we also noted 
the occurrence of lateral growth appendages in the H37∆ami1S strain, similar to those found 
in the M. smegmatis ∆ami1strain but these were not associated with notable division defects. 
In M. smegmatis, lateral growth in the ∆ami1strain occurred under nutrient rich conditions but 
in Mtb, we noted this defect during nutrient starvation. None of these lateral buds where found 
near the septum suggesting their formation was primarily a result of DivIVA mis-localisation 
rather than cell division arrest. The fact that these branches only occurred in the MPL media 
and not in 7H9T, suggests that Ami1 becomes important during conditions of stress or that Mtb 
alters the composition of its cell division machinery under these conditions. This is supported 
by the data indicating loss of ami1 resulted in increased susceptibility to nitrosative stress and 
the inability to replicate proficiently in activated macrophages. Furthermore, loss of ami1 led 
to a reduction in the ability to form persisters in the presence on isoniazid, affirming the 
importance of ami1 for this process. We chose isoniazid for this analysis as persistence studies 
in Mtb routinely use this antibiotic. Hence, these observations require further investigation 
using various antibiotics including those that displayed increase potency against the 
H37∆ami1S strain.  
In Mtb, Ami4 seems to be important for oxidative stress. Loss of ami4 did not affect the ability 
of Mtb to survive under starvation, nitrosative and antibiotic stress; however, we noted an 
increase in bacterial tolerance to oxidative stress. This was unexpected as it contradicted a 
finding by Mestre et al (2013), who reported that transposon-mediated disruption of ami4 
resulted in hypersensitivity to oxidative stress (Mestre et al., 2013). In our study, this phenotype 
persisted in the complemented strain suggesting that it may be due poor expression from the 
vector used for complementation. However, expression analysis demonstrated similar 
expression levels of ami4 in both the H37RvS and H37∆ami4S::pAmi4TB, suggesting that 
failure to complement the oxidative stress phenotype was most likely due to second site effects 
that may not be related to Ami4 function. Hence, no definitive conclusions can be made regards 
Ami4 function in Mtb.  
In summary, this preliminary characterisation of amidases in Mtb suggests a possible role for 
these enzymes in tolerance to stress and growth under specialist conditions. It is possible that 
Ami1 in Mtb functions similarly to the B. subtilis cwlD, which plays an important role in the 
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formation of special structures in the PG and that Ami4 functions like the C. anabaena amiC2, 
which is important for the formation of specifically oxygen tolerant bacterial heterocysts 
(Berendt et al., 2012, Sekiguchi et al., 1995). However, these explanations are largely 
speculative and require more research.  
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6   Concluding remarks 
In model organisms such as E. coli, amidases predominantly appear to be hydrolytic enzymes 
that are important for cell division through mediating coordinated degradation of the division 
septum (Korsak et al., 2005, Heidrich et al., 2001, Smith et al., 2000). Until recently, amidase 
function in mycobacteria has remained unresolved. We set out to address this knowledge gap 
through a characterisation of amidase_3 domain containing enzymes in M. smegmatis. This 
revealed that Ami1 is required for cell division in M. smegmatis but is most likely not the only 
septal degradation system, as deletion thereof was not lethal. In E. coli, deletion of multiple 
amidases is required to manifest a severe division defect; however, this does not seem to be the 
case in mycobacteria. Deletion of ami1 was also accompanied by ectopic DivIVA localisation 
that resulted in the formation of lateral branches, which were able to segregate the 
chromosome. Loss of ami1 also led to defective septal cell wall turnover and increased 
permeability of the cell wall. In contrast, depletion of ami2 resulted in cessation of bacterial 
growth and the formation of morphologically aberrant cells. Cellular localisation studies place 
Ami2 at the cell pole, possibly with a role in coordinating PG growth. Preliminary 
characterisation of the Mtb Ami1 and Ami4 suggest a role in growth and survival under 
specialist conditions. 
7   Future studies 
In E. coli, amidases are produced in an inactive form and require post-translational activation 
by M23-domain-containing peptidases. It will be important to assess whether a similar situation 
prevails in mycobacteria and similarly, if the mycobacterial amidases require interaction with 
other divisome proteins to exert their function. In Mtb, a more detailed characterisation of 
Ami1 function is required as our preliminary analysis suggests a divergence of function 
between Mtb and M. smegmatis. This would involve transcriptional analysis of the ami1 
defective mutant under various conditions and the use of division reporters to characterise cell 
division in this mutant.  
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8 Appendix 
8.1  Appendix A: Culture Media 
Lysogeny Agar (LA) 
10 g Tryptone, 10 g NaCl, 5 g Yeast extract, 30 g Agar and sdH2O up to 1 l 
Lysogeny Broth (LB) 
10 g Tryptone, 10 g NaCl, 5 g Yeast extract and  sdH2O up to 1 l 
2 × TY Broth 
16 g Tryptone, 5 g NaCl, 10 g Yeast extract and sdH2O up to 1 l 
Middlebrook 7H9 media 
4.7 g Difco Middlebrook 7H9 powder, 2 ml glycerol, 10 ml 100 × glucose-salt (M. smegmatis) 
or 100 ml Middlebrook OADC (Mtb), 2 ml Tween80 and sdH2O up to 1 l 
Middlebrook 7H10 media 
19 g Difco Middlebrook 7H9 powder, 2 ml glycerol, 10 ml 100 × glucose-salt (M. smegmatis) 
or 100 ml Middlebrook OADC (Mtb) and sdH2O up to 1 l 
Sautons minimal media (pH 7.2) 
0.05 g Ammonium ferric citrate, 4 g Asparagine, 2 g Citric acid, 0.5 g Magnesium sulphate,  
0.5 g Potassium dihydrogenorthophosphate, 48 ml glycerol and sdH2O up to 1 l pH with 
Ammonium hydroxide 
Modified M. phlei media  
20 ml glycerol, 0.6 g Magnesium sulphate, 5 g Potassium dihydrogenorthophosphate, 2 g 
Sodium citrate, 0.85 g Sodium nitrate, 5 ml Tyloxapol, pH 6.6 (with 10 M NaOH) and sdH2O 
up to 1 l (filter sterilised) 
100 × Glucose-salt 
10 g Glucose, 4.25 g NaCl and sdH2O up to 500 ml 
Tween80 (25 %) 
10 ml Tween80 dissolved in 40 ml dH2O then sterilised by filtration 
X-gal (2 %) 
1 g X-gal in 50 ml deionised DMF 
Media was sterilised by autoclaving at 121 °C for 20 min 
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8.2  Appendix B – solutions 
DNA manipulation solutions  
1 M Tris-HCl   : 60.56 g Tris, pH 8.0 with HCl and sdH2O up to 500 ml 
0.5 M EDTA   : 18.6 g powder, pH 8.0 with NaOH and sdH2O up to 500 ml 
1 M Glucose    : 90 g Glucose and sdH2O up to 500 ml 
10 % SDS   : 50 g Sodium Dodecyl Sulfate and sdH2O up to 500 ml 
5 M NaOH   : 20 g Sodium hydroxide and sdH2O up to 100 ml 
Soln I    : 50 mM glucose, 25 mM Tris-HCl, 10 mM EDTA, pH 8.0  
Soln II   : 0.2 M NaOH, 1.0 % SDS  
Soln III : 49 g potassium acetate, 11.5 ml glacial acetic acid, and sdH2O 
up to 100 ml  
TE buffer   : 1 ml 1 M Tris-HCl, 2 ml 0.5 M EDTA  
TAE buffer : 242 g Tris base, 100 ml 0.5 M EDTA, 57.1 ml glacial acetic 
acid, pH 8.0, 1000 ml final volume dH2O  
Chloroform: Isoamyl : 24 ml Chloroform, 1 ml Isoamyl alcohol  
Phenol: chloroform  : 1 ml Phenol, 1 ml Chloroform  
3M Sodium acetate  : 24.6 g Sodium acetate and sdH2O up to 100 ml  
CTAB/NaCl : 4.1 % NaCl, 10 % Cetyltrimethylammonium bromide dissolved 
in dH2O (filter sterilised)  
 
Southern blotting solutions  
Denaturation solution : 0.5 M NaOH, 1.5 M NaCl in dH2O  
Depurination solution : 0.25 M HCl in dH2O  
TBE (5 ×)  : 500 ml 10 × Tris-Borate-EDTA solution (Sigma) and 500 ml 
dH2O  
5 M Sodium citrate : 129.03 g sodium citrate and sdH2O up to 100 ml 
SSC (20 ×)   : 3 M NaCl, 0.3 M sodium citrate in dH2O  
Soln I    : 10 ml 20X SSC, 1 ml 10 % SDS, and sdH2O up to 100 ml  
Soln II   : 2.5 ml 20X SSC, 1 ml 10 % SDS, and sdH2O up to 100 ml 
Maleic acid buffer  : 116.1 g maleic acid powder, 87. 66 g NaCl, pH 7.5 with NaOH 
pellets and sdH2O up to 1 l  
Wash buffer : 0.1M Maleic acid buffer, 0.3 % Tween20  
Blocking solution (Roche) : 1 × blocking solution in maleic acid buffer  
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Detection buffer  : 0.1M Tris-HCl, 0.1M NaCl in dH2O (pH 9.5)  
Antibody solution (Roche) : Dilute 1 in 10 000 in blocking solution  
CSPD (Roche)  : Disodium 2-chloro-5-(4-methoxyspiro (2-dioxetane-3,2 (2-
dioxetane-3,2′-(5′-chloro)-tricyclo[3.3.1.1. 3, 7. ]decan)-. 4-yl)-
1-phenyl phosphate 
SDS Gel Electrophoresis and Western blotting solutions 
Running buffer  : 303 g Tris, 144 g glycine, 10 g SDS and sdH2O up to 1 l  
Coomasie blue : 2 g Coomasie, 400 ml EtOH and 100 ml acetic acid and sdH2O 
up to 1 l  
De-stain : 400 ml EtOH, 100 ml acetic acid and sdH2O up to 1 l  
Transfer buffer : 3 g Tris, 14.4 g glycine, 1 g SDS, 200 ml methanol and sdH2O 
up to 1 l  
TBS (10×) : 24.2 g Tris Base, 80 g NaCl in and sdH2O up to 1 l  
TBST : 100 ml  10 × TBS, 1 ml Tween20 and sdH2O up to 1 l 
Blocking solution  : 5 g Nonfat dry milk (CellSignal) and TBST up to 100 ml 
CPS Reagent (Sigma) : Chemiluminescent Peroxidase Substrate 
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8.3  Appendix C – Molecular weight markers 
 
 
                                      
 
 
                             
DNA Molecular weight 
marker III 
DNA Molecular weight 
marker III 
DNA Molecular weight 
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8.4  Appendix D – Additional Figures 
 
 
 
 
 
 
 
 
 
 
 
A                                                                                                       
                                                         
B. subtilis 168 CwlC              IFIDPGHGGSDPGA-TG--------------------NGLQEKTLTLQIA 
B. licherniformis CwlM            IFIDPGHGGSDTGA-SA--------------------NGLQEKQLTLQTA 
Paenibacillus polymyxa CwlU       VVIDPGHGGKDPGAGSV--------------------TGRHEKEFTLAVA 
E. coli K12 AmiA                  VVLDPGHGGIDTGAIGR--------------------NGSKEKHVVLAIA 
E. coli K12 AmiC                  IMLDPGHGGEDSGAVGK--------------------YKTREKDVVLQIA 
E. coli K12 AmiB                  IAIDAGHGGQDPGAIGP--------------------GGTREKNVTIAIA 
B. subtilis 168 CwlB              IFIDPGHGDQDSGAIG---------------------NGLLEKEVNLDIA 
B. anthracis 4229 pXO2-42         IIIDPGHGGIDGGHKG---------------------IYMNESPVVYDTA 
M. smegmatis mc2155 Ami2          VIIDPGRGGSDHGLIMQGP-----------------HGPISEADILWDLA 
M. tuberculosis H37Rv Ami2        IIIDPGRGGVDHGLIAQGP-----------------AGPISEADLLWDLA 
M. leprae TN Ami2                 IIIDPGRGGADRGLITQGP-----------------TGPISEADVLWDLA 
M. tuberculosis H37Rv Ami1        VFIDPGHNGANDASIGRQVPTGRGGTKNCQASGTSTNSGYPEHTFTWETG 
M. leprae TN Ami1                 VFIDPGHNGSNDASISRQVPTGRGGTKDCQASGTSTNSGYPEHTFTWDTA 
M. smegmatis mc2155 Ami1          VFLDPGHNGANDASIGRQVPTGRGGTKNCQESGTATDDGYPEHSFTWDTT 
                                  : :*.*:.. : .                            *  .  
                                      (H341)                             (E355) 
                                                                
                                                       
B. subtilis 168 CwlC              LALRTILTNEYEGVSLLLSRTS------DQYVSLNDRTNAANNWGADFFL 
B. licherniformis CwlM            LALRNMLLNEYQNVSVLLSRTS------DQTVSLTQRTNAANSWGADYFL 
Paenibacillus polymyxa CwlU       LKVQQLAQNDPD-IQIVLTRNG------DTYPTLDERPQLANNQQASVFV 
E. coli K12 AmiA                  KNVRSILRNHG--IDARLTRSG------DTFIPLYDRVEIAHKHGADLFM 
E. coli K12 AmiC                  RRLRSLIEKEGN-MKVYMTRNE------DIFIPLQVRVAKAQKQRADLFV 
E. coli K12 AmiB                  RKLRTLLNDDPM-FKGVLTRDG------DYFISVMGRSDVARKQNANFLV 
B. subtilis 168 CwlB              KRVNTKLNASG--ALPVLSRSN------DTFYSLQERVNKAASAQADLFL 
B. anthracis 4229 pXO2-42         VRVQKLFAQKTP-FTALLTRDAYSRPGKNATDSLGKRVEFAKKNKGDIFV 
M. smegmatis mc2155 Ami2          SRLEGRMTAIG--MDTVLSRPP------NRSPSDAERAQTANGVGADLMI 
M. tuberculosis H37Rv Ami2        SRLEGRMAAIG--METHLSRPT------NRSPSDAERAATANAVGADLMI 
M. leprae TN Ami2                 SRLEGRMAAIG--IETFLSRTT------NGSPSDSERAAIANNVGAELMI 
M. tuberculosis H37Rv Ami1        LRLRAALNALG--VRTALSRGN----DNALGPCVDERANMANALRPNAIV 
M. leprae TN Ami1                 LQVRAALDGLG--VRTALSRGD----DTGLGPCVDARANMANALHPNASV 
M. smegmatis mc2155 Ami1          LRVRAALTALG--VRTAMSRGN----DNALGPCVDERAAMANSLRPHAIV 
                                    :.             ::*                *   *        : 
                                                           
                                                  
B. subtilis 168 CwlC              SIHVN----SGGGTGFESYIYPDVG------------------------- 
B. licherniformis CwlM            SIHMN----AGGGTGFEDYIYPGVG------------------------- 
Paenibacillus polymyxa CwlU       SIHGNSMPTSNNGKANGSETYYAR-------------------------- 
E. coli K12 AmiA                  SIHADGF-TNPKAAGASVFALSNRGASSAMAKYLSERENRADEVAGKKA- 
E. coli K12 AmiC                  SIHADAF-TSRQPSGSSVFALSTKGATSTAAKYLAQTQN-ASDLIGGVS- 
E. coli K12 AmiB                  SIHADAA-PNRSATGASVWVLSNRRANSEMASWLEQHEK-QSELLGGAGD 
B. subtilis 168 CwlB              SIHANAN-DSSSPNGSETYYDTTYQA------------------------ 
B. anthracis 4229 pXO2-42         SIHANGFNGNAHGTETFYYKAPTQKSNP---------------------- 
M. smegmatis mc2155 Ami2          SLRCATQ-PSPAANGVASFYFGNSHGSVS--------------------- 
M. tuberculosis H37Rv Ami2        SLRCETQ-TSLAANGVASFHFGNSHGSVS--------------------- 
M. leprae TN Ami2                 SLRCETQ-TSPAANGVASFHFGNSHGSVS--------------------- 
M. tuberculosis H37Rv Ami1        SLHADGG--PASGRGFHVNYSAPPLNAIQ--------------------- 
M. leprae TN Ami1                 SLHGDGG--PASGRGFHVIYSAPPLNPVQ--------------------- 
M. smegmatis mc2155 Ami1          SIHADGG--PPTGRGFHVLYSSPPLNAAQ--------------------- 
                                  *::                                                
                                  (H415) 
β1 α1 β2 β3 α2 
α2 β4 α3 β5 
β5 β6 α4 
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B. subtilis 168 CwlC              ------------------------APTTTYQSTIHSEVIQAVDFADRGKK 
B. licherniformis CwlM            ------------------------APTTTYRDIMHEEILKVVDFRDRGKK 
Paenibacillus polymyxa CwlU       ------------------------QESLSLATIMHKHLVAATEFKDNGIK 
E. coli K12 AmiA                  ----TDKDHLLQQVLFDLVQTDTIKNSLTLGSHILKKIKPVHKLHSRNTE 
E. coli K12 AmiC                  ----KSGDRYVDHTMFDMVQSLTIADSLKFGKAVLNKLGKINKLHKNQVE 
E. coli K12 AmiB                  VLANSQSDPYLSQAVLDLQFGHSQRVGYDVATSMISQLQRIGEIHKRRPE 
B. subtilis 168 CwlB              ------------------------ANSKRLAEQIQPKLAANLGTRDRGVK 
B. anthracis 4229 pXO2-42         ----------------------YVNDSRILAEKIQKRLITALQTRDRGVK 
M. smegmatis mc2155 Ami2          ------------------------TIGRNLADFIQREVVARTGLRDCRTH 
M. tuberculosis H37Rv Ami2        ------------------------TIGRNLADFIQREVVARTGLRDCRVH 
M. leprae TN Ami2                 ------------------------TIGRNLADFIQREIVARTGLRDCRTH 
M. tuberculosis H37Rv Ami1        -----------------------AGPSVQFARIMRDQLQASGIPKANYIG 
M. leprae TN Ami1                 -----------------------AGPSVQFARIMRDQLQASGIPPANYIG 
M. smegmatis mc2155 Ami1          -----------------------SGPSVQFAKVMRDQLAASGIPPATYIG 
                                                                   :  .:         
                                                      
                                                 
B. subtilis 168 CwlC              ------TANFHVLRESAMPALLTENGFIDTVSDANKLKTSSFIQSLARGH 
B. licherniformis CwlM            ------TANFHVLRETAMPALLTENGFVDNTNDAEKLKSSAFIQSIARGH 
Paenibacillus polymyxa CwlU       ------VANHVVTRKSQMPAVLLECGYLSNPSNEAAMFTEETQQKIAEGI 
E. coli K12 AmiA                  ------QAAFVVLKSPSVPSVLVETSFITNPEEERLLGTAAFRQKIATAI 
E. coli K12 AmiC                  ------QAGFAVLKAPDIPSILVETAFISNVEEERKLKTATFQQEVAESI 
E. coli K12 AmiB                  ------HASLGVLRSPDIPSVLVETGFISNNSEERLLASDDYQQQLAEAI 
B. subtilis 168 CwlB              ------TAAFYVIKYSKMPSVLVETAFITNASDASKLKQAVYKDKAAQAI 
B. anthracis 4229 pXO2-42         ------IGNLYVLRENTMPSVLTELGFVDNKADGKKLDSPEWRQRAAEAI 
M. smegmatis mc2155 Ami2          ------GRTWDLLRLTRMPTVQVDIGYITNPGDRGLLVSPQTRDAIAEGV 
M. tuberculosis H37Rv Ami2        ------GRTWDLLRLTRMPTVQVDIGYITNPHDRGMLVSTQTRDAIAEGI 
M. leprae TN Ami2                 ------GRTWDLLRLTRMPTVQIDIGYITNPRDRGVLIGTQNRDAIAEGI 
M. tuberculosis H37Rv Ami1        QDGLYGRSDLAGLNLAQYPSILVELGNMKNPADSALMESAEGRQKYANAL 
M. leprae TN Ami1                 QSGLCGRSDLAGLNLAQYSSILIELGNMKNPADSALMESSEGRKKYADAV 
M. smegmatis mc2155 Ami1          QGGLNPRSDIAGLNLAQFPSVLVECGNMKNPVDSALMKSPEGRQKYADAI 
                                               .    .::  : . : .  :   :      .  * .  
                                                       (E486) 
                                  
                                   
B. subtilis 168 CwlC              ANGLE  
B. licherniformis CwlM            ANGLA  
Paenibacillus polymyxa CwlU       VDGLK  
E. coli K12 AmiA                  AEGVI  
E. coli K12 AmiC                  LAGIK  
E. coli K12 AmiB                  YKGLR  
B. subtilis 168 CwlB              HDGT-  
B. anthracis 4229 pXO2-42         YAGIL  
M. smegmatis mc2155 Ami2          LAAVK  
M. tuberculosis H37Rv Ami2        LAAVK  
M. leprae TN Ami2                 LAAVK  
M. tuberculosis H37Rv Ami1        VRGVA  
M. leprae TN Ami1                 VRGVE  
M. smegmatis mc2155 Ami1          VRGIA  
                                    .   
α4 
β7 α5 β8 α6 α7 
α7 
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Figure D1: Clustal alignment of the amino acid sequences of amidases from various organisms. Alignments were 
carried out using Clustal Omega (http://www.ebi.ac.uk/Tools/msa/clustalO/). The conserved domains are 
highlighted in yellow (100% homologous) and turquoise (≥ 70% homologous).   A. Alignment of amidase_3 
domains, red boxes and red bold text indicate conserved catalytic H341, E355, H415 and E486 residues as well 
as the mycobacterial H341R, H415R and E486D substitutions in Ami2 (blue boxes). B. Alignment of amidase_2 
domains conserved catalytic residues (red boxes, red bold text). Shown are the conserved E104 and K159 catalytic 
residues in ami4 as well as the E104P and K159T substitutions in ami3 (blue boxes).  
B                                                            
                                                                                                                                 
E. coli K12 AmiD                -------YPRIKVLVIH---YTADDFDS----SLATLTDKQVSSHYLVPA  
E. coli K12 AmpD                ----RPDDETPTLLVVHNISLPPGEFGGPWIDALFTGTIDPQAHPFFAEI  
B. subtilis 168 XlyA            ---RPGYAMTPLYITVHNTANTAVGADAAAHARYLKNPDTTTSWHFTVD-  
B. subtilis 168 XlyB            ------NAMSAEYITIHNTAN---DASAANEISYMIGNTSSTSFHFAVD-  
M. smegmatis mc2155 Ami4        ---GHGDFKDIRGVMVHHTGSDTATAASIAN-GRPDLPGPLSQLHIARD-  
M. tuberculosis H37Rv Ami4      ---GHGDFRDIRGVMWHHTGNSRETAKSIAR-GRPDLPGPLANLHIAHS-  
M. smegmatis mc2155 Ami3        --IRAGIVHHTAGSNDYAPEDSAGIVRSIYEYHTRTLGWCDIAYNALVDK  
M. tuberculosis H37Rv Ami3      RGVRAAVVHHTAGSNDYSPLESAGIVKAIYTYHSKTLGWCDIAYNALVDK  
                                                :          .                  
                          
                                         
                                                                     
E. coli K12 AmiD                VPPRYNG-------KPRIWQLVPEQELAWHAGISA--WRGATRLNDTSIG  
E. coli K12 AmpD                AHLRVSAHCL-IRRDGEIVQYVPFDKRAWHAGVSQ--YQGRERCNDFSIG  
B. subtilis 168 XlyA            --------------DTEIYQHLPLNENGWHAGDG---NGSGNRA---SIG  
B. subtilis 168 XlyB            --------------DQEVIQGLPLNRNAWHTGDGT--NGPGNRK---SIG  
M. smegmatis mc2155 Ami4        ----------------GTVTIVAVG-VAWHAGVGMYPWIPANMGNWHLIG  
M. tuberculosis H37Rv Ami4      ----------------GVVTIVAVG-VCWHAGRGSYPWLPTDNANWHMIG  
M. smegmatis mc2155 Ami3        YGQVFEGRAGGMDRPVEGAHTGGFNRDTWGVAMMG----NFDAVPPTPIQ  
M. tuberculosis H37Rv Ami3      YGQVFEGSAGGLTKPVEGFHTGGFNRNTWGVAMIG----NFDDVAPTPIQ  
                                                            * ..                *  
 
                                  
                                                  
E. coli K12 AmiD                IELENRGWQKSAGVKYFAPFEPAQIQALIPLAKDIIARYHIKPENVVAHA  
E. coli K12 AmpD                IELEG---------TDTLAYTDAQYQQLAAVTRALIDCYPDIAKNMTGHC  
B. subtilis 168 XlyA            IEICE--------NADG--DFAKATANAQWLIKTLMAEHNISLANVVPHK  
B. subtilis 168 XlyB            VEICY--------SKSGGPKYEAAEALAISFVAQLLKERGWGIDRVRKHQ  
M. smegmatis mc2155 Ami4        IECANTGTSPTAPHR--QNWPDAQYFAMVRCCAAINRRLAQTSARTIGHK  
M. tuberculosis H37Rv Ami4      VECAWPTIRRDGSYDAGERWPDAQIVSMRDVAAALTLKLGYGPERNIGHK  
M. smegmatis mc2155 Ami3        LRTTGRLLGWRLGLDRIDPHGTVVLASEGGSFTHFPRGATPTLPAIFTHR  
M. tuberculosis H37Rv Ami3      IRTVGRLLGWRLGMDDVDPRSMVDLQSAGSSYTTFPGGAIARLPAIFTHR  
                                :.                                :             *  
                               (E104) 
 
                                
                                 
E. coli K12 AmiD                DIAP--QRKDDPGP-  
E. coli K12 AmpD                DIAP--DRKTDPGPA  
B. subtilis 168 XlyA            YWS----GKECPRK-  
B. subtilis 168 XlyB            DWS----GKYCPHR-  
M. smegmatis mc2155 Ami4        EYAGRAQGKWDPGA-  
M. tuberculosis H37Rv Ami4      EYAGAAQGKWDPGN-  
M. smegmatis mc2155 Ami3        DVG----NTDCPGNA  
M. tuberculosis H37Rv Ami3      DVG----NTDCPGNA  
                                  .     .  * 
                               (K159) 
 
β1                     α1                             β2   
β3  β4 β5                          β6       β7          β8     
β9        β10      β11                     α2                     α3 β12 α4 
α4 
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Figure D2.  Genotypic analysis of the Δami1 deletion strain by PCR and Southern blot analysis. The genomic map of the relevant locus is shown for the wild type mc2155 
and Δami1 strains. Also shown on the left is the PCR confirmation of the genotype and Southern blotting is shown on the right. For PCR confirmation, chromosomal DNA was 
used to amplify the ami1 alleles from the wild type and mutant strains using the primer pairs described in Table S3 and indicated by red arrows above. The expected sizes of 
the amplicons are as follows: ami1 - 608 bp and ∆ami1 - 327 bp. For Southern blot analysis, chromosomal DNA from the Single crossover (SCO), parental and mutant strain 
was digested with BamHI. The probe used for hybridisation is shown as a solid green box and the expected sizes are indicated by the blue arrows. Maps are not drawn to scale. 
This analysis was conducted in a previous MSc study (Senzani, 2014). 
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Figure D3. Deletion of ami1 does not affect growth kinetics, colony morphology and sliding motility. (A) Growth 
curve depicting the growth kinetics of the mc2155 and Δami1 strains. Error bars represent the standard deviation of 
three experiments. (B) I. Colony morphology of mc2155 and Δami1 on 7H10 agar. II. Sliding motility assays with the 
mc2155 and Δami1 strains. Shown is the sliding motility on M63 media containing 0.3 % agar. This analysis was 
conducted in a previous MSc study (Senzani, 2014). 
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Figure D4: PCR Screen of the mc2155::pAmi1GFP  and ∆ami1::pAmi1GFP strain. PCR screen for the 2 possible 
∆ami1::pAmi1GFP clones showing the expected PCR product size (1315 bp); Lane 1: Roche Marker VI, Lane 2: no 
template control and Lanes 3 and 4: mc2155::pAmi1GFP  clone 1 and 2 and Lanes 5 and 6 : ∆ami1::pAmi1GFP clone 
1 and 2. 
 
 
Figure D5: PCR Screen of the mc2155::pFtsZGFP and ∆ami1::pFtsZGFP strains. PCR screen for the 2 possible 
mc2155::pFtsZGFP and ∆ami1:: pFtsZGFP clones showing the expected PCR product size (695 bp); Lane 1: Roche 
Marker IV, Lane 2: no template control and Lanes 3 and 4: clone 1 and 2 for mc2155::pFtsZGFP and  Lanes 5 and 6: 
clone 1 and 2 for ∆ami1::pFtsZGFP. 
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Figure D6: diagrammatic representation of the merodiploid deletion protocol showing the steps involved in deleting 
the native ami2 allele beginning with the introduction of a functional ami2 gene at the attB site followed by the 
deletion of the native allele using homologues recombination (figure drawn by S. Senzani) 
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Figure D7: Transmission electron microscopy (TEM) of the mc2155 and ami2KDP strains. Shown is TEM 
depicting the formation of polar bulges in the ami2KDP strain grown in the absence of ATc (taken from MSc 
dissertation, Senzani, 2014). 
 
 
Figure D8: solid media growth morphology of the ami2KDP strain. (I) Shown is the colony formation phenotype of 
the ami2KDP strain grown on 7H10S containing 0 ng/ml ATc, displaying the formation of miniature malformed 
colonies and (II) the sliding morphology phenotype on media containing 0.3 % agar without ATc, resulting in the 
diffusion of bacterial cells into the media as oppose to growing on the surface as seen in the mc2155 and am2KDP 50 
ng/ml ATc plates (taken from MSc dissertation, Senzani, 2014). 
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Table D1: MIC of the mc2155, ∆ami1 and Δami1::pMVami1 strains 
Drug WT Δami1 Δami1::pMVami1 
Ampicillin 150 78  >1250 
Erythromycin 6.25 3.1 100 - 200 
Vancomycin 0.78 0.20 >50 
Rifampicin 0.625 0.3125 1.25 - 2.5 
Cefamandole 500 500 2000 
Cefoxitin 40 10 ≥80 
Cefotaxime 93.75 23 >750 
Ceftriaxone 250 62 >1000 
Cefapirin 50 25 800 - 1600 
D-cycloserine 32 62 32 
 
 
 
Figure D9: PCR Screen of the mc2155::pAmi2GFP and ∆ami1::pAmi2GFP strains. PCR screen for the 2 possible 
mc2155::pAmi2GFP and ∆ami1::pAmi2GFP clones showing the expected PCR product size (1786 bp); Lane 1: Roche 
Marker IV, Lane 2: no template control and Lanes 3 and 4: clone 1 and 2 for mc2155::pAmi2GFP and  Lanes 5 and 6: 
clone 1 and 2 for ∆ami1:: pAmi2GFP. 
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8.5 Appendix E – Movies 
All movies in this study can be found in the attached envelope, or downloaded from: 
https://mega.nz/#F!q3phHaKL!-ZRwWOp6YIE31_yYqYHIhA 
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